
<html lang="en"     class="pb-page"  data-request-id="e91d9f3d-c86e-4ac2-b28e-4ded3794e37b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.7b01371;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-3;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo" /></meta><meta name="dc.Creator" content="Juraj  Velcicky" /></meta><meta name="dc.Creator" content="Ursula  Bodendorf" /></meta><meta name="dc.Creator" content="Pascal  Rigollier" /></meta><meta name="dc.Creator" content="Robert  Epple" /></meta><meta name="dc.Creator" content="Daniel R.  Beisner" /></meta><meta name="dc.Creator" content="Danilo  Guerini" /></meta><meta name="dc.Creator" content="Philip  Smith" /></meta><meta name="dc.Creator" content="Bo  Liu" /></meta><meta name="dc.Creator" content="Roland  Feifel" /></meta><meta name="dc.Creator" content="Peter  Wipfli" /></meta><meta name="dc.Creator" content="Reiner  Aichholz" /></meta><meta name="dc.Creator" content="Philippe  Couttet" /></meta><meta name="dc.Creator" content="Ina  Dix" /></meta><meta name="dc.Creator" content="Toni  Widmer" /></meta><meta name="dc.Creator" content="Ben  Wen" /></meta><meta name="dc.Creator" content="Trixi  Brandl" /></meta><meta name="dc.Description" content="Signal peptide peptidase-like 2a (SPPL2a) is an aspartic intramembrane protease which has recently been shown to play an important role in the development and function of antigen presenting cells s..." /></meta><meta name="Description" content="Signal peptide peptidase-like 2a (SPPL2a) is an aspartic intramembrane protease which has recently been shown to play an important role in the development and function of antigen presenting cells s..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 23, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01371" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2018 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01371" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01371" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01371" /></link>
        
    
    

<title>Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01371" /></meta><meta property="og:title" content="Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0014.jpeg" /></meta><meta property="og:description" content="Signal peptide peptidase-like 2a (SPPL2a) is an aspartic intramembrane protease which has recently been shown to play an important role in the development and function of antigen presenting cells such as B lymphocytes and dendritic cells. In this paper, we describe the discovery of the first selective and orally active SPPL2a inhibitor (S)-2-cyclopropyl-N1-((S)-5,11-dioxo-10,11-dihydro-1H,3H,5H-spiro[benzo[d]pyrazolo[1,2-a][1,2]diazepine-2,1′-cyclopropan]-10-yl)-N4-(5-fluoro-2-methylpyridin-3-yl)succinamide 40 (SPL-707). This compound shows adequate selectivity against the closely related enzymes γ-secretase and SPP and a good pharmacokinetic profile in mouse and rat. Compound 40 significantly inhibited processing of the SPPL2a substrate CD74/p8 fragment in rodents at doses ≤10 mg/kg b.i.d. po. Oral dosing of 40 for 11 days at ≥10 mg/kg b.i.d. recapitulated the phenotype seen in Sppl2a knockout (ko) and ENU mutant mice (reduced number of specific B cells and myeloid dendritic cells). Thus, we believe that SPPL2a represents an interesting and druggable pharmacological target, potentially providing a novel approach for the treatment of autoimmune diseases by targeting B cells and dendritic cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01371"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01371">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01371&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01371&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01371&amp;href=/doi/10.1021/acs.jmedchem.7b01371" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 865-880</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01340" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01402" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juraj++Velcicky">Juraj Velcicky</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-6564-1448" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ursula++Bodendorf">Ursula Bodendorf</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Rigollier">Pascal Rigollier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Epple">Robert Epple</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+R.++Beisner">Daniel R. Beisner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol "><sup>¢</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Danilo++Guerini">Danilo Guerini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Smith">Philip Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bo++Liu">Bo Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roland++Feifel">Roland Feifel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Wipfli">Peter Wipfli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reiner++Aichholz">Reiner Aichholz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Couttet">Philippe Couttet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ina++Dix">Ina Dix</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Toni++Widmer">Toni Widmer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Wen">Ben Wen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Trixi++Brandl">Trixi Brandl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Global Discovery Chemistry, <sup>‡</sup>Autoimmunity Transplantation Inflammation, <sup>§</sup>Pharmacokinetic Sciences, <sup>∥</sup>Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">⊥</span> <span class="aff-text">The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">#</span> <span class="aff-text">Chemical and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div><div class="corresp-info"><strong>*</strong> Phone: +41-61-3243399. E-mail: <a href="/cdn-cgi/l/email-protection#ee849b9c8f84c0988b828d878d8597ae8081988f9c9a879dc08d8183"><span class="__cf_email__" data-cfemail="6c06191e0d06421a09000f050f07152c02031a0d1e18051f420f0301">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01371&amp;href=/doi/10.1021%2Facs.jmedchem.7b01371" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 865–880</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 23, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 September 2017</li><li><span class="item_label"><b>Published</b> online</span>23 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 February 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01371" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01371</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ec-1612971054143.svg" alt="ACS Editors’ Choice" /></img><span>ACS Editors’ Choice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01371"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5360</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01371" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Juraj&quot;,&quot;last_name&quot;:&quot;Velcicky&quot;},{&quot;first_name&quot;:&quot;Ursula&quot;,&quot;last_name&quot;:&quot;Bodendorf&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Rigollier&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Epple&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;R. Beisner&quot;},{&quot;first_name&quot;:&quot;Danilo&quot;,&quot;last_name&quot;:&quot;Guerini&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Bo&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;Feifel&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Wipfli&quot;},{&quot;first_name&quot;:&quot;Reiner&quot;,&quot;last_name&quot;:&quot;Aichholz&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Couttet&quot;},{&quot;first_name&quot;:&quot;Ina&quot;,&quot;last_name&quot;:&quot;Dix&quot;},{&quot;first_name&quot;:&quot;Toni&quot;,&quot;last_name&quot;:&quot;Widmer&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Trixi&quot;,&quot;last_name&quot;:&quot;Brandl&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;865-880&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01371&quot;},&quot;abstract&quot;:&quot;Signal peptide peptidase-like 2a (SPPL2a) is an aspartic intramembrane protease which has recently been shown to play an important role in the development and function of antigen presenting cells such as B lymphocytes and dendritic cells. In this paper, we describe the discovery of the first selective and orally active SPPL2a inhibitor (S)-2-cyclopropyl-N1-((S)-5,11-dioxo-10,11-dihydro-1H,3H,5H-spiro[benzo[d]pyrazolo[1,2-a][1,2]diazepine-2,1′-cyclopropan]-10-yl)-N4-(5-fluoro-2-methylpyridin-3-yl)succinamide 40 (SPL-707). This compound shows adequate selectivity against the closely related enzymes γ-secretase and SPP and a good pharmacokinetic profile in mouse and rat. Compound 40 significantly inhibited processing of the SPPL2a substrate CD74/p8 fragment in rodents at doses ≤10 mg/kg b.i.d. po. Oral dosing of 40 for 11 days at ≥10 mg/kg b.i.d. recapitulated the phenotype seen in Sppl2a knockout (ko) and ENU mutant mice (reduced number of specific B cells and myeloid dendritic cells). Thus, we believe that SPP&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01371&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01371" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01371&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01371" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01371&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01371" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01371&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01371&amp;href=/doi/10.1021/acs.jmedchem.7b01371" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01371" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01371" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01371%26sid%3Dliteratum%253Aachs%26pmid%3D29359565%26genre%3Darticle%26aulast%3DVelcicky%26date%3D2018%26atitle%3DDiscovery%2Bof%2Bthe%2BFirst%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BSignal%2BPeptide%2BPeptidase-Like%2B2a%2B%2528SPPL2a%2529%2BInhibitor%2BDisplaying%2BPronounced%2BImmunomodulatory%2BEffects%2BIn%2BVivo%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D3%26spage%3D865%26epage%3D880%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290694" title="Bioluminescent probes">Bioluminescent probes</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/jmcmar.2018.61.issue-3/20180208/jmcmar.2018.61.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Signal peptide peptidase-like 2a (SPPL2a) is an aspartic intramembrane protease which has recently been shown to play an important role in the development and function of antigen presenting cells such as B lymphocytes and dendritic cells. In this paper, we describe the discovery of the first selective and orally active SPPL2a inhibitor (<i>S</i>)-2-cyclopropyl-<i>N</i>1-((<i>S</i>)-5,11-dioxo-10,11-dihydro-1<i>H</i>,3<i>H</i>,5<i>H</i>-spiro[benzo[<i>d</i>]pyrazolo[1,2-<i>a</i>][1,2]diazepine-2,1′-cyclopropan]-10-yl)-<i>N</i>4-(5-fluoro-2-methylpyridin-3-yl)succinamide <b>40</b> (<b>SPL-707</b>). This compound shows adequate selectivity against the closely related enzymes γ-secretase and SPP and a good pharmacokinetic profile in mouse and rat. Compound <b>40</b> significantly inhibited processing of the SPPL2a substrate CD74/p8 fragment in rodents at doses ≤10 mg/kg b.i.d. po. Oral dosing of <b>40</b> for 11 days at ≥10 mg/kg b.i.d. recapitulated the phenotype seen in Sppl2a knockout (ko) and ENU mutant mice (reduced number of specific B cells and myeloid dendritic cells). Thus, we believe that SPPL2a represents an interesting and druggable pharmacological target, potentially providing a novel approach for the treatment of autoimmune diseases by targeting B cells and dendritic cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Regulated intramembrane proteolysis (RIP) is one of the processes controlling communication between cells and the extracellular environment.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> RIP is mediated by a special family of proteases, the intramembrane cleaving proteases (I-CLiPs), which control signaling pathways by cleaving the transmembrane region of their substrates into extracellular and intracellular domains.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Depending on their catalytic center, metallo, aspartyl, and serine I-CLiPs have been described.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The most prominent and best characterized member of this enzyme class is γ-secretase, an aspartyl I-CLiP involved in the generation of the Aβ peptide from the amyloid precursor protein (APP), which is found in amyloid plaques in the brain of Alzheimer disease patients and thus is involved in the pathology of Alzheimer’s disease.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> SPPL2a (signal peptide peptidase-like 2a) has recently been described as an enzyme related to presenilins, the catalytic subunit of γ-secretase.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> SPPL2a is an aspartyl I-CLiP mainly located in the membrane of endosomes,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> containing nine transmembrane domains (TMD) bearing the two catalytic aspartates on TMD6 and TMD7. It belongs to the signal peptide peptidase/signal peptide peptidase-like (SPP/SPPL) family of aspartic intramembrane proteases which includes SPP, SPPL2a, SPPL2b, SPPL2c, and SPPL3. Whereas the topology of the γ-secretase complex enables cleavage of type I transmembrane proteins, members of the SPP/SPPL family cleave type II transmembrane proteins. In addition, γ-secretase is known as a complex, with presenilin being the catalytically active part and three other proteins (nicastrin, presenilin enhancer 2 (Pen-2) and anteriorpharynx-defective 1 (Aph-1), while SPPL2a does not seem to require any additional cofactors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> SPPL2a was initially shown to be engaged in the processing of the TNFα <i>N</i>-terminal fragment (NTF) in vitro, leading to IL-12 production in human dendritic cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> SPPL2a cleavage of type II membrane proteins like TNFα requires a prior shedding of their ectodomain by sheddases (mainly metalloproteases such as, e.g., ADAM 10 or ADAM17),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> a process which generates the actual SPPL2a substrates, the remaining membrane bound NTF.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Several type II-oriented transmembrane proteins including FasL/CD95,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Bri2(Itm2b),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> CD74,<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> TMEM106B,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and NRG1 type III,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and even a type III protein FVenv (viral),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> were shown to be processed by SPPL2a. To date, however, the NTF of CD74 (invariant chain of the major histocompatibility complex II, MHC-II) is the only substrate shown to be cleaved by SPPL2a in vivo.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> Prior to cleavage by SPPL2a, CD74 is processed sequentially by several proteases, including cathepsin S, which is necessary for the generation of the CLIP peptide, which plays an important role in MHC-II associated antigen presentation. Processing of full-length CD74 finally leads to the generation of the <i>N</i>-terminal 8 kDa CD74, p8 (CD74/p8) transmembrane fragment, which in turn is further processed by SPPL2a generating a short cytoplasmic peptide p4 (4 kDa). Studies in SPPL2a deficient mice showed that accumulation of nonphysiological amounts of CD74/p8 leads to an arrest of splenic B cell maturation, resulting in the depletion of mature B cells. In addition, accumulation of p8 leads to a strong reduction in myeloid dendritic cell (mDC) numbers in SPPL2a-deficient mice.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> However, in Sppl2a/CD74 double knockout (ko) mice, the development of mature B cells and mDCs was restored,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> indicating that the accumulation of the CD74/p8 fragment has a detrimental effect on the development of antigen presenting cells like B cells and mDCs. The disturbed B cell development observed upon inhibition of SPPL2a correlates with an impaired tonic B cell receptor, and the accumulation of the CD74/p8 negatively impacts the PI3K/Akt signaling pathway, leading to activation of pro-apoptotic genes p21, p27, and Bim in B220<sup>+</sup> cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These results suggest that SPPL2a is strongly involved in the regulation of the adaptive immunity, and thus by inhibiting SPPL2a it might be possible to reduce its antigen presenting capacity.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Such a reduction could be therapeutically beneficial in autoimmune diseases, among others rheumatoid arthritis or multiple sclerosis, where presentation of autoantigens is a strong driver of the pathology.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> To further investigate the effect of SPPL2a inhibition on the immune system, we aimed to develop an orally available, selective, low molecular weight SPPL2a inhibitor, and our results are disclosed in this publication.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">SPPL2a is an aspartyl i-CLiP related to presenilin, the catalytic subunit of the γ-secretase complex. For decades, γ-secretase was an important target explored by many pharmaceutical companies interested in the discovery of a low molecular weight inhibitor for the treatment of Alzheimer’s disease and cancer.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Thanks to these efforts, several γ-secretase inhibitors were developed and reached the clinic. Besides the amyloid precursor protein (APP) whose proteolysis by γ-secretase leads to β-amyloid (Aβ) formation, the primary component of the amyloid plaques found in the brain of Alzheimer disease patients, Notch is another prominent γ-secretase substrate class.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Aberrant Notch1 signaling is implicated in different cancer subtypes and therefore focus of several clinical investigations of γ-secretase inhibitors for the treatment of cancer.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, inhibition of Notch signaling bares the risk of serious side effects including severe intestinal toxicity or development of skin cancer as seen in Alzheimer patients treated with γ-secretase inhibitors.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Recently, it was shown that some γ-secretase inhibitors are only partially selective and inhibit also SPPL-family members.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Therefore, we have tested several literature described γ-secretase inhibitors for their effect on SPPL2a along with <b>41</b> (<b>Z</b>-<b>LL</b><sub><b>2</b></sub>),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> a literature known SPPL2a inhibitor. A reporter gene assay (RGA) was used to evaluate the inhibition of the SPPL2a activity. The assay uses HEK293 cells cotransfected with expression vectors for human SPPL2a, TNFα-NTF fused to the VP16 transactivation domain, Gal4 transcription factor, and a Gal4-driven luciferase reporter plasmid. In the absence of an SPPL2a inhibitor, the <i>N</i>-terminal fragment of the cleaved substrate fused to VP16/Gal4 translocates into the nucleus and drives expression of luciferase which is assessed by luminescent measurement. The same assay format was used also for the assessment of the inhibitory effect on γ-secretase mediated cleavage of Notch1. However, in this case, only a Notch1-based substrate fused to VP16/Gal4 and the luciferase reporter plasmid are cotransfected into HEK293 cells, which bear endogenous γ-secretase activity.</div><div class="NLM_p">While <b>41</b> was highly potent on SPPL2a with a selectivity of >1000 against γ-secretase processing of Notch1 (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), its peptidic nature and the presence of a ketone functionality discouraged us to further optimize this scaffold. On the other hand, the γ-secretase inhibitor <b>42</b> (<b>LY-411,575</b>)<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> displays more drug like properties<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and its high potency on SPPL2a in the low nanomolar range made it an appealing starting point. Even if <b>42</b> inhibits γ-secretase mediated Notch1 processing with a significantly lower, subnanomolar IC<sub>50</sub> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), replacement of the dibenzoazepinone in <b>42</b> with a benzodiazepinone tricycle<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and the use of a succinate instead of an α-amino acid backbone provided compound <b>30</b>, which kept the SPPL2a potency while losing γ-secretase activity. The new scaffold seemed fairly modular for achieving our goal, i.e., finding a selective, orally available SPPL2a inhibitor.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potential Starting Points for Optimization of SPPL2a Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">hSPPL2a<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> RGA [μM]</th><th class="colsep0 rowsep0" align="center">γ-secretase<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> RGA [μM]</th><th class="colsep0 rowsep0" align="center">selectivity (γ-secretase/hSPPL2a)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char="±">0.006 ± 0.004</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>1666</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char="±">0.010 ± 0.005</td><td class="colsep0 rowsep0" align="center"><0.0003</td><td class="colsep0 rowsep0" align="center"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char="±">0.005 ± 0.001</td><td class="colsep0 rowsep0" align="center">0.017 ± 0.004</td><td class="colsep0 rowsep0" align="center">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in HEK293 cells cotransfected with TNFα-NTF/VP16-GAL4 fusion, human SPPL2a, and the Gal4-driven luciferase reporter plasmid. Luciferase expression was assessed by luminescent measurement.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in HEK293 cells cotransfected with Notch1-VP16-GAL4 fusion and Gal4-driven luciferase reporter plasmid; Gal4 driven Luciferase expression assessed by luminescent measurement. RGA = reporter gene assay.</p></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The tricycles were accessed by formation of the central diazepinone ring (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Compound <b>2</b> was synthesized by a cyclization of pyrazolidine<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> with a chloro-ester <b>1</b> being prepared by thionyl chloride mediated ring opening of isochromanone.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The primary amine in <b>4</b> was introduced by oxime (<b>3</b>) formation followed by its reduction. The required (<i>S</i>)-amine <b>7</b> was obtained by chiral separation of <i>rac</i>-Boc-amine <b>5</b> using preparative chiral SFC and acidic cleavage of the Boc-group in <b>6</b>. RuO<sub>2</sub>-mediated oxidation<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> of the benzylic position in <b>6</b> led to compound <b>8</b>, which provided an enantiomerically pure oxo-analogue <b>9</b> after cleavage of the Boc-protecting group.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Tricyclic Amines <b>7</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, 0 °C to rt, 16 h (96%); (b) pyrazolidine·2HCl, DIPEA, NaI, NaOAc, DMF, rt, 16 h (57%); (c) LiHMDS, <i>i</i>-pentyl-ONO, THF, 0 °C, 2 h (67%); (d) Zn, HCl, AcOH, rt, 2 h; (e) Boc<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, rt, 16 h; (f) chiral separation using preparative chiral SFC (37% over 3 steps); (g) HCl, dioxane/CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (94–99%); (h) RuO<sub>2</sub>·H<sub>2</sub>O (cat.), NaIO<sub>4</sub>, EtOAc/H<sub>2</sub>O, rt, 15 min (91%).</p></p></figure><div class="NLM_p">Fluoro-tricyclic amine <b>15</b> was prepared from fluoroisochromanone <b>11</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) using the synthesis described for <b>7</b>. The prerequisite 8-fluoro-isochromane-3-one (<b>11</b>) was synthesized starting from 2-bromo-6-fluorobenzoic acid by a copper mediated introduction of a carboethoxymethyl group,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> followed by chemoselective NaBH<sub>4</sub> reduction of the acid <b>10</b> upon its activation to a mixed anhydride and TsOH cyclization. A spiro-cyclopropyl analogue of the oxo-tricycle <b>9</b> was prepared according to the same route as described for <b>7</b>, with the exception that the intermediate <b>17</b> was obtained by cyclization<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> of homophthalic anhydride with spiro-cyclopropyl pyrazolidine <b>16</b>. This intermediate (<b>16</b>) was prepared from cyclopropanedimethanol by its activation into bismesylate, followed by its reaction with <i>N</i>,<i>N</i>′-di-Boc-hydrazine and cleavage of Boc-protecting groups.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Fluoro and Cyclopropyl Tricyclic Amines <b>15</b> and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOEt/EtOH, CuBr, reflux, 2 h (92%); (b) (1) EtOOCCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h, (2) NaBH<sub>4</sub>, THF/H<sub>2</sub>O, −15 °C, 1 h, (3) TsOH·H<sub>2</sub>O (cat.), PhMe, 80 °C, 1 h (77%); (c) SOCl<sub>2</sub>, MeOH, 0 °C to rt, 16 h (77%); (d) pyrazolidine·2HCl, DIPEA, NaI, NaOAc, DMF, 200 °C, 10 min (40%); (e) LiHMDS, <i>i</i>-pentyl-ONO, THF, 0 °C, 2 h (used in the next step); (f) H<sub>2</sub> (4 bar), Pd/C, HCl, EtOH, rt, 16 h (quantitative over two steps); (g) (1) Boc<sub>2</sub>O, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, (2) chiral separation using preparative chiral HPLC (44%); (h) HCl, dioxane/CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 2 h (100%); (i) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 16 h (59%); (j) NaH, (BocNH)<sub>2</sub>, DMF, rt, 16 h (93%); (k) HBr/AcOH, Et<sub>2</sub>O, rt, 16 h (91%); (l) homophthalic anhydride, AcOH/py, 130 °C, 20 h (69%); (m) Zn, HCl, AcOH, rt, 2 h (55%); (n) (1) Boc<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, rt, 2 h, (2) chiral separation using preparative chiral SFC (48%).</p></p></figure><div class="NLM_p">The required chiral succinates were prepared using the Evans auxiliary method<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> developed for preparation of enantiomerically pure α-branched aliphatic carboxylic acids (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Accordingly, the acylated (<i>S</i>)-oxazolidines (<b>19</b> and <b>22</b>) were stereoselectively alkylated with <i>t</i>-Bu bromoacetate and the desired monoprotected succinates <b>21</b> and <b>24</b> were obtained with high diastereoselectivity (as assessed by <sup>1</sup>H NMR of <b>20</b> and <b>23</b>) after cleavage of the chiral auxiliary in intermediates <b>20</b> and <b>23</b>. These acids were subsequently attached to the tricyclic amines by amide coupling. After hydrolysis of the <i>t</i>-Bu ester, aromatic amines were introduced by amide coupling employing either EDC in pyridine or by activation of the acid with MsCl. Such conditions were required to complete the coupling with a reasonable yield because most of the used anilines were poor nucleophiles. In the case of <i>o</i>-toluidine, HATU as a coupling reagent also provided the corresponding product <b>31</b> in a good yield. The absolute stereochemistry of the SPPL2a active compounds was unambiguously determined by the X-ray crystal structure obtained for <b>40</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Succinates and Completion of the Molecules<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) cyclo-Pr-CH<sub>2</sub>COOH, EDC, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (86%); (b) NaHMDS, THF, −78 °C, 1 h, then <i>t</i>-BuOOCCH<sub>2</sub>Br, −78 °C, 1 h (54–75%); (c) LiOH, H<sub>2</sub>O<sub>2</sub>, THF/H<sub>2</sub>O, 0 °C, 2 h (70–91%); (d) TOTU, DIPEA, CH<sub>3</sub>CN, rt, 16 h (<b>25</b> and <b>27</b>, 64–95%); (e) EDC, py, rt, 4–18 h (<b>26</b> and <b>28</b>, 80–89%); (f) HATU, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (<b>29</b>, 82%); (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (80–98%); (h) Ar-NH<sub>2</sub>, EDC, py, rt, 16 h (<b>30</b>, <b>32</b>–<b>34</b>, <b>36</b>–<b>40</b>, 50–78%); (i) Ar-NH<sub>2</sub>, HATU, DIPEA, DMF, rt, 2 h (<b>31</b>, 60%); (j) Ar-NH<sub>2</sub>, 1-Me-1<i>H</i>-imidazole, MsCl, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (<b>35</b>, 58%).</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Optimization</h3><div class="NLM_p">The initial optimization was focused on improving the selectivity against γ-secretase. SAR around the aniline part revealed that this region was very sensitive for both SPPL2a activity and γ-secretase selectivity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). While the methyl substituent in the <i>ortho</i>-position (<b>31</b>) was tolerated by SPPL2a, the γ-secretase activity was negatively influenced, leading to the first nonpeptidic SPPL2a inhibitor with decent γ-secretase selectivity. In contrast, the methyl substituent in <i>para</i>-position was not well accepted by SPPL2a, but such an analogue (<b>33</b>) was potently inhibiting γ-secretase. Interestingly, the <i>meta</i>-substituent (<b>32</b>) seemed to be still tolerated by SPPL2a while it was less potent on γ-secretase, thus providing some degree of selectivity against γ-secretase also by <i>meta</i>-substitution. Without any structural information, it is difficult to fully understand what drives the SPPL2a selectivity. Still, one may speculate that in SPPL2a there is a pocket fitting the <i>ortho</i>-substituent which seems to be shifted toward the <i>para</i>-position in γ-secretase. In addition, in SPPL2a the pocket must be of a limited size as already trifluoromethyl substituent is detrimental for SPPL2a activity as exemplified by <b>34</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Improvement in Selectivity against γ-Secretase by Variation of the Aromatic Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in HEK293 cells cotransfected with TNFα-NTF/VP16-GAL4 fusion, human SPPL2a, and the Gal4-driven luciferase reporter plasmid. Luciferase expression was assessed by luminescent measurement.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in HEK293 cells cotransfected with Notch1-VP16-GAL4 fusion and Gal4-driven luciferase reporter plasmid; Gal4 driven luciferase expression assessed by luminescent measurement. RGA = reporter gene assay, nd = not determined.</p></div></div><div></div></div><div class="NLM_p">Further in vitro profiling of <b>31</b>, at that stage the most promising compound, showed that it also blocked the SPPL2a dependent processing of the CD74/p8 fragment in the mouse B cell line A20 with an IC<sub>50</sub> of 0.37 μM (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). It means that the endogenous SPPL2a and the cleavage of its endogenous, in vivo relevant substrate could be potently inhibited by <b>31</b>. Moreover, <b>31</b> also kept activity in a CD74/p8-based mouse whole blood assay (see methods for detailed assay description) with an IC<sub>50</sub> of 0.55 μM. In addition, <b>31</b> showed favorable pharmacokinetic parameters in mice (clearance, 46 mL/min/kg; Vss, 1.2 L/kg; <i>t</i><sub>1/2</sub>, 0.7 h; <i>F</i>, ∼100%, AUC<sub>po dn</sub>, 908 h·nM), which allowed to assess its in vivo effects on SPPL2a mediated processing of the CD74/p8 fragment. Oral dosing of <b>31</b> or <b>42</b> to mice resulted in a pronounced accumulation of the SPPL2a substrate CD74/p8 in splenocytes of treated mice 4 h after compound administration (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Even a single 10 mg/kg oral dose of <b>31</b> strongly inhibited CD74/p8 processing at an average terminal spleen concentration of 127 ± 37 nM at the 4 h time point (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B), which was already below the determined whole blood activity of <b>31</b>. This probably led to the observed higher variability within the 10 mg/kg dosing group. However, even in the 10 mg/kg dose group, the exposure of <b>31</b> was long enough above the critical concentration necessary to inhibit SPPL2a in vivo to enable visible CD74/p8 accumulation. In addition, the expression of Hes1 mRNA, a direct Notch1 target gene and established biomarker for monitoring Notch1 mediated toxicity,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> was assessed in jejunum and thymus from the same animals (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C). The data showed that <b>31</b> did not affect Notch1 processing at any dose. On the contrary, a significant reduction of Hes1 mRNA levels were observed in mice treated with <b>42</b>, indicative of γ-secretase inhibition and as a consequence of perturbed Notch1 signaling (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C). This indicates that a 50-fold selectivity over γ-secretase, as measured in our cellular assays, was sufficient to avoid the unwanted side effects caused by inhibition of Notch1 processing in vivo even at the 100 mg/kg dose.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selective SPPL2a inhibitor <b>31</b> inhibits CD74/p8 processing in vivo and spares γ-secretase activity. (A) Mice (<i>n</i> = 3 per group) received either a single oral dose of 100 mg/kg <b>42</b> or 10, 30, and 100 mg/kg of SPPL2a selective inhibitor <b>31</b>. In vivo inhibition of SPPL2a was assessed by measuring CD74/p8 accumulation in splenocytes 4 h later. CD74 full-length (FL) and CD74/p8 were detected by Western blot analysis of splenocyte lysates (with an antimouse CD74 antibody, shown on the left; quantification of the p8 bands relative to the reference <b>42</b> and normalized to FL CD74 are shown on the right; each lane on the Western blot corresponds to an individual animal). (B) Total plasma and spleen concentrations (means ± SEM) of <b>31</b> at termination of the study (4 h after single oral dosing). (C) In vivo inhibition of γ-secretase was assessed by mRNA levels of Hes1 in thymus and jejunum. Statistics are one-way ANOVA followed by Dunnett’s test compared to matched vehicle group: * <i>p</i> ≤ 0.05; ** <i>p</i> ≤ 0.01; *** <i>p</i> ≤ 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To evaluate the reversibility of SPPL2a inhibition and accumulation of CD74/p8, an in vitro washout experiment was performed (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In this experiment, B cells were incubated with <b>31</b> for 16 h to allow maximal accumulation of CD74/p8. Then the cells were washed with medium lacking inhibitor and further incubated at 37 °C for up to 2 h and subsequently analyzed for remaining p8 levels by Western blotting. The kinetic analysis showed a fast reversibility of the CD74/p8 accumulation with a 50% reduction within ∼25 min after washout, and a reduction to undetectable levels after 2 h. These data demonstrate that inhibition of SPPL2a with compound <b>31</b> is reversible. It indicates that a continuous inhibition of SPPL2a in vivo is needed for ensuring a robust accumulation of CD74/p8, a process required for a functional in vivo effect, e.g., a reduction of B cells and dendritic cells as described for Sppl2a deficient mice.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> On the basis of this hypothesis, the PK parameters of <b>31</b> (clearance and <i>t</i><sub>1/2</sub>) in mouse and rat appeared suboptimal and, consequently, high doses would be required to reach a prolonged high level of SPPL2a inhibition in vivo, essential for testing in chronic animal models. Therefore, <b>31</b> was not considered for the exploration of the pharmacological effects of an SPPL2a inhibitor in a broad range of chronic animal models and focus was shifted toward the further improvement of the PK parameters.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CD74/p8 accumulation is reversible upon inhibitor withdrawal. The mouse B cell line A20 was incubated in vitro with 2 μM <b>31</b> for 16 h to achieve maximal CD74/p8 accumulation. Subsequently, cells were washed in medium without inhibitor and either lysed directly (time point 0) or further incubated for up to 120 min without inhibitor and analyzed for remaining p8 levels by Western blotting using an antimouse CD74 antibody. p8 Bands were quantified using a ChemiDoc TM MP imaging system and evaluated with Image Lab 4.1 (BioRad). Data are blotted relative to the p8 levels detected at 0 h (all data points were determined in duplicate, the p8 band with the highest intensity was set arbitrarily to 100%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For further compound optimization toward lower total clearance, the metabolism of unlabeled <b>31</b> was examined following incubations with liver microsomes from mouse (MLM), rat (RLM), and human (HLM). The results, summarized in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, suggested that <b>31</b> was metabolized more rapidly in human liver microsomes but leading to the same metabolic profile compared to rodent’s liver microsomes (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The structure of the identified metabolites were proposed based on elemental composition, fragmentation relative to the parent compound, and number of exchangeable hydrogen atoms. The investigation proposed metabolism of <b>31</b> by aromatic and aliphatic C-hydroxlyation which affects mainly the aniline (m3, m4) and the tricycle part (m2, m5–m8) while the linker moiety remained unaffected.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Metabolite profiling study on <b>31</b> in liver microsomes. <b>31</b> was incubated at 37 °C for 60 min with liver microsomes from human, rat, and mouse. The structure of the identified metabolites was proposed based on elemental composition, fragmentation relative to the parent compound, and number of exchangeable hydrogen atoms. <i>P</i> = parent, m = metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Uncorrected Relative Peak Area of <b>31</b> and Metabolites Observed with Incubation of Liver Microsomes of Mouse, Rat, and Human</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="9" align="center" char=".">uncorrected relative peak area (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">metabolite</th><th class="colsep0 rowsep0" align="center" char=".">m1 (<b>25</b>)</th><th class="colsep0 rowsep0" align="center" char=".">m2</th><th class="colsep0 rowsep0" align="center" char=".">m3</th><th class="colsep0 rowsep0" align="center" char=".">m4</th><th class="colsep0 rowsep0" align="center" char=".">m5</th><th class="colsep0 rowsep0" align="center" char=".">m6</th><th class="colsep0 rowsep0" align="center" char=".">m7</th><th class="colsep0 rowsep0" align="center" char=".">m8</th><th class="colsep0 rowsep0" align="center" char=".">P (<b>31</b>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MLM<a class="ref internalNav" href="#t3fn2" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">92.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RLM<a class="ref internalNav" href="#t3fn3" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="."><0.1</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">93.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM<a class="ref internalNav" href="#t3fn4" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">70.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn2"><div class="footnote" id="t3fn2"><sup>a</sup><p class="last">Liver microsomes: mouse.</p></div><div class="footnote" id="t3fn3"><sup>b</sup><p class="last">Liver microsomes: rat.</p></div><div class="footnote" id="t3fn4"><sup>c</sup><p class="last">Liver microsomes: human.</p></div></div></div><div class="NLM_p">In addition to the oxidative metabolism, a proteolytic amide cleavage was observed which leads to metabolite m1 (<b>25</b>) at low abundance. By formation of carboxylic acid <b>25</b>, the release of <i>o</i>-toluidine can be assumed. This metabolite is a known carcinogen suspected of causing bladder cancer.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Therefore, the aromatic amine had to be replaced (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). While the exact mechanism leading to the mutagenic effect of anilines is not yet fully understood, it seems that DNA damage mediated by oxidative <i>o</i>-toluidine metabolites (<i>o</i>-nitrosotoluene and 4-amino-3-methylphenol) is responsible for its carcinogenicity.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> There is a general agreement that the carcinogenicity of aromatic amines is mainly driven by their metabolic <i>N</i>-oxidation into corresponding <i>N</i>-hydroxylamines. Such species can further be <i>O</i>-conjugated by acetylation or sulfonylation which, after cleavage, leads to a nitrenium ion that reacts with and modifies DNA.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Mutagenicity of aromatic amines was shown to increase with increasing lipophilicity, a parameter that might indicate the ability of chemicals to undergo metabolism required for their activation.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Hence, more polar, heterocyclic amines were explored and combined with the <i>ortho</i>-methyl substituent required for γ-secretase selectivity (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Optimization of the Aromatic Amine Part for Improvement in Properties<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn7"><div class="footnote" id="t4fn7"><sup>Table g</sup><p class="last">*Single experiment.</p></div><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in HEK293 cells cotransfected with TNFα-NTF/VP16-GAL4 fusion, human SPPL2a, and the Gal4-driven luciferase reporter plasmid. Luciferase expression was assessed by luminescent measurement;</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in HEK293 cells cotransfected with Notch1-VP16-GAL4 fusion and Gal4-driven luciferase reporter plasmid; Gal4 driven luciferase expression assessed by luminescent measurement.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in A20 B cell line using FACS readout measuring CD74/p8 accumulation.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">CL: Clearance measured as a mean of 3 animals (Balb\c mouse) after iv dosing (5 mg/kg) using 2.5 mg/mL PEG300/D5W (3:1) solution formulation.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">CL: Clearance measured as a mean of 4 animals (Sprague–Dawley rat) after iv dosing (1 mg/kg) using NMP:PEG200 (30:70) formulation.</p></div><div class="footnote" id="t4fn6"><sup>Table f</sup><p class="last">Equilibrium solubility determined by saturation shake flask method<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> at pH 6.8 using DMSO solution. RGA = reporter gene assay, nd = not determined.</p></div></div><div></div></div><div class="NLM_p">A simple pyridine analogue <b>35</b> was not well tolerated by SPPL2a. Because the 3,5-difluorophenyl compound <b>30</b> showed a high SPPL2a activity and halogens such as fluorine or chlorine in <i>meta</i>-position to the aromatic amine may reduce the risk of mutagenicity,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><b>35</b> was decorated with a fluorine in the 5-position. The resulting analogue <b>36</b> showed indeed a dramatic improvement in potency, while the 3-amino-5-fluoro-2-methylpyridine proved to be negative in the Ames test,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> a gene mutation test in bacteria which uses back-mutation to histidine proficiency as the end point. Moreover, the compound was more potent in the CD74/p8 processing assay, including the CD74/p8 processing in the presence of mouse whole blood (IC<sub>50</sub> of 0.050 μM for <b>36</b> vs 0.550 μM for <b>31</b>), and  showed also improved γ-secretase selectivity and solubility (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_p">As the next step, the tricycle was optimized to block the main metabolic weak spot, the benzylic-CH<sub>2</sub> position. For this purpose, two hypotheses were tested. The first idea was based on the assumption that a neighboring halogen (e.g., in the <i>ortho</i>-position on the phenyl ring) may decrease the electron density at this position and may therefore protect it from metabolic oxidation. While the fluorine atom in <b>37</b> was tolerated for keeping SPPL2a potency, the in vivo clearance in rat was indeed improved (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). However, the oral exposure remained unchanged as a result of lower oral bioavailability (54% for <b>37</b> vs ∼100% for <b>36</b>) most probably caused by decreased solubility of <b>37</b> (257 μM at pH 6.8 vs >1000 μM for <b>36</b>). The second approach aimed for direct blocking of the oxidation by adding an oxo-substituent to the benzylic position (<b>38</b>). Unfortunately, the oxo-substituent in this position was not well tolerated as the SPPL2a potency was significantly decreased (<b>38</b> vs <b>36</b>, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Because <b>38</b> became fairly polar with a log <i>P</i> of 0.9 as compared to 1.7 for <b>36</b>, we set out to increase the overall lipophilicity to compensate the decreased potency, which might have been caused by impaired cell permeability due to the high polarity. Adding a cyclopropyl group into the linker led to analogue <b>39</b> with increased SPPL2a potency and a log <i>P</i> of 1.6, being comparable to <b>36</b>. A second cyclopropyl group on the tricycle like in compound <b>40</b> (<b>SPL</b>-<b>707</b>) helped again to increase the lipophilicity (log <i>P</i> of 2.3) and resulted in a further improved SPPL2a potency. While <b>40</b> displayed similar potency as <b>36</b>, a significantly lower clearance and much higher oral exposure was observed for this compound in rats and mice. The oral exposure determined following a 10 mg/kg dose of <b>40</b> in rats appeared suitable to achieve sustained exposure after b.i.d. dosing in a chronic in vivo study because the drug concentration might be sufficient to achieve CD74/p8 accumulation even at later time points (<i>C</i><sub>max,1h dn</sub>, 805 nM; C<sub>7h dn</sub>, 421 nM). In addition, this compound displayed the best mouse pharmacokinetic parameters measured for any SPPL2a inhibitor in this series (CL, 5 mL/min/kg; <i>F</i>, 94%; AUC<sub>po dn</sub>, 6071 h·nM; C<sub>7h dn</sub>, 264 nM) and thus allowed for testing the compound in both mouse and rat models.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Optimization of the Tricycle and Linker toward Improved Pharmacokinetic Profile<a class="ref internalNav" href="#t5fn10" aria-label="j">j</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn10"><div class="footnote" id="t5fn10"><sup>Table j</sup><p class="last">*Single experiment.</p></div><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in HEK293 cells cotransfected with TNFα-NTF/VP16-GAL4 fusion, human SPPL2a, and the Gal4-driven luciferase reporter plasmid. Luciferase expression was assessed by luminescent measurement.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in HEK293 cells cotransfected with Notch1-VP16-GAL4 fusion and Gal4-driven luciferase reporter plasmid; Gal4 driven luciferase expression assessed by luminescent measurement.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">log <i>P</i> was measured by a rapid-throughput octanol-buffer lipophilicity measurement based on 96-well shake flask equilibrium and LC/MS/MS analysis.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">IC<sub>50</sub> determined as a mean ± SD (<i>n</i> ≥ 3) in A20 B cell line using FACS readout measuring CD74/p8 accumulation.</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">CL: Clearance measured as a mean of 3 animals (Balb/c mouse) after iv dosing (5 mg/kg) using PEG300/D5W (3:1) solution formulation.</p></div><div class="footnote" id="t5fn6"><sup>Table f</sup><p class="last">CL: Clearance measured as a mean of 3 animals (Sprague–Dawley rat) after iv dosing (1 mg/kg) using NMP:PEG200 (30:70) formulation.</p></div><div class="footnote" id="t5fn7"><sup>Table g</sup><p class="last">Exposure (AUC; dn = dose-normalized to 1 mg/kg) measured as a mean of 4 animals (female Sprague–Dawley rat) after po dosing (3 mg/kg) using CMC:Water:Tween (0.5:99:0.5) formulation.</p></div><div class="footnote" id="t5fn8"><sup>Table h</sup><p class="last">CL: Clearance measured as a mean of 3 animals (Wistar rat) after iv dosing (3 mg/kg) using PEG300/D5W (3:1) formulation.</p></div><div class="footnote" id="t5fn9"><sup>Table i</sup><p class="last">Exposure (AUC; dn = dose-normalized to 1 mg/kg) measured as a mean of 3 animals (Wistar rat) after po dosing (10 mg/kg) using MC:water:Tween (0.5:99:0.5) formulation. RGA = reporter gene assay, nd = not determined.</p></div></div><div></div></div><div class="NLM_p">Before exploring any in vivo activity of <b>40</b>, the compound was tested in mouse and rat SPPL2a assays which confirmed similar potency (IC<sub>50</sub> of 0.18 μM for mouse and 0.056 μM for rat) as for the human enzyme (IC<sub>50</sub> of 0.16 μM) (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). For this purpose, a different assay format was used, a high content imaging assay (HCA).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> It uses double stable cell lines expressing human, mouse, or rat SPPL2a and doxycyclin inducible TNFα-NTF-based, EGFP-labeled substrates. The EGFP-labeled substrates contain a nuclear localization signal (NLS) which drives translocation of the cleaved substrate into the nucleus. The inhibition of SPPL2a prevents substrate cleavage and thus also the translocation of EGFP-NLS to the nucleus. The readout is fluorescence intensity (EGFP) difference between the nuclear area and a cytoplasmatic ring region (see methods and Zhang et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> for a detailed assay description). The same assay format was used to assess selectivity against proteases from the same family. Compound <b>40</b> showed 25-fold selectivity over SPP with an IC<sub>50</sub> of 3.7 μM and some preference for SPPL2a over SPPL2b with a 3-fold selectivity, comparing IC<sub>50</sub> values generated with comparable assay formats for the different proteases (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). While SPP is involved in several important cell functions and SPP ko mice are not viable, no adverse effects are known for SPPL2b inhibition. Like for 3-amino-5-fluoro-2-methylpyridine, <b>40</b> was also negative in the Ames test.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Selectivity Profile of <b>40</b> against Related Proteases and Its Activity on Mouse and Rat SPPL2a</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">SPPL2a HCA<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> [μM]</th><th class="colsep0 rowsep0" align="center" char="±">SPP HCA<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> [μM]</th><th class="colsep0 rowsep0" align="center" char="±">SPPL2b HCA<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> [μM]</th><th class="colsep0 rowsep0" align="center" char="±">γ-secretase RGA<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> [μM]</th><th class="colsep0 rowsep0" align="center" char="±">mSPPL2a HCA<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> [μM]</th><th class="colsep0 rowsep0" align="center" char="±">rSPPL2a HCA<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> [μM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">3.73 ± 1.46</td><td class="colsep0 rowsep0" align="char" char="±">0.43 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">6.1 ± 2.6</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.056 ± 0.007</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">HCA = high content imaging assay. Stable U-2 OS cell lines expressing either human, rat, or mouse SPPL2a or human SPPL2b constitutively and an inducible EGFP-labeled TNFα-based substrate, or human SPP constitutively and an inducible EGFP-labeled EnvSigSeq-SEAP fusion protein substrate were used for the imaging assays, to monitoring inhibition of substrate translocation into the nucleus (see methods).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">RGA = reporter gene assay. IC<sub>50</sub> determined as a mean (<i>n</i> ≥ 3) in HEK293 cells cotransfected with Notch1-VP16-GAL4 fusion; Gal4 driven luciferase expression assessed by luminescent measurement.</p></div></div></div><div class="NLM_p">Thereafter, <b>40</b> was tested in the wash-out experiment as described for <b>31</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Complete disappearance of CD74/p8 after removal of <b>40</b> occurred after 2 h, while 50% reduction was observed at around 50 min (data not shown). These results are consistent with those observed for <b>31</b>, reinforcing the need for continuous SPPL2a inhibition to achieve a permanent p8 accumulation. Subsequently, <b>40</b> was tested first in the mouse PK/PD model described for <b>31</b>. However, to predict performance in a chronic study with b.i.d. dosing using 8 and 16 h dosing intervals, readout of the study was set to 16 h post oral dosing of <b>40</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). A similar inhibition of CD74/p8-fragment processing was seen following a single oral dose of either 30 mg/kg of <b>40</b> or 150 mg/kg of <b>31</b>. A significant p8 accumulation (∼50% of maximal) was observed even at the 10 mg/kg dose of <b>40</b>, while no p8 accumulation was detected for the lower doses of <b>40</b>, as could be expected by the low plasma levels observed at 16 h post dose (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of CD74/p8-fragment processing in mice after oral treatment with <b>40</b>. (A) Mice received single oral doses of 150 mg/kg <b>31</b> or 1, 3, 10, and 30 mg/kg <b>40</b>. Then 16 h after dosing, inhibition of SPPL2a in vivo was assessed by measuring CD74/p8 accumulation in splenocyte lysates by Western blot analysis with an antimouse CD74 antibody. Relative quantification of the p8 bands is shown, where the samples with the strongest signal was set arbitrarily as 100%. (B) Total plasma concentrations (means ± SEM) of <b>40</b> at termination of the study 16 h after dosing showed an overdose proportional increase. Statistics are one-way ANOVA followed by Dunnett’s test compared to matched vehicle group: * <i>p</i> ≤ 0.05; ** <i>p</i> ≤ 0.01; *** <i>p</i> ≤ 0.001; **** <i>p</i> ≤ 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>40</b> was also highly efficacious in a 24 h rat PK/PD model, in which two oral doses of <b>40</b> were administered to more accurately predict performance in chronic b.i.d. dosing studies with 8 and 16 h dosing intervals (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). In this experiment, full inhibition of CD74/p8 processing was achieved already with 1 mg/kg <b>40</b> b.i.d. in blood and 3 mg/kg <b>40</b> b.i.d. dose in spleen, as assessed by measuring relative CD74/p8 accumulation (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). Total blood and spleen concentrations of <b>40</b> were indicative for a nearly dose proportional increase in trough concentration between 1 and 10 mg/kg (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). Based on the results obtained in the PK/PD models, <b>40</b> was expected to inhibit SPPL2a activity continuously and therefore be efficacious in multiday in vivo studies at an oral dose of 3 mg/kg b.i.d. in rat and 10–15 mg/kg b.i.d. in mice, respectively.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of CD74/p8-fragment processing in rat after oral treatment with <b>40</b>. (A) Female Lewis rats received <b>40</b> (1, 3, 10, and 30 mg/kg b.i.d.; first dose at 0 h, second dose at 8 h). Then 16 h after the second dose (24 h in total), inhibition of SPPL2a in vivo was assessed by measuring CD74/p8 accumulation in blood and splenocyte extracts by Western blot analysis with an antirat CD74 antibody (top) and relative quantification of the p8 bands shown (bottom). *p8 bands which were arbitrarily set as 100%. Note: the low CD74/p8 accumulation detected in two samples of the 10 mg/kg dose group in blood is probably due to an artifact arising from technical challenges in cell preparation from blood and lack of a possibility to normalize beyond initial blood volume used for the cell preparation. (B) Total spleen and blood concentration (means ± SEM) of <b>40</b> at termination (24 h after first dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the published Sppl2a ko and Sppl2a ENU mutant mouse phenotype, there is a fair amount of evidence that accumulation of CD74/p8 is interfering with the development/maturation and function of specific B cell subsets and mDCs.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> The fact that the SPPL2a knockout phenotype is rescued in the SPPL2a/CD74 double knockout mice strongly argues in favor of a dominant effect of CD74/p8 accumulation.<a onclick="showRef(event, 'ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref13">(11, 13)</a> To understand to which extent a pharmacological inhibition of SPPL2a recapitulates the Sppl2a ko phenotype or whether the phenotype rather results from SPPL2a ablation during development, <b>40</b> was administered orally at 3, 10, and 30 mg/kg b.i.d. to mice for 11 days (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Treatment of mice with the SPPL2a inhibitor <b>40</b> leads to a reduction in B cells and myeloid dendritic cells without affecting γ-secretase activity. Mice were treated orally with 3, 10, and 30 mg/kg <b>40</b> b.i.d. (with 8 and 16 h dosing intervals) for 11 days. The study was terminated 16 h after the last dose of <b>40</b> on day 12. Mice dosed with 30 mg/kg <b>40</b> b.i.d. showed a significant body weight loss by day 5, therefore Nutra Cal high calorie gel food supplement was added to all cages on day 5, which resulted in the animals regaining weight. (A) Total B cells numbers in spleen, analyzed by flow cytometry by B220<sup>+</sup> staining, a significant reduction of total B cell numbers were observed in the 10 and 30 mg/kg <b>40</b> treatment groups. (B) FACS analysis of different B cell subsets in spleen, FO = follicular B cells, T1 = transitional T1 B cells, T2 = transitional T2 cells, MZ = marginal zone B cells; a significant reduction of FO, T1, and MZ B cell numbers were observed in the 10 and 30 mg/kg <b>40</b> treatment groups and a significant reduction in all <b>40</b> dose groups for the T2 B cell numbers. (C) Flow cytometry analysis of mDCs and pDCs numbers in spleen, a significant reduction of mDC numbers were observed in the 3, 10, and 30 mg/kg <b>40</b> treatment groups, whereas the trend toward a reduction in pDC numbers did not reach significance for any of the dose groups. (D) total plasma concentration of <b>40</b> at predose on day 12 (<i>C</i><sub>trough</sub> level), showing an over dose proportional increase in through levels. (E) Hes1 mRNA levels in the thymus measured by qPCR and expressed as fold-change compared to the vehicle treated group, no significant changes for any of the dose groups were observed. Statistics are one-way ANOVA followed by Dunnett’s test compared to matched vehicle group: * <i>p</i> ≤ 0.05; ** <i>p</i> ≤ 0.01; *** <i>p</i> ≤ 0.001; **** <i>p</i> ≤ 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">At termination of this experiment, B cell and DC numbers and subsets in the spleen were analyzed by flow cytometry. At oral doses of 10 and 30 mg/kg b.i.d. <b>40</b>, a highly significant, dose-dependent reduction of total B cell numbers was observed (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A) as a result of specific reduction of mature B cell subsets (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). In addition, mDC numbers showed a significant, dose-dependent reduction in all dosing groups, whereas plasmacytoid DC (pDC) numbers were not significantly affected (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). In line with the observations in the PK/PD models, the lower through plasma concentration of <b>40</b> at termination of the study in the 3 mg/kg b.i.d. dosing group (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D) resulted only in partial accumulation of CD74/p8 (not shown) and as a consequence partial reduction of B cell and mDC numbers. This strongly argues for the need of continuous, full SPPL2a inhibition during the course of the study to achieve pronounced effects on B cell and mDC numbers. Overall, the extent of changes in B cell subsets and mDCs seen in the highest dose group closely resembled the phenotype observed in the Sppl2a mutant and ko mice, therefore clearly showing that the ko phenotype is mostly independent from the effect of SPPL2a deficiency during development. T cell numbers and CD4 CD8 ratio did not show any significant changes at any of the doses of <b>40</b>, in line to what was observed in Sppl2a mutant/ko mice (not shown). In addition, also at the highest dose, <b>40</b> did not interfere with γ-secretase dependent Notch1 signaling as seen by unchanged Hes1 mRNA levels in the thymus (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>E).</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this paper, we describe the discovery of the first selective and orally active SPPL2a inhibitor <b>40</b>. Compound <b>40</b> was developed starting from the γ-secretase inhibitor <b>42</b>. Because of some severe toxic side effects (e.g., intestinal toxicity or development of skin cancer) seen with γ-secretase inhibitors in the clinic, most probably originating from the inhibition of Notch-processing, we wished to find SPPL2a inhibitors avoiding the cross-reactivity with γ-secretase. SAR driven optimization revealed that an aromatic methyl group in the <i>ortho</i>-position to aniline NH was key for achieving selectivity over γ-secretase for this series. The new analogues showed that a selectivity window of >50 against γ-secretase was sufficient for avoiding the Notch-mediated toxic effects in vivo. The suboptimal pharmacokinetic parameters were optimized based on the results obtained from a metabolic weak spot identification study. In mouse and rat, <b>40</b> showed highly significant inhibition of CD74/p8 processing at doses ≤10 mg/kg b.i.d. po. In addition, after oral dosing of <b>40</b> for 11 days at 10 mg/kg b.i.d. to mice, the phenotype seen with ko and ENU mutant mice (reduced number of B cells and mDCs) was entirely recapitulated. Therefore, we believe that our findings show that SPPL2a is a novel target with promising therapeutic application and could be explored as an approach for the treatment of autoimmune diseases, where antigen presentation is an important driver of pathology.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p">All reagents and solvents were purchased from commercial suppliers and used without further purification. All reactions were performed under inert conditions (argon) unless otherwise stated. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker 400 MHz or a Bruker 600 MHz NMR spectrometer. Chemical shifts are reported in parts per million (ppm) relative to an internal solvent reference. Significant peaks are tabulated in the order multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; quintet; m, multiplet; br, broad), coupling constants, and number of protons. Final compounds were purified to ≥95% purity as assessed by analytical liquid chromatography.</div><div class="NLM_p">LCMS method a: Waters UPLC Acquity; column, Acquity HSS T3 1.8 μm, 2.1 mm × 50 mm at 60 °C; eluent A, water + 0.05% HCOOH + 3.75 mM NH<sub>4</sub>OAc; eluent B, MeCN + 0.04% HCOOH; gradient, 10–95% B in 1.5 min; flow, 1.0 mL/min.</div><div class="NLM_p">LCMS method b: Waters UPLC Acquity; column, Acquity HSS T3 1.8 μm, 2.1 mm × 50 mm at 60 °C; eluent A, water + 0.05% HCOOH + 3.75 mM NH<sub>4</sub>OAc; eluent B, MeCN + 0.04% HCOOH; gradient, 5–98% B in 1.4 min; flow, 1.0 mL/min.</div><div class="NLM_p">LCMS method c: Waters UPLC Acquity; column, Acquity HSS T3, 1.8 μm, 2.1 mm × 50 mm, at 60 °C; eluent A, water + 0.05% HCOOH + 3.75 mM NH<sub>4</sub>OAc; eluent B, MeCN + 0.04% HCOOH; gradient, 5–98% B in 9.4 min hold 0.4 min; flow, 0.8 mL/min.</div><div class="NLM_p">LCMS method d: Agilent LCMS; column, Waters SunFire C18, 2.5 μm, 3 mm × 30 mm; eluent A, water + 0.1% HCOOH; eluent B, MeCN + 0.1% HCOOH; gradient, 10–98% B in 2.5 min; flow, 1.4 mL/min.</div><div class="NLM_p last">LCMS method e: Agilent LCMS; column, Waters Acquity HSS T3, 1.8 μm, 2.1 mm × 50 mm, at 60 °C; eluent A, H<sub>2</sub>O + 0.05% TFA; eluent B, MeCN + 0.035% TFA; gradient, 10–100% B in 1.35 min; flow, 0.9 mL/min.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Synthesis of Compound <b>40</b> (SPL-707)</h3><div id="sec6_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 5,6-Diazaspiro[2.4]heptane Dihydrobromide (<b>16</b>)</h4><div class="NLM_p last"><i>Step 1</i>: A solution of MsCl (57.2 mL, 734 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (160 mL) was added dropwise at 0 °C to a solution of cyclopropane-1,1-diyldimethanol (25 g, 245 mmol) and Et<sub>3</sub>N (136 mL, 979 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (250 mL). The reaction mixture was stirred at rt for 16 h. Then 1 M aq HCl (900 mL) was added and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to a volume of 100–150 mL. Hexane was added, and the resulting precipitate was filtered off, washed with hexane, and dried in vacuum to give cyclopropane-1,1-diylbis(methylene) dimethanesulfonate (37.5 g, 145 mmol, 59%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 4.14 (s, 4H), 3.19 (s, 6H), 0.77 (s, 4H). <i>Step 2</i>: A solution of di-<i>tert</i>-butyl hydrazine-1,2-dicarboxylate (18.6 g, 80 mmol) in dry DMF (65 mL) was added dropwise at 0 °C to a suspension of NaH (60% dispersion in oil, 6.7 g, 168 mmol) in dry DMF (40 mL), and the suspension was stirred at rt for 1 h. After addition of cyclopropane-1,1-diylbis(methylene) dimethanesulfonate (20.7 g, 80 mmol), the reaction mixture was stirred at rt for 16 h. It was then poured onto ice and water (1.3 L). The formed precipitate was filtered off, washed with water, and dried in vacuum to afford di-<i>tert</i>-butyl 5,6-diazaspiro[2.4]heptane-5,6-dicarboxylate (22.2 g, 74 mmol, 93% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.56 (d, <i>J</i> = 10.6 Hz, 2H), 3.17 (d, <i>J</i> = 10.6 Hz, 2H), 1.41 (s, 18H), 0.63–0.68 (m, 4H). LCMS (method e) <i>m</i>/<i>z</i>: 619.4 [2 M + Na]<sup>+</sup>. <i>t</i><sub>R</sub> = 1.57 min. <i>Step 3</i>: Hydrobromic acid solution (33 wt % in AcOH, 38.5 mL, 0.22 mol) was added slowly at 0 °C to a solution of di-<i>tert</i>-butyl 5,6-diazaspiro[2.4]heptane-5,6-dicarboxylate (12 g, 40 mmol) in Et<sub>2</sub>O (200 mL), and the mixture was stirred at rt for 16 h. After cooling to 0 °C, the solid was filtered off, washed with Et<sub>2</sub>O, and dried in vacuum to give the compound <b>16</b> as dihydrobromide (9.5 g, 36 mmol, 91% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.80 (br s, 4H), 3.06 (s, 4H), 0.76 (s, 4H). LCMS (method e) <i>m</i>/<i>z</i>: 99.2 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 0.26 min.</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1<i>H</i>-Spiro[benzo[<i>d</i>]pyrazolo[1,2-<i>a</i>][1,2]diazepine-2,1′-cyclopropane]-5,11(3<i>H</i>,10<i>H</i>)-dione (<b>17</b>)</h4><div class="NLM_p last">Compound <b>16</b> dihydrobromide (5.2 g, 20 mmol) was added at rt to a solution of homophthalic anhydride (3.3 g, 20 mmol) in AcOH (35 mL) and pyridine (18 mL). The solution was then stirred at 130 °C for 20 h. After cooling to rt, the mixture was diluted with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with 10% aq HCl, 5% aq NaHCO<sub>3</sub>, water, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude product was purified by column chromatography (20–50% EtOAc in hexane) to afford the compound <b>17</b> (3.3 g, 14 mmol, 69% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.79 (dd, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.54–7.58 (m, 1H), 7.41–7.47 (m, 2H), 4.20 (d, <i>J</i> = 11.0 Hz, 1H), 4.14 (d, <i>J</i> = 13.4 Hz, 1H), 3.88 (d, <i>J</i> = 10.6 Hz, 1H), 3.46–3.57 (m, 2H), 3.23 (d, <i>J</i> = 10.5 Hz, 1H), 0.75–0.79 (m, 4H). LCMS (method e) <i>m</i>/<i>z</i>: 243.2 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 1.11 min.</div></div><div id="sec6_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>S</i>)-10-Amino-1<i>H</i>,3<i>H</i>,5<i>H</i>-spiro[benzo[<i>d</i>]pyrazolo[1,2-<i>a</i>][1,2]diazepine-2,1′-cyclopropane]-5,11(10<i>H</i>)-dione (HCl Salt) (<b>18</b>)</h4><div class="NLM_p last"><i>Step 1</i>: 1 M LiHMDS in THF (26 mL, 26 mmol) was added dropwise at 0 °C to a suspension of <b>17</b> (4.1 g, 17 mmol) and isopentyl nitrite (3.4 mL, 26 mmol) in THF (34 mL). The reaction mixture was stirred at rt for 2 h. AcOH was added, and the mixture was evaporated twice in vacuum to yield the (<i>E</i>,<i>Z</i>)-10-(hydroxyimino)-1<i>H</i>-spiro[benzo[<i>d</i>]pyrazolo[1,2-<i>a</i>][1,2]diazepine-2,1′-cyclopropane]-5,11(3<i>H</i>,10<i>H</i>)-dione as an oil which was used in the next step without further purification. LCMS (method e) <i>m</i>/<i>z</i>: 272.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.10 and 1.13 min. <i>Step 2</i>: 4 M aq HCl (4.3 mL, 17 mmol) was added at rt to a mixture of crude product from <i>step 1</i> (4.6 g, 17.0 mmol) in AcOH (92 mL). The mixture was cooled to 0 °C, and Zn powder (4.5 g, 68 mmol) was added slowly. After the addition, the reaction mixture was stirred at rt for 1.5 h. The inorganic zinc residues were filtered off and washed with CH<sub>2</sub>Cl<sub>2</sub>. The filtrate was concentrated, redissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with 10% aq NaOH and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by column chromatography (0–4% MeOH in CH<sub>2</sub>Cl<sub>2</sub>(NH<sub>3</sub>)) to yield <i>rac</i>-10-amino-1<i>H</i>,3<i>H</i>,5<i>H</i>-spiro[benzo[<i>d</i>]pyrazolo[1,2-<i>a</i>][1,2]diazepine-2,1′-cyclopropane]-5,11(10<i>H</i>)-dione (2.4 g, 9.3 mmol, 55%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.73–7.78 (m, 2H), 7.62 (td, <i>J</i> = 7.6, 1.4, 1H), 7.40–7.45 (m, 1H), 4.97 (s, 1H), 4.21 (d, <i>J</i> = 11.2 Hz, 1H), 3.88 (d, <i>J</i> = 10.8 Hz, 1H), 3.54 (d, <i>J</i> = 11.2 Hz, 1H), 3.27 (d, <i>J</i> = 10.8 Hz, 1H), 2.28 (s, 2H), 0.70–0.85 (m, 4H). LCMS (method e) <i>m</i>/<i>z</i>: 258.2 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 0.79 min. <i>Step 3</i>: Boc<sub>2</sub>O (76 g, 347 mmol) was added at rt to the product of <i>step 2</i> (68 g, 231 mmol) and Na<sub>2</sub>CO<sub>3</sub> (110 g, 1.04 mol) in dioxane/water (1:1 mixture, 1.4 L), and the resulting mixture was stirred at rt for 2 h. The formed precipitate was filtered off, washed twice with water, and dried under vacuum. The solid was dissolved in dioxane containing 3% formic acid, and the enantiomers were separated by preparative chiral HPLC (Thar SFC-200 instrument; mobile phase, scCO<sub>2</sub>/EtOH 70:30; column, Chiralpak IC, 5 μM, 250 mm × 30 mm) to provide the (<i>S</i>)-enantiomer (42 g, 117 mmol, >99.5% ee, 48%) and the (<i>R</i>)-enantiomer (43 g, 120 mmol, >99.5% ee, 49%). Analytical data for the (<i>S</i>)-enantiomer. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.81 (d, <i>J</i> = 7.5 Hz, 1H), 7.61–7.71 (m, 2H), 7.45–7.51 (m, 2H), 5.74 (d, <i>J</i> = 8.9 Hz, 1H), 4.21 (d, <i>J</i> = 11.1 Hz, 1H), 3.90 (d, <i>J</i> = 10.7 Hz, 1H), 3.62 (d, <i>J</i> = 11.1 Hz, 1H), 3.27 (d, <i>J</i> = 10.7 Hz, 1H), 1.42 (s, 9H), 0.71–0.82 (m, 4H). LCMS (method a) <i>m</i>/<i>z</i>: 358.2 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 1.05 min. [α]<sup>23</sup><sub>D</sub> −125.0 (<i>c</i> = 1.0, MeOH). <i>Step 4</i>: <i>tert</i>-Butyl (<i>S</i>)-(5,11-dioxo-10,11-dihydro-1<i>H</i>,3<i>H</i>,5<i>H</i>-spiro[benzo[<i>d</i>]pyrazolo[1,2-<i>a</i>][1,2]diazepine-2,1′-cyclopropan]-10-yl)carbamate (2.0 g, 5.6 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (28 mL) and treated at 0 °C with 4 M aq HCl in dioxane (28 mL, 112 mmol). After stirring at 0 °C for 1 h, the reaction mixture was concentrated. The residue was treated with CH<sub>2</sub>Cl<sub>2</sub> and evaporated. It was then triturated with Et<sub>2</sub>O, the precipitate was filtered off and dried in vacuum to yield the product <b>18</b> as an HCl salt (1.7 g, 5.6 mmol, quant), white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.33 (br s, 3H), 7.89 (d, <i>J</i> = 7.4 Hz, 1H), 7.75 (t, <i>J</i> = 7.2 Hz, 1H), 7.60 (t, <i>J</i> = 7.3 Hz, 1H), 7.46 (d, <i>J</i> = 7.9 Hz, 1H), 5.83 (s, 1H), 4.26 (d, <i>J</i> = 11.1 Hz, 1H), 3.91 (d, <i>J</i> = 10.9 Hz, 1H), 3.53 (d, <i>J</i> = 11.1 Hz, 1H), 3.42 (d, <i>J</i> = 10.3 Hz, 1H), 0.74–0.89 (m, 4H). LCMS (method b) <i>m</i>/<i>z</i>: 258.2 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 0.46 min. [α]<sup>23</sup><sub>D</sub> −160.4 (<i>c</i> = 1.0, MeOH).</div></div><div id="sec6_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>S</i>)-4-Benzyl-3-(2-cyclopropylacetyl)oxazolidin-2-one (<b>22</b>)</h4><div class="NLM_p last">EDC (1.7 g, 8.9 mmol) was added at rt to a mixture of (<i>S</i>)-4-benzyloxazolidin-2-one (800 mg, 4.5 mmol), 2-cyclopropylacetic acid (600 mg, 6.0 mmol), and DMAP (565 mg, 4.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and the mixture was stirred at rt for 16 h. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water, 1 M aq HCl, satd aq NaHCO<sub>3</sub>, satd aq NH<sub>4</sub>Cl, water, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to yield the compound <b>22</b> (1.01 g, 3.9 mmol, 86%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.32–7.38 (m, 2H), 7.28–7.32 (m, 1H), 7.23–7.25 (m, 2H), 4.70–4.78 (m, 1H), 4.19–4.28 (m, 2H), 3.36 (dd, <i>J</i> = 13.4, 3.2 Hz, 1H), 2.97 (dd, <i>J</i> = 17.0, 6.7 Hz, 1H), 2.75–2.89 (m, 2H), 1.14–1.31 (m, 1H), 0.59–0.69 (m, 2H), 0.22–0.31 (m, 2H). LCMS (method b) <i>m</i>/<i>z</i>: 260.2 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 1.05 min. [α]<sup>23</sup><sub>D</sub> +90.6 (<i>c</i> = 1.0, MeOH).</div></div><div id="sec6_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-Benzyl-2-oxooxazolidin-3-yl)-3-cyclopropyl-4-oxobutanoate (<b>23</b>)</h4><div class="NLM_p last">First, 1 M NaHMDS in THF (5.9 mL, 5.9 mmol) was added dropwise at −78 °C to a solution of <b>22</b> (1.0 g, 3.9 mmol) in THF (30 mL). After stirring at −78 °C for 1 h, <i>tert</i>-butyl 2-bromoacetate (1.2 mL, 7.8 mmol) was added and the solution was stirred for additional 1 h at −78 °C. The reaction mixture was treated with satd aq NH<sub>4</sub>Cl (2 mL) and allowed to warm to rt before it was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The crude product was purified by column chromatography (0–50% EtOAc in hexane) to yield the compound <b>23</b> (0.8 g, 2.1 mmol, 54%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.27–7.38 (m, 5H), 4.71 (td, <i>J</i> = 6.7, 3.3 Hz, 1H), 4.13–4.22 (m, 2H), 3.70–3.79 (m, 1H), 3.39 (dd, <i>J</i> = 13.4, 3.2 Hz, 1H), 2.97 (dd, <i>J</i> = 16.8, 10.8 Hz, 1H), 2.73 (dd, <i>J</i> = 13.4, 10.3 Hz, 1H), 2.59 (dd, <i>J</i> = 16.8, 4.3 Hz, 1H), 1.43 (s, 9H), 0.89–1.01 (m, 1H), 0.48–0.61 (m, 2H), 0.40–0.48 (m, 1H), 0.18–0.35 (m, 1H). LCMS (method b) <i>m</i>/<i>z</i>: 374.3 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 1.29 min. [α]<sup>23</sup><sub>D</sub> +69.0 (<i>c</i> = 1.0, MeOH).</div></div><div id="sec6_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-cyclopropyl-4-oxobutanoic Acid (<b>24</b>)</h4><div class="NLM_p last">Hydrogen peroxide (30% in water; 0.88 mL, 8.6 mmol) followed by LiOH (0.18 g, 4.3 mmol) in water (1 mL) were added at 0 °C to a solution of <b>23</b> (0.8 g, 2.1 mmol) in THF (20 mL), and the reaction mixture was stirred at 0 °C for 2 h. It was then treated with satd aq NaHSO<sub>3</sub> (20 mL) and satd aq NaHCO<sub>3</sub> (50 mL) at 0 °C. THF was distilled off under reduced pressure, and the aqueous layer was washed with CH<sub>2</sub>Cl<sub>2</sub>, then cooled to 0 °C, acidified with 4 M aq HCl to pH 2, and extracted with CH<sub>2</sub>Cl<sub>2</sub>. Combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to yield the product <b>24</b> (0.34 g, 1.5 mmol, 70%) as a colorless viscous oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 12.12 (s, 1H), 2.53 (dd, <i>J</i> = 16.3, 9.8 Hz, 1H), 2.40 (dd, <i>J</i> = 16.0, 5.3 Hz, 1H), 1.87–1.95 (m, 1H), 1.37 (s, 9H), 0.75–0.87 (m, 1H), 0.38–0.49 (m, 2H), 0.29–0.36 (m, 1H), 0.12–0.21 (m, 1H). LCMS (method b) <i>m</i>/<i>z</i>: 213.2 [M – H]<sup>−</sup>. <i>t</i><sub>R</sub> = 0.90 min. [α]<sup>23</sup><sub>D</sub> +51.2 (<i>c</i> = 1.0, MeOH).</div></div><div id="sec6_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i>)-3-Cyclopropyl-4-(((<i>S</i>)-5,11-dioxo-10,11-dihydro-1<i>H</i>,3<i>H</i>,5<i>H</i>-spiro[benzo[<i>d</i>]pyrazolo[1,2-<i>a</i>][1,2]diazepine-2,1′-cyclopropan]-10-yl)amino)-4-oxobutanoic Acid (<b>29</b>)</h4><div class="NLM_p last"><i>Step 1</i>: DIPEA (12.5 mL, 72 mmol) and HATU (11.0 g, 29 mmol) were added at rt to a mixture of <b>18</b> (HCl salt, 7.1 g, 24 mmol) and <b>24</b> (5.7 g, 26 mmol) in DMF (120 mL). The mixture was stirred at rt for 48 h. After concentration, the residue was dissolved in EtOAc, washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. It was then purified by column chromatography (10–50% EtOAc in cyclohexane) to provide (<i>S</i>)-<i>tert</i>-butyl 3-cyclopropyl-4-(((<i>S</i>)-5,11-dioxo-3,5,10,11-tetrahydro-1<i>H</i>-spiro[benzo[<i>d</i>]pyrazolo[1,2-<i>a</i>][1,2]diazepine-2,1′-cyclopropan]-10-yl)amino)-4-oxobutanoate (9.0 g, 20 mmol, 84%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.97 (d, <i>J</i> = 7.4 Hz, 1H), 7.48–7.54 (m, 2H), 7.41–7.45 (m, 1H), 7.30 (d, <i>J</i> = 6.8 Hz, 1H), 6.07 (d, <i>J</i> = 6.7 Hz, 1H), 4.47 (d, <i>J</i> = 11.4 Hz, 1H), 4.04 (d, <i>J</i> = 10.9 Hz, 1H), 3.54 (d, <i>J</i> = 11.3 Hz, 1H), 3.33 (d, <i>J</i> = 10.9 Hz, 1H), 2.93 (dd, <i>J</i> = 16.9, 9.4 Hz, 1H), 2.60 (dd, <i>J</i> = 16.9, 4.4 Hz, 1H), 2.14 (td, <i>J</i> = 9.7, 4.4 Hz, 1H), 1.48 (s, 9H), 1.05–1.12 (m, 1H), 0.78–0.97 (m, 4H), 0.62–0.75 (m, 2H), 0.50–0.56 (m, 1H), 0.29–0.35 (m, 1H). LCMS (method b) <i>m</i>/<i>z</i>: 454.4 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 1.10 min. [α]<sup>23</sup><sub>D</sub> −58.0 (<i>c</i> = 1.0, MeOH). <i>Step 2</i>: TFA (30 mL, 390 mmol) was addded at rt to a solution of product from <i>step 1</i> (8.8 g, 20 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (195 mL). The mixture was stirred at rt for 2 h and concentrated. The residue was triturated with Et<sub>2</sub>O, and the precipitate was filtered off and dried in vacuum to yield the compound <b>29</b> (7.4 g, 18 mmol, 95%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.98 (dd, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.49–7.55 (m, 2H), 7.43 (t, <i>J</i> = 7.5 Hz, 1H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 6.08 (d, <i>J</i> = 6.6 Hz, 1H), 4.48 (d, <i>J</i> = 11.4 Hz, 1H), 4.05 (d, <i>J</i> = 11.0 Hz, 1H), 3.55 (d, <i>J</i> = 11.4 Hz, 1H), 3.34 (d, <i>J</i> = 11.0 Hz, 1H), 3.05 (dd, <i>J</i> = 16.8, 9.3 Hz, 1H), 2.77 (dd, <i>J</i> = 16.8, 3.8 Hz, 1H), 2.18 (td, <i>J</i> = 9.8, 3.8 Hz, 1H), 1.09–1.17 (m, 1H), 0.95–1.00 (m, 1H), 0.82–0.92 (m, 4H), 0.71–0.78 (m, 1H), 0.58–0.64 (m, 1H), 0.36–0.41 (m, 1H). LCMS (method b) <i>m</i>/<i>z</i>: 398.3 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 0.74 min. [α]<sup>23</sup><sub>D</sub> −54.6 (<i>c</i> = 1.0, MeOH).</div></div><div id="sec6_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-2-Cyclopropyl-<i>N</i>1-((<i>S</i>)-5,11-dioxo-10,11-dihydro-1<i>H</i>,3<i>H</i>,5<i>H</i>-spiro[benzo[<i>d</i>]pyrazolo[1,2-<i>a</i>][1,2]diazepine-2,1′-cyclopropan]-10-yl)-<i>N</i>4-(5-fluoro-2-methylpyridin-3-yl)succinamide (<b>40</b>)</h4><div class="NLM_p last">EDC (6.4 g, 33.5 mmol) was added at rt to a solution of <b>29</b> (6.7 g 16.8 mmol) and 5-fluoro-2-methylpyridin-3-amine hydrochloride (3.3 g 20 mmol) in pyridine (84 mL). The mixture was stirred at rt for 16 h. More 5-fluoro-2-methylpyridin-3-amine hydrochloride (323 mg, 2 mmol) and EDC (765 mg, 4 mmol) were added, and the mixture was stirred at rt for 16 h. The reaction mixture was concentrated, the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and extracted with satd aq NaHCO<sub>3</sub>, water, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude material was purified by column chromatography (0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) followed by crystallization from MeOH/Et<sub>2</sub>O to provide the compound <b>40</b> (7.2 g, 14.2 mmol, 71%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.49 (s, 1H), 8.72 (d, <i>J</i> = 7.8 Hz, 1H), 8.21 (br s, 1H), 7.88 (d, <i>J</i> = 10.5 Hz, 1H), 7.80 (d, <i>J</i> = 7.1 Hz, 1H), 7.48 (d, <i>J</i> = 7.6 Hz, 1H), 7.42 (t, <i>J</i> = 7.3 Hz, 1H), 7.32–7.39 (m, 1H), 6.00 (d, <i>J</i> = 7.6 Hz, 1H), 4.24–4.26 (m, 1H), 4.24 (d, <i>J</i> = 11.1 Hz, 1H), 3.95 (d, <i>J</i> = 10.8 Hz, 1H), 3.66 (d, <i>J</i> = 11.0 Hz, 1H), 3.26–3.31 (m, 1H), 2.86–2.98 (m, 1H), 2.58–2.72 (m, 2H), 2.29 (s, 3H), 0.86–0.97 (m, 1H), 0.81 (s, 3H), 0.69–0.76 (m, 1H), 0.59–0.69 (m, 1H), 0.49–0.58 (m, 1H), 0.39–0.49 (m, 1H), 0.21–0.33 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 101 MHz): δ 173.6, 170.7, 167.0, 155.8, 146.5, 138.8, 133.3, 131.9, 131.7, 131.5, 130.0, 129.4, 127.8, 123.4, 117.2, 117.0, 52.6, 51.9, 45.5, 38.5, 20.4, 20.3, 14.1, 9.6, 9.4, 4.1, 3.6. LCMS (method c) <i>m</i>/<i>z</i>: 506.2 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> = 3.97 min (100% purity). HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>27</sub>H<sub>29</sub>FN<sub>5</sub>O<sub>4</sub> 506.2204, found 506.2196. [α]<sup>23</sup><sub>D</sub> −104.4 (<i>c</i> = 1.0, MeOH). X-ray crystal structure confirmed the structure and absolute stereochemistry.</div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> X-ray Crystallographic Data</h3><div class="NLM_p last">X-ray crystallographic data obtained for <b>40</b> has been deposited with the Cambridge Crystallographic Data Center as CCDC 1574028 and are included in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cellular Assays</h3><div id="sec6_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Cell Culture</h4><div class="NLM_p last">The mouse B cell line A20 (TIB208, purchased from ATCC) was maintained in complete RPMI1640 medium containing 10% FBS. U-2 OS cells (HTB96, purchased from ATCC) were maintained in DMEM/GlutaMaxTM-I (Invitrogen) supplemented with 10% FBS (Invitrogen). HEK293 cells (CRL-1573, purchased from ATCC). All cells were negatively tested for mycoplasma contamination either by the vendor or in-house.</div></div><div id="sec6_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> SPPL2a and Notch1/γ-Secretase RGA’s in HEK293 Cells</h4><div class="NLM_p last">The SPPL2a luciferase RGA is based on a TNFα(aa1-76)-NTF substrate and the γ-secretase assay has been developed using Notch1 as substrate. The latter assay has been described previously.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In brief, DNA vectors encoding human Notch1-VP16-Gal4 fusion protein and a Gal4-luciferase reporter for the γ-secretase RGA, or human SPPL2a, VP16-TNFa(aa1-76)-NTF substrate, and the Gal4-luciferase reporter plasmid for the SPPL2a RGA, were transiently transfected in HEK293 cells using FuGENE (Promega). After transfection, the cell suspensions were diluted and distributed to white solid 384-well plate at 10000 cells/50 μL/well. After 3 h, 200 nL of compound in DMSO was stamped into the wells in concentration response covering final inhibitor concentrations of 10 μM to 0.3 nM in triplicate. Subsequently, plates were incubated for 24 h at 37 °C, 5% CO<sub>2</sub> in a humidified incubator before the addition of 30 μL Bright Glo (Promega). After incubation for 5 min at rt, luminescence was measured and IC<sub>50</sub> values were determined by plotting compound concentration vs normalized luminescence values.</div></div><div id="sec6_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> SPPL2a, SPP, SPPL2b, Mouse SPPL2a, and Rat SPPL2a High-Content Imaging Assays (HCA) in U-2 OS Cells</h4><div class="NLM_p last">The high-content imaging assays for human SPPL2a, SPPL2b, and SPP using stable U-2 OS cell lines have been described previously.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In brief, stable U-2 OS cell lines expressing either human SPPL2a or SPPL2b constitutively and a EGFP-labeled TNFα(aa1-76) NTF substrate under a doxycycline-regulated promoter or human SPP constitutively and a EGFP-labeled EnvSigSeq-SEAP fusion protein substrate under a doxycycline-regulated promoter were used for the imaging assays. The imaging assays to monitor mouse SPPL2a and rat SPPL2a activity were established analogous to the human SPPL2a assay but using the sequence of mouse and rat TNFα(aa1-77)-NTF fused to EGFP-NLS, respectively. For all stable cell lines, cells were seeded at 3000 cells/30 μL/384-well in DMEM/GlutaMaxTM-I (Invitrogen) supplemented with tetracycline-free 10% FBS (Amimed) and incubated at 37 °C, 5% CO<sub>2</sub> for 3–4 h. Subsequently, 3.3 μL of inhibitors, prediluted in doxycycline-containing medium for 11-point concentration–response curves, were added to each well using a CyBi well liquid handling device (Cybio AG, Jena, Germany) to result in final inhibitor concentrations ranging from 100 μM to 1 nM (final DMSO concentration 0.9% (v/v)) and 5 μg/mL doxycycline). The cells were incubated with inhibitor at 37 °C, 5% CO<sub>2</sub> for 24 h. Thereafter cell were fixed in 4% PFA/PBS and in parallel, nuclei were stained with Hoechst (Invitrogen) 1:5000 in PBS for 30 min. The plates were imaged using a Cellomics ArrayScan VTI HCS reader with 10×/0.3NA objective (Thermo Fisher Scientific, USA). Six images per well were acquired. Images for the EGFP signal (Ex395, Em509) and the Hoechst nuclear dye (Ex350, Em425) were acquired simultaneously with image analysis using the “Nuclear Translocation” assay algorithm of the Cellomics ArrayScan software. Nuclei were detected based on the Hoechst staining, the nuclear mask was transferred to the EGFP channel, and a 4 pixel wide cytoplasm ring region was defined around the nucleus. The intensity of the EGFP signal was measured both in the nuclear and in the cytoplasm ring region of each individual cell (in general 800–1000 individual cells were analyzed per well), and the difference of the average nuclear versus average cytoplasmic intensity of the EGFP signal was calculated (“CircRingAvgIntenDiffCh2” = “CircAvgIntenCh2” – “RingAvgIntenCh2″). Additionally the number of cells were acquired (feature termed “ValidCellCount”) and used to calculate cell toxicity (CC<sub>50</sub>). Percent inhibition was calculated relative to the positive (0.5 μM <b>42</b> = 100% inhibition) and negative (DMSO = 0% inhibition) controls. The IC<sub>50</sub> value was calculated from the plot of percentage of inhibition vs inhibitor concentration using nonlinear regression analysis software, e.g., Origin (OriginLab Corp.).</div></div><div id="sec6_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> CD74/p8 Mouse Whole Blood Assay</h4><div class="NLM_p last">First, 200 μL of mouse whole blood were transferred in a 800 μL V-deep well plate containing 10 μL of 20× conc compound in DMSO/D-PBS (final concentration of DMSO was 0.5%) and incubated for 5.5 h at 37 °C, 5% CO<sub>2</sub> under the rotation. The blood was then transferred to 1 mL U-deep well plate containing 600 μL of RBC lysis buffer. After extensive washing with RBC lysis buffer, the cell pellet was resuspended 2–3 times with 2× 300 μL of D-PBS and centrifuged. The cell pellet was lysed with 40 μL of lysis buffer (25 mM Tris/HCl pH 6.8/150 mM NaCl/2 mM EDTA/1% Triton X-100/0.5% deoxycholate + complete protease inhibitors) for 20 min and cleared by centrifugation at 4000 rpm for 30 min at 4 °C. Then 12 μL of the lysate was mixed with 10 μL of SDS denaturing solution. The solution was processed by Western blotting, and the CD74/p8 bands were visualized after incubation with a rat antimouse CD74 Ab (ln<sup>–1</sup>). Dose response was determined by quantifying the p8 band intensity calibrated with the CD74 full-length/b-actin band.</div></div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Metabolite Identification</h3><div id="sec6_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> In Vitro Experiment with Liver Microsomes</h4><div class="NLM_p last">Stock solutions of <b>31</b> (2 mmol/L) were prepared in DMSO. Alamethicin solution was prepared (0.125 mmol/L) in water. UDPGA solution (24 mmol/L) was prepared in phosphate buffer 100 mM pH 7.4. In a further experiment, 50 mmol/L GSH in phosphate buffer 100 mM, pH 7.4, was added as a second cofactor. In all samples with active enzymes, a 1:1 mixture of GSH and [<sup>13</sup>C2-<sup>15</sup>N-glycine]-GSH was used. In vitro metabolites were produced by incubation of <b>31</b> at 37 °C for up to 60 min with liver microsomes from mouse, rat, and human. Then 3 μL of liver microsomes, containing 20 mg of protein/mL, were mixed with 417 μL of phosphate buffer, 60 μL of alamethicin solution, and 60 μL of UDPGA. To this reaction mixture, 3 μL of stock solution (2 mM in DMSO) of <b>31</b> was added and preincubated for 3 min at 37 °C. After preincubation, the final reaction was started by addition of 60 μL of the NADPH-regenerating system, containing isocitrate-dehydrogenase (1 U/mL), NADP (1 mmol/L), and isocitrate (5 mmol/L). After 1 h, the reaction was stopped with 600 μL of ice-cold acetonitrile. Experiments were conducted according to a generic protocol. The reaction mixture was stored at −80 °C.</div></div><div id="sec6_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Sample Preparation of In Vitro Samples</h4><div class="NLM_p last">Prior to use, the mixture was centrifuged (10000<i>g</i>, 5 min) and 100 μL of supernatant diluted with 400 μL of water. This final solution was centrifuged again, and aliquots of 5–10 μL were used for HPLC/MS analysis.</div></div><div id="sec6_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Capillary High-Performance Liquid Chromatography–Mass Spectrometry (HPLC/MS)</h4><div class="NLM_p last">Capillary HPLC was performed on a system consisting of a Chorus-220 HPLC pump (CTC Analytics, Zwingen, Switzerland), a Hot Dog-5090 column oven (Prolab, Reinach, Switzerland), and a HTS-PAL autosampler with cooled sample stacks (CTC Analytics, Zwingen, Switzerland). Separations were performed on a Reprosil-Pure-C18-AQ HPLC column (150 mm × 0.3 mm i.d., 3.0 μm particle size) from Maisch (Ammerbuch-Entringen, Germany). Separations were performed at 45 °C. The flow rate was 4.5 μL/min, and the injection volume was 1 μL per separation. The solvent system used consisted of aqueous ammonium formate (10 mM, with 0.02% TFA, pH 4)/MeCN (95/5, v/v) as solvent A and aqueous ammonium formate (10 mM, with 0.02% TFA, pH 4)/MeCN/MeOH (5/90/5, v/v/v) as solvent B. The metabolites were separated using a linear solvent gradient: 0 min (5% B), 2 min (5% B), 27 min (95% B), and 32 min (95% B, 6.5 μL/min). Re-equilibration of the column was performed at 5% B for 5 min. Prior to analysis, 10 μL of sample was diluted 1/100 (v/v) with water/MeCN (90/10, v/v). Samples were kept in the autosampler at 10 °C. A LTQ XL Orbitrap (Linear Quadrupole 2D Ion Trap/Orbitrap, Thermo Scientific, CA, USA) mass spectrometer was used operating in positive mode electrospray ionization (ESI). Settings for the mass spectrometer were 12 (arbitrary units) for sheath gas flow rate (N<sub>2</sub>) and a capillary temperature of 275 °C. Auxiliary and sweep gas were not used. The settings for capillary voltage and tube lens voltage were 45 and 95 V, respectively. Auto gain control (AGC) target settings were 5 × 10<sup>5</sup> and 1 × 10<sup>4</sup> for full MS and MS/MS, respectively. The resolution was set to 30000 in full scan mode. The omnipresent polysiloxane background ion [C<sub>2</sub>H<sub>6</sub>SiO]<sub>6</sub><sup>+</sup> with <i>m</i>/<i>z</i> 445.12003 was used as external lock mass.</div></div></div><div id="sec6_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> In Vivo Experiments</h3><div class="NLM_p">All animals used were 5–12 weeks of age and were maintained in the specific pathogen-free facilities. All animal studies were performed in accordance with the animal experimentation guidelines and laws laid down by the Swiss Federal and Cantonal Authorities. Procedures conducted in the US were approved by the Genomics Institute of the Novartis Research Foundation Institutional Animal Care and Use Committee.</div><div id="sec6_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> In Vivo Pharmacokinetic Studies in Rats</h4><div class="NLM_p last">First, 96–120 h before administration of the test substance, adult female wild-type Sprague–Dawley rats (Iffa Credo, France) were anesthetized with isoflurane and catheters were surgically implanted under aseptic precautions (use of sterile instruments and surgical material in combination with local antibiotic prophylaxis) into the femoral artery and vein. Then the catheters were exteriorized in the neck region, connected to a Harvard swivel system (Harvard Instruments), and filled with 0.9% saline containing 100 U·mL<sup>–1</sup> heparin. After recovery from anesthesia, the animals were housed individually in special cages with free access to food and tap water until and throughout the experiment. Analgesic treatment with Temgesic (10 μg/kg sc, application volume 1 mL/kg) was performed the evening following surgery and the next morning. Compound administration in cassette format was in the morning (6–8 AM). Blood samples were collected at various time points from the femoral artery catheter into Eppendorf tubes coated with sodium EDTA. Blood samples were immediately frozen at −20 °C until final processing (maximum storage was 8 days). Intravenous and oral dosing was typically performed in the same animals after a 48 h wash-out interval between the single dose applications. The test substances were administered intravenously as a solution in 1-methyl-2-pyrrolidone and polyethylene glycol 200 (30:70, v/v) at a dose of 1 mg/kg per compound and orally as a homogeneous aqueous suspension in Tween 80 and carboxymethyl cellulose sodium 0.5/0.5/99 (w/w) at a dose of 3 mg/kg per compound.</div></div><div id="sec6_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> In Vivo Rapid PK Studies in Rats and Mice</h4><div class="NLM_p last">Total of six animals were used for each compound, three for intravenous and three for oral administration. For mouse rapid PK studies, six blood samples (50 μL each) were taken via tail vein bleed and the blood samples from the three animals were pooled and centrifuged to obtain pooled plasma samples. For rat rapid PK studies, six blood samples (100 μL each) were taken via saphenous vein puncture. After centrifugation, 20 μL of the plasma samples are pooled across the three rats based on time point within a dosing arm. The pooled plasma samples were diluted appropriately using a generic dilution scheme to ensure that concentrations are within the dynamic range of the standard curve (1–5000 ng/mL). Automated sample preparation and protein precipitation were carried out. Liquid chromatography/mass spectrometry (LC/MS/MS) analysis was used with a fast generic gradient elution method together with atmospheric pressure chemical ionization (APCI) or electrospray (ESI) in the positive or negative ion mode on an API-4000 triple quadruple mass spectrometer.</div></div><div id="sec6_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Mouse and Rat PK Analysis</h4><div class="NLM_p last">The concentrations of compounds in whole blood were quantified using a liquid chromatography/mass spectrometry (LC-MS/MS) assay. To 10 μL of each blood sample, 2 μL (conc 2.5 μg/mL) of an internal standard was added and the samples were precipitated with 120 μL of acetonitrile. The samples were vortexed thoroughly then centrifuged (10 min, 4 °C). The supernatant (120 μL) was transferred to a clean 96-well plate and mixed with 50 μL of Milli-Q water. The samples were injected (2 μL) onto suitable analytical columns, using gradient methods at various flow rates. Mobile phases typically consisting of 0.1% formic acid in water (solvent A) and 0.1% formic acid in acetonitrile (solvent B) were used. Compounds and the internal standards were eluted at various retention times. The HPLC systems were interfaced to mass spectrometers. MS/MS analyses were carried out using electrospray ionization (ESI), typically in the positive ionization mode. Compounds and the internal standards were monitored using multiple reaction monitoring (MRM). The standard curves employed for sample quantitation ranged over several log units. The lower limit of quantitation (LLOQ) in blood was determined and used as cutoff for the analytical sensitivity. Known amounts of the compounds were spiked into blood to create quality control samples with three to four known concentrations. The accuracy of the in vivo blood sample concentration determination was considered acceptable when the intra-assay accuracies obtained for the quality control samples were within 70% to 130% of the expected concentrations. Subsequently, from the time concentration data, pharmacokinetic parameters were calculated by noncompartmental regression analyses using an in house fitting program.</div></div><div id="sec6_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Analysis of CD74/p8 Accumulation PK/PD Models in Mice and Rats (Blood and Spleen)</h4><div class="NLM_p last">Spleens (rat or mouse) were rinsed in PBS, and the splenocytes were release by mechanical shearing. The cell suspension was centrifuged, and the cell pellet was washed twice in RBC lysis buffer (AMIMED, BioConcept). Aliquots corresponding to 2 × 10<sup>6</sup> cells splenocytes were lysed in 30 μL of lysis buffer (25 mM Tris/HCl pH 6.8 + 150 mM NaCl + 2 mM EDTA + 1% Triton X-100 + 0.5% deoxycholate + complete protease inhibitors from Boehringer) and spun down, and the supernatant was used for Western blotting. Then 200 μL of blood were mixed with 2000 μL of RBC lysis buffer (Amimed; no. 3-13F00-H) then spun down. This treatment was repeated two more time with 300 μL of RBC lysis buffer. The final cell pellet was resuspended in 40 μL of lysis buffer (25 mM Tris/HCl pH 6.8 + 150 mM NaCl + 2 mM EDTA + 1% Triton X-100 + 0.5% deoxycholate + complete protease inhibitors from Boehringer. Mouse CD74/p8 was detected with the ln<sup>–1</sup> Ab used at a dilution of 1:2000 (BD Bioscience no. 555317). Rat CD74/p8 was detected with newly developed Ab. The rat AB was obtained after immunizing rabbits with two peptides (QLPILGQRARAPESNCNR and DDQRDLISNHEQLPIC) encompassing sequences at the N-Terminus of rat CD74 (Eurogentec SA, Belgium). The affinity purified antibody showed a high specificity for rat rCD74/p8 and was used at 1:200 for the experiments with rat material</div></div><div id="sec6_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Analysis of CD74/p8 Accumulation in Mice after Chronic Dosing of Compound <b>40</b></h4><div class="NLM_p last">Animals were gavaged po with the indicated doses of compound in either 0.5% MC:0.5% Tween (40) or PEG:D5W, 3:1. At the indicated time points, spleens were dissected and placed in a Miltenyi GentleMACS C tube with 3 mL cell culture media (DMEM – 10% FBS) and run through one cycle (1 min) of dissociation using the Ms_Spleen_01 program. Spleens were filtered through a cell 40 μM strainer washed with cell culture medium, and red blood cells were lysed with 3 mL of ACK lysis buffer for 5 min at room temperature. Cells were washed twice with cell culture medium and counted to determine total cell numbers. For CD74, 1 × 10<sup>6</sup> cells were lysed with 100 μL of cell lysis buffer (Cell Signaling Technologies), containing PMSF and a protease inhibitor cocktail (HALT, Peirce Scientific). Then 18 μg of cell lysate was run on a 10% Tris-Bis Gel (Novex) and blotted onto nitrocellulose. Membranes were blocked with 5% BSA in TBS-tween. Both full length CD74 and CD74 p8 were detected using rat antimouse CD74, clone IN-1 (BD Pharmingen), and an Alexa488 labeled antirat IgG antibody (LiCor). Blots were scanned on the LI-Cor Odyssey. The full length CD74 band was used to control for loading differences. Percent inhibition was calculated compared by comparing experimental ratio (CD74p8/CD74 full length) to reference compound ratio (<b>42</b> or <b>31</b>).</div></div><div id="sec6_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> PK Sampling</h4><div class="NLM_p last">First, 50 μL of blood was sampled retro-orbitally into LiHep coated tubes (Sardstedt) at the indicated time points. For chronically dosed mice, a trough exposure sample was obtained prior to AM dosing. Samples were kept on ice until plasma separation. Samples were spun at 2823<i>g</i> for 5 min at rt to separate out plasma. Samples were stored at −20 °C until analysis.</div></div><div id="sec6_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Flow Cytometry of Spleen Cells</h4><div class="NLM_p last">Aliquots of 1 × 10<sup>6</sup> splenocytes were stained in FACS buffer (1× HBSS, 2% FBS, 5 mM EDTA) with the following antimouse antibody cocktails for 30 min on ice in the dark (all antibodies purchased from Biolegend B cells (B220 (clone RA3-6B2), CD21 (clone 7E9), CD23 (clone B3B4), IgM (clone 7E9), and IgD (clone 11–26c.2a)). T-cells: (CD4 (clone GK1.5), CD62L (clone MEL-14), CD3 (clone 17A2), CD8 (clone 53-6.7), and CD44 (clone IM7)). Plasma cells/GC B cells: (B220 (clone RA3-6B2), GL7 (cloneGL7), CD95 (clone SA367H8), CD19 (clone 6D5), CD138 (clone 281-2), and CD11c (clone N418)). Dendritic cells: (PDCA1 (clone 927), CD3 (clone 17A2), NK-1 (clone PK136), CD19 (clone 6D5), CD8 (clone 53-6.7), CD11c (clone N418), and MHCII (clone M5/114.15.2)). Samples were acquired on a BD Fortessa flow cytometer (Beckton Dickinson, Mountain View, CA). Data was analyzed using FlowJo software.</div></div><div id="sec6_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Hes1 mRNA Analysis; RNA Extraction and Real-Time PCR</h4><div class="NLM_p last">Thymi and jejunum were excised from mice and placed into 1 mL of RNALater solution (Ambion). Samples were kept at 4 °C overnight. The next day, samples were washed with H<sub>2</sub>O (1 mL) and frozen at −80 °C until further analysis. Total RNA samples were extracted from 10 mg of thymus and jejunum by using the MagNA Pure LC RNA isolation high performance kit according to the manufacturer instructions (Roche Diagnostic). Taqman assays were purchased from Applied Biosystems and used for real-time polymerase chain reaction (RT-PCR) analysis as previously described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Statistical significance of mRNA measurements was assessed using the two-sample unequal variance, two-tailed distribution (heteroscedastic Student’s <i>t</i>-test, Excel). Coefficients of variation with a <i>P</i> value <0.05 were considered to be statistically significant.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01371">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01371" class="ext-link">10.1021/acs.jmedchem.7b01371</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis procedures and characterization data for all compounds, HPLC and NMR charts and X-ray crystallographic data for compound <b>40</b> (CCDC 1574028) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_001.pdf">jm7b01371_si_001.pdf (1.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_002.csv">jm7b01371_si_002.csv (1.48 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01371" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juraj Velcicky</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6564-1448" title="Orcid link">http://orcid.org/0000-0001-6564-1448</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#95ffe0e7f4ffbbe3f0f9f6fcf6feecd5fbfae3f4e7e1fce6bbf6faf8"><span class="__cf_email__" data-cfemail="29435c5b4843075f4c454a404a42506947465f485b5d405a074a4644">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ursula Bodendorf</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Rigollier</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Epple</span> - <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel R. Beisner</span> - <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danilo Guerini</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Smith</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo Liu</span> - <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland Feifel</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Wipfli</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reiner Aichholz</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Couttet</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ina Dix</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toni Widmer</span> - <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Wen</span> - <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Trixi Brandl</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Autoimmunity Transplantation Inflammation, §Pharmacokinetic Sciences, ∥Preclinical Safety, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">The
Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d164e3692-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank D. Pflieger, R. Steiner, J. Müller, T. Rohrbach, S. Nakagawa, J. McKenna, S. Kopec, P. Pannini, M. Azimioara, V. Nikulin, C. Cow, H. Schütz, C. Hartwieg, M. Kamke, T.-T.-T. Tran, D. Buffet, O. Dreier,and S. Zaharevitz for their excellent assistance and support of the work described in this paper.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i49" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i49"> Abbreviations Used</h2><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">ethyldiisopropyl amine</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)-propyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">ENU</td><td class="NLM_def"><p class="first last"><i>N</i>-ethyl-<i>N</i>-nitrosourea</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence-activated cell sorting</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium-hexafluorphosphate</p></td></tr><tr><td class="NLM_term">ko</td><td class="NLM_def"><p class="first last">knockout</p></td></tr><tr><td class="NLM_term">TOTU</td><td class="NLM_def"><p class="first last"><i>O</i>-[(ethoxycarbonyl)cyanomethylenamino]-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">MC</td><td class="NLM_def"><p class="first last">methylcellulose</p></td></tr><tr><td class="NLM_term">UDPGA</td><td class="NLM_def"><p class="first last">uridine 5′-diphospho-glucuronic acid</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Regulated intramembrane proteolysis-lessons from amyloid precursor protein processing</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07248.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1111%2Fj.1471-4159.2011.07248.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=21413990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFCmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=779-796&author=S.+F.+Lichtenthalerauthor=C.+Haassauthor=H.+Steiner&title=Regulated+intramembrane+proteolysis-lessons+from+amyloid+precursor+protein+processing&doi=10.1111%2Fj.1471-4159.2011.07248.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing</span></div><div class="casAuthors">Lichtenthaler, Stefan F.; Haass, Christian; Steiner, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">779-796</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Regulated intramembrane proteolysis (RIP) controls the communication between cells and the extracellular environment.  RIP is essential in the nervous system, but also in other tissues.  In the RIP process, a membrane protein typically undergoes two consecutive cleavages.  The first one results in the shedding of its ectodomain.  The second one occurs within its transmembrane domain, resulting in secretion of a small peptide and the release of the intracellular domain into the cytosol.  The proteolytic cleavage fragments act as versatile signaling mols. or are further degraded.  An increasing no. of membrane proteins undergo RIP.  These include growth factors, cytokines, cell adhesion proteins, receptors, viral proteins and signal peptides.  A dysregulation of RIP is found in diseases, such as leukemia and Alzheimer's disease.  One of the first RIP substrates discovered was the amyloid precursor protein (APP).  RIP processing of APP controls the generation of the amyloid β-peptide, which is believed to cause Alzheimer's disease.  Focusing on APP as the best-studied RIP substrate, this review describes the function and mechanism of the APP RIP proteases with the goal to elucidate cellular mechanisms and common principles of the RIP process in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-9xiT7_ssWrVg90H21EOLACvtfcHk0lhjoyjSMZ0HBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFCmt7w%253D&md5=37055c2d190701cc5c8eaf80c439a42f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07248.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07248.x%26sid%3Dliteratum%253Aachs%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DRegulated%2520intramembrane%2520proteolysis-lessons%2520from%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D117%26spage%3D779%26epage%3D796%26doi%3D10.1111%2Fj.1471-4159.2011.07248.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Urban, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, M.</span><span> </span><span class="NLM_article-title">Intramembrane proteolysis controls diverse signaling pathways throughout evolution</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1016/S0959-437X(02)00334-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2FS0959-437X%2802%2900334-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=512-518&author=S.+Urbanauthor=M.+Freeman&title=Intramembrane+proteolysis+controls+diverse+signaling+pathways+throughout+evolution&doi=10.1016%2FS0959-437X%2802%2900334-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0959-437X%2802%2900334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-437X%252802%252900334-9%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DS.%26aulast%3DFreeman%26aufirst%3DM.%26atitle%3DIntramembrane%2520proteolysis%2520controls%2520diverse%2520signaling%2520pathways%2520throughout%2520evolution%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2002%26volume%3D12%26spage%3D512%26epage%3D518%26doi%3D10.1016%2FS0959-437X%2802%2900334-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Intramembrane-cleaving proteases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">13969</span><span class="NLM_x">–</span> <span class="NLM_lpage">13973</span><span class="refDoi"> DOI: 10.1074/jbc.R800039200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.R800039200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=13969-13973&author=M.+S.+Wolfe&title=Intramembrane-cleaving+proteases&doi=10.1074%2Fjbc.R800039200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R800039200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R800039200%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DIntramembrane-cleaving%2520proteases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D13969%26epage%3D13973%26doi%3D10.1074%2Fjbc.R800039200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">MacLeod, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillert, E.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, G. S.</span><span> </span><span class="NLM_article-title">The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer’s disease</span> <span class="citation_source-journal">Future Sci. OA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">FSO.15.9</span><span class="refDoi"> DOI: 10.4155/fso.15.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.4155%2Ffso.15.9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=FSO.15.9&author=R.+MacLeodauthor=E.-K.+Hillertauthor=R.+T.+Cameronauthor=G.+S.+Baillie&title=The+role+and+therapeutic+targeting+of+%CE%B1-%2C+%CE%B2-+and+%CE%B3-secretase+in+Alzheimer%E2%80%99s+disease&doi=10.4155%2Ffso.15.9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4155%2Ffso.15.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffso.15.9%26sid%3Dliteratum%253Aachs%26aulast%3DMacLeod%26aufirst%3DR.%26aulast%3DHillert%26aufirst%3DE.-K.%26aulast%3DCameron%26aufirst%3DR.%2BT.%26aulast%3DBaillie%26aufirst%3DG.%2BS.%26atitle%3DThe%2520role%2520and%2520therapeutic%2520targeting%2520of%2520%25CE%25B1-%252C%2520%25CE%25B2-%2520and%2520%25CE%25B3-secretase%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFuture%2520Sci.%2520OA%26date%3D2015%26volume%3D1%26spage%3DFSO.15.9%26doi%3D10.4155%2Ffso.15.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Weihofen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemberg, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span> </span><span class="NLM_article-title">Identification of signal peptide peptidase, a presenilin-type aspartic protease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">2215</span><span class="NLM_x">–</span> <span class="NLM_lpage">2218</span><span class="refDoi"> DOI: 10.1126/science.1070925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1126%2Fscience.1070925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=12077416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFGhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=2215-2218&author=A.+Weihofenauthor=K.+Binnsauthor=M.+K.+Lembergauthor=K.+Ashmanauthor=B.+Martoglio&title=Identification+of+signal+peptide+peptidase%2C+a+presenilin-type+aspartic+protease&doi=10.1126%2Fscience.1070925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of signal peptide peptidase, a presenilin-type aspartic protease</span></div><div class="casAuthors">Weihofen, Andreas; Binns, Kathleen; Lemberg, Marius K.; Ashman, Keith; Martoglio, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5576</span>),
    <span class="NLM_cas:pages">2215-2218</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Signal peptide peptidase (SPP) catalyzes intramembrane proteolysis of some signal peptides after they have been cleaved from a preprotein.  In humans, SPP activity is required to generate signal sequence-derived human lymphocyte antigen-E epitopes that are recognized by the immune system, and to process hepatitis C virus core protein.  We have identified human SPP as a polytopic membrane protein with sequence motifs characteristic of the presenilin-type aspartic proteases.  SPP and potential eukaryotic homologs may represent another family of aspartic proteases that promote intramembrane proteolysis to release biol. important peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ6nsu9YfU2bVg90H21EOLACvtfcHk0lgPgyuNvkipUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFGhtrg%253D&md5=65ab559d2949577e92d7e9da70031698</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1070925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1070925%26sid%3Dliteratum%253Aachs%26aulast%3DWeihofen%26aufirst%3DA.%26aulast%3DBinns%26aufirst%3DK.%26aulast%3DLemberg%26aufirst%3DM.%2BK.%26aulast%3DAshman%26aufirst%3DK.%26aulast%3DMartoglio%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520signal%2520peptide%2520peptidase%252C%2520a%2520presenilin-type%2520aspartic%2520protease%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D2215%26epage%3D2218%26doi%3D10.1126%2Fscience.1070925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mentrup, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span> </span><span class="NLM_article-title">Latest emerging functions of SPP/SPPL intramembrane proteases</span> <span class="citation_source-journal">Eur. J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span><span class="refDoi"> DOI: 10.1016/j.ejcb.2017.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.ejcb.2017.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=28366434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVCjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2017&pages=372-382&author=T.+Mentrupauthor=R.+Fluhrerauthor=B.+Schr%C3%B6der&title=Latest+emerging+functions+of+SPP%2FSPPL+intramembrane+proteases&doi=10.1016%2Fj.ejcb.2017.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Latest emerging functions of SPP/SPPL intramembrane proteases</span></div><div class="casAuthors">Mentrup, Torben; Fluhrer, Regina; Schroeder, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-382</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  Signal peptide peptidase (SPP) and the four related SPP-like (SPPL) proteases are homologues of the presenilins, which comprise the catalytic center of the γ-secretase complex.  SPP/SPPL proteases are GxGD-type aspartyl intramembrane proteases selective for substrates with a type II membrane topol.  Subcellular localisations of SPP/SPPL proteases range from the early secretory pathway to the plasma membrane and the endocytic system.  Similarly diverse are their functional roles at the cellular level covering the turnover of signal peptides and membrane proteins, a contribution to the ERAD pathway as well as the regulation of cellular protein glycosylation and certain signaling pathways.  Much less well understood are the physiol. functions of SPP/SPPL proteases in complex organisms.  Whereas a major role of SPPL2a for homeostasis of B cells and dendritic cells has been documented in mice, in vivo functions of SPP and the other SPPLs remain largely elusive to date.  SPP/SPPL proteases contribute to regulated intramembrane proteolysis (RIP), a sequential processing of single-spanning transmembrane proteins by an ectodomain sheddase and an intramembrane-cleaving protease (I-CLIP).  However, recent studies reported the cleavage of tail-anchored and multi-pass membrane proteins by SPP as well as the capability of SPPL3 to accept substrates without a preceding ectodomain shedding.  This revealed that the mechanistic properties within this family are more diverse than initially thought.  With this review, we aim to provide an update on recent achievements in defining the function and (patho-) physiol. relevance of SPP/SPPL proteases and to highlight open questions in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEEXnd2id2-bVg90H21EOLACvtfcHk0lgPgyuNvkipUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVCjtLc%253D&md5=425b512d8753cea339a384582855e95a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ejcb.2017.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejcb.2017.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMentrup%26aufirst%3DT.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26atitle%3DLatest%2520emerging%2520functions%2520of%2520SPP%252FSPPL%2520intramembrane%2520proteases%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D2017%26volume%3D96%26spage%3D372%26epage%3D382%26doi%3D10.1016%2Fj.ejcb.2017.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Friedmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauben, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maylandt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleeger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vreugde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span> </span><span class="NLM_article-title">SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1038/ncb1440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1038%2Fncb1440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=16829952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFWqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=843-848&author=E.+Friedmannauthor=E.+Haubenauthor=K.+Maylandtauthor=S.+Schleegerauthor=S.+Vreugdeauthor=S.+F.+Lichtenthalerauthor=P.-H.+Kuhnauthor=D.+Staufferauthor=G.+Rovelliauthor=B.+Martoglio&title=SPPL2a+and+SPPL2b+promote+intramembrane+proteolysis+of+TNF%CE%B1+in+activated+dendritic+cells+to+trigger+IL-12+production&doi=10.1038%2Fncb1440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production</span></div><div class="casAuthors">Friedmann, Elena; Hauben, Ehud; Maylandt, Kerstin; Schleeger, Simone; Vreugde, Sarah; Lichtenthaler, Stefan F.; Kuhn, Peer-Hendrik; Stauffer, Daniela; Rovelli, Giorgio; Martoglio, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">843-848</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Homologs of signal peptide peptidase (SPPLs) are putative aspartic proteases that may catalyze regulated intramembrane proteolysis of type II membrane-anchored signaling factors.  Here, the authors show that four human SPPLs are each sorted to a different compartment of the secretory pathway.  The authors demonstrate that SPPL2a and SPPL2b, which are sorted to endosomes and the plasma membrane, resp., are functional proteases that catalyze intramembrane cleavage of tumor necrosis factor alpha (TNFα).  The two proteases promoted the release of the TNFα intracellular domain, which in turn triggers expression of the pro-inflammatory cytokine interleukin-12 by activated human dendritic cells.  The authors' study reveals a crit. function for SPPL2a and SPPL2b in the regulation of innate and adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqqsJFjHHbobVg90H21EOLACvtfcHk0lgPgyuNvkipUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFWqur4%253D&md5=dda66127e85387cde033b66726c6fc18</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncb1440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1440%26sid%3Dliteratum%253Aachs%26aulast%3DFriedmann%26aufirst%3DE.%26aulast%3DHauben%26aufirst%3DE.%26aulast%3DMaylandt%26aufirst%3DK.%26aulast%3DSchleeger%26aufirst%3DS.%26aulast%3DVreugde%26aufirst%3DS.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DKuhn%26aufirst%3DP.-H.%26aulast%3DStauffer%26aufirst%3DD.%26aulast%3DRovelli%26aufirst%3DG.%26aulast%3DMartoglio%26aufirst%3DB.%26atitle%3DSPPL2a%2520and%2520SPPL2b%2520promote%2520intramembrane%2520proteolysis%2520of%2520TNF%25CE%25B1%2520in%2520activated%2520dendritic%2520cells%2520to%2520trigger%2520IL-12%2520production%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2006%26volume%3D8%26spage%3D843%26epage%3D848%26doi%3D10.1038%2Fncb1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Voss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span> </span><span class="NLM_article-title">Mechanism, specificity, and physiology of Signal Peptide Peptidase (SPP) and SPP-like proteases</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1828</span><span class="NLM_x">, </span> <span class="NLM_fpage">2828</span><span class="NLM_x">–</span> <span class="NLM_lpage">2839</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.03.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bbamem.2013.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=24099004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOgur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1828&publication_year=2013&pages=2828-2839&author=M.+Vossauthor=B.+Schr%C3%B6derauthor=R.+Fluhrer&title=Mechanism%2C+specificity%2C+and+physiology+of+Signal+Peptide+Peptidase+%28SPP%29+and+SPP-like+proteases&doi=10.1016%2Fj.bbamem.2013.03.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases</span></div><div class="casAuthors">Voss, Matthias; Schroeder, Bernd; Fluhrer, Regina</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1828</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2828-2839</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Signal peptide peptidase (SPP) and the homologous SPP-like (SPPL) proteases SPPL2a, SPPL2b, SPPL2c and SPPL3 belong to the family of GxGD intramembrane proteases.  SPP/SPPLs selectively cleave transmembrane domains in type II orientation and do not require addnl. co-factors for proteolytic activity.  Orthologues of SPP and SPPLs have been identified in other vertebrates, plants, and eukaryotes.  In line with their diverse subcellular localizations ranging from the ER (SPP, SPPL2c), the Golgi (SPPL3), the plasma membrane (SPPL2b) to lysosomes/late endosomes (SPPL2a), the different members of the SPP/SPPL family seem to exhibit distinct functions.  Here, we review the substrates of these proteases identified to date as well as the current state of knowledge about the physiol. implications of these proteolytic events as deduced from in vivo studies.  Furthermore, the present knowledge on the structure of intramembrane proteases of the SPP/SPPL family, their cleavage mechanism and their substrate requirements are summarized.  This article is part of a Special Issue entitled: Intramembrane Proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZysnLRit4f7Vg90H21EOLACvtfcHk0li29bRvKUdr9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOgur3I&md5=60410dfbc6511de4bb2e029a3dbda3e7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DVoss%26aufirst%3DM.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26aulast%3DFluhrer%26aufirst%3DR.%26atitle%3DMechanism%252C%2520specificity%252C%2520and%2520physiology%2520of%2520Signal%2520Peptide%2520Peptidase%2520%2528SPP%2529%2520and%2520SPP-like%2520proteases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2013%26volume%3D1828%26spage%3D2828%26epage%3D2839%26doi%3D10.1016%2Fj.bbamem.2013.03.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kirkin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahuzac, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardiola-Serrano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckerath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novac, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wels, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hueber, A.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zornig, M.</span><span> </span><span class="NLM_article-title">The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1678</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4402175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1038%2Fsj.cdd.4402175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=17557115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFymtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1678-1687&author=V.+Kirkinauthor=N.+Cahuzacauthor=F.+Guardiola-Serranoauthor=S.+Huaultauthor=K.+Luckerathauthor=E.+Friedmannauthor=N.+Novacauthor=W.+S.+Welsauthor=B.+Martoglioauthor=A.-O.+Hueberauthor=M.+Zornig&title=The+Fas+ligand+intracellular+domain+is+released+by+ADAM10+and+SPPL2a+cleavage+in+T-cells&doi=10.1038%2Fsj.cdd.4402175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells</span></div><div class="casAuthors">Kirkin, V.; Cahuzac, N.; Guardiola-Serrano, F.; Huault, S.; Lueckerath, K.; Friedmann, E.; Novac, N.; Wels, W. S.; Martoglio, B.; Hueber, A.-O.; Zoernig, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1678-1687</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fas ligand (FasL) is a type II transmembrane protein belonging to the tumor necrosis factor family.  Its binding to the cognate Fas receptor triggers the apoptosis that plays a pivotal role in the maintenance of immune system homeostasis.  The cell death-inducing property of FasL has been assocd. with its extracellular domain, which can be cleaved off by metalloprotease activity to produce sol. FasL.  The fate of the remaining membrane-anchored N-terminal part of the FasL mol. has not been detd.  Here we show that post-translational processing of overexpressed and endogenous FasL in T-cells by the disintegrin and metalloprotease ADAM10 generates a 17-kDa N-terminal fragment, which lacks the receptor-binding extracellular domain.  This FasL remnant is membrane anchored and further processed by SPPL2a, a member of the signal peptide peptidase-like family of intramembrane-cleaving proteases.  SPPL2a cleavage liberates a smaller and highly unstable fragment mainly contg. the intracellular FasL domain (FasL ICD).  We show that this fragment translocates to the nucleus and is capable of inhibiting gene transcription.  With ADAM10 and SPPL2a we have identified two proteases implicated in FasL processing and release of the FasL ICD, which has been shown to be important for retrograde FasL signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrziEQPMDtDZrVg90H21EOLACvtfcHk0li29bRvKUdr9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFymtbc%253D&md5=8201ec4f8ca123cd41076e64cdf40049</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402175%26sid%3Dliteratum%253Aachs%26aulast%3DKirkin%26aufirst%3DV.%26aulast%3DCahuzac%26aufirst%3DN.%26aulast%3DGuardiola-Serrano%26aufirst%3DF.%26aulast%3DHuault%26aufirst%3DS.%26aulast%3DLuckerath%26aufirst%3DK.%26aulast%3DFriedmann%26aufirst%3DE.%26aulast%3DNovac%26aufirst%3DN.%26aulast%3DWels%26aufirst%3DW.%2BS.%26aulast%3DMartoglio%26aufirst%3DB.%26aulast%3DHueber%26aufirst%3DA.-O.%26aulast%3DZornig%26aufirst%3DM.%26atitle%3DThe%2520Fas%2520ligand%2520intracellular%2520domain%2520is%2520released%2520by%2520ADAM10%2520and%2520SPPL2a%2520cleavage%2520in%2520T-cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D1678%26epage%3D1687%26doi%3D10.1038%2Fsj.cdd.4402175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1644</span><span class="NLM_x">–</span> <span class="NLM_lpage">1652</span><span class="refDoi"> DOI: 10.1074/jbc.M706661200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M706661200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=1644-1652&author=L.+Martinauthor=R.+Fluhrerauthor=K.+Reissauthor=E.+Kremmerauthor=P.+Saftigauthor=C.+Haass&title=Regulated+intramembrane+proteolysis+of+Bri2+%28Itm2b%29+by+ADAM10+and+SPPL2a%2FSPPL2b&doi=10.1074%2Fjbc.M706661200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M706661200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M706661200%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DReiss%26aufirst%3DK.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DRegulated%2520intramembrane%2520proteolysis%2520of%2520Bri2%2520%2528Itm2b%2529%2520by%2520ADAM10%2520and%2520SPPL2a%252FSPPL2b%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D1644%26epage%3D1652%26doi%3D10.1074%2Fjbc.M706661200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Beisner, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langerak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otero, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltshire, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodendorf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span> </span><span class="NLM_article-title">The intramembrane protease SPPL2a is required for B cell and DC development and survival via cleavage of the invariant chain</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1084/jem.20121072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1084%2Fjem.20121072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23267013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Oitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=23-30&author=D.+R.+Beisnerauthor=P.+Langerakauthor=A.+E.+Parkerauthor=C.+Dahlbergauthor=F.+J.+Oteroauthor=S.+E.+Suttonauthor=L.+Poirotauthor=W.+Barnesauthor=M.+A.+Youngauthor=S.+Niessenauthor=T.+Wiltshireauthor=U.+Bodendorfauthor=B.+Martoglioauthor=B.+Cravattauthor=M.+P.+Cooke&title=The+intramembrane+protease+SPPL2a+is+required+for+B+cell+and+DC+development+and+survival+via+cleavage+of+the+invariant+chain&doi=10.1084%2Fjem.20121072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain</span></div><div class="casAuthors">Beisner, Daniel R.; Langerak, Petra; Parker, Albert E.; Dahlberg, Carol; Otero, Francella J.; Sutton, Sue E.; Poirot, Laurent; Barnes, Whitney; Young, Michael A.; Niessen, Sherry; Wiltshire, Tim; Bodendorf, Ursula; Martoglio, Bruno; Cravatt, Benjamin; Cooke, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-30</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">B cell development requires tight regulation to allow for the generation of a diverse repertoire while preventing the development of autoreactive cells.  We report, using N-ethyl-N-nitrosourea (ENU)-induced mutagenesis, the identification of a mutant mouse (chompB) with a block in early B cell development.  The blockade occurs after the transitional 1 (T1) stage and leads to a decrease in mature B cell subsets and deficits in T cell-dependent antibody responses.  Addnl., chompB mice have decreases in myeloid dendritic cells (DCs).  The mutation was mapped to the intramembrane protease signal peptide peptidase-like 2a (Sppl2a), a gene not previously implicated in immune cell development.  Proteomic anal. identified the invariant chain (CD74) as a key substrate of Sppl2a and suggests that regulated intramembrane proteolysis of CD74 by Sppl2a contributes to B cell and DC survival.  Moreover, these data suggest that modulation of Sppl2a may be a useful therapeutic strategy for treatment of B cell dependent autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz5IaIoDFCJrVg90H21EOLACvtfcHk0li29bRvKUdr9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Oitbs%253D&md5=001a2fe7aca2a8d5bb669833e155dff9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1084%2Fjem.20121072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20121072%26sid%3Dliteratum%253Aachs%26aulast%3DBeisner%26aufirst%3DD.%2BR.%26aulast%3DLangerak%26aufirst%3DP.%26aulast%3DParker%26aufirst%3DA.%2BE.%26aulast%3DDahlberg%26aufirst%3DC.%26aulast%3DOtero%26aufirst%3DF.%2BJ.%26aulast%3DSutton%26aufirst%3DS.%2BE.%26aulast%3DPoirot%26aufirst%3DL.%26aulast%3DBarnes%26aufirst%3DW.%26aulast%3DYoung%26aufirst%3DM.%2BA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DWiltshire%26aufirst%3DT.%26aulast%3DBodendorf%26aufirst%3DU.%26aulast%3DMartoglio%26aufirst%3DB.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26atitle%3DThe%2520intramembrane%2520protease%2520SPPL2a%2520is%2520required%2520for%2520B%2520cell%2520and%2520DC%2520development%2520and%2520survival%2520via%2520cleavage%2520of%2520the%2520invariant%2520chain%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D23%26epage%3D30%26doi%3D10.1084%2Fjem.20121072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bergmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Short, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miosge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teh, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roots, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeelall, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakishnan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjollema, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimmer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornall, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodnow, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enders, A.</span><span> </span><span class="NLM_article-title">B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8– dendritic cells require the intramembrane endopeptidase SPPL2A</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1084/jem.20121076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1084%2Fjem.20121076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23267016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=31-40&author=H.+Bergmannauthor=M.+Yabasauthor=A.+Shortauthor=L.+Miosgeauthor=N.+Barthelauthor=C.+E.+Tehauthor=C.+M.+Rootsauthor=K.+R.+Bullauthor=Y.+Jeelallauthor=K.+Horikawaauthor=B.+Whittleauthor=B.+Balakishnanauthor=G.+Sjollemaauthor=E.+M.+Bertramauthor=F.+Mackayauthor=A.+J.+Rimmerauthor=R.+J.+Cornallauthor=M.+A.+Fieldauthor=T.+D.+Andrewsauthor=C.+C.+Goodnowauthor=A.+Enders&title=B+cell+survival%2C+surface+BCR+and+BAFFR+expression%2C+CD74+metabolism%2C+and+CD8%E2%80%93+dendritic+cells+require+the+intramembrane+endopeptidase+SPPL2A&doi=10.1084%2Fjem.20121076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A</span></div><div class="casAuthors">Bergmann, Hannes; Yabas, Mehmet; Short, Alanna; Miosge, Lisa; Barthel, Nadine; Teh, Charis E.; Roots, Carla M.; Bull, Katherine R.; Jeelall, Yogesh; Horikawa, Keisuke; Whittle, Belinda; Balakishnan, Bhavani; Sjollema, Geoff; Bertram, Edward M.; Mackay, Fabienne; Rimmer, Andrew J.; Cornall, Richard J.; Field, Matthew A.; Andrews, T. Daniel; Goodnow, Christopher C.; Enders, Anselm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Druggable proteins required for B lymphocyte survival and immune responses are an emerging source of new treatments for autoimmunity and lymphoid malignancy.  In this study, we show that mice with an inactivating mutation in the intramembrane protease signal peptide peptidase-like 2A (SPPL2A) unexpectedly exhibit profound humoral immunodeficiency and lack mature B cell subsets, mirroring deficiency of the cytokine B cell-activating factor (BAFF).  Accumulation of Sppl2a-deficient B cells was rescued by overexpression of the BAFF-induced survival protein B cell lymphoma 2 (BCL2) but not BAFF and was distinguished by low surface BAFF receptor and IgM and IgD B cell receptors.  CD8-neg. dendritic cells were also greatly decreased.  SPPL2A deficiency blocked the proteolytic processing of CD74 MHC II invariant chain in both cell types, causing dramatic build-up of the p8 product of Cathepsin S and interfering with earlier steps in CD74 endosomal retention and processing.  The findings illuminate an important role for the final step in the CD74-MHC II pathway and a new target for protease inhibitor treatment of B cell diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz2NdHY5Fb0bVg90H21EOLACvtfcHk0li50U37UD3jIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OitbY%253D&md5=d9fe646a22d2639d4fdf22e271736b98</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1084%2Fjem.20121076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20121076%26sid%3Dliteratum%253Aachs%26aulast%3DBergmann%26aufirst%3DH.%26aulast%3DYabas%26aufirst%3DM.%26aulast%3DShort%26aufirst%3DA.%26aulast%3DMiosge%26aufirst%3DL.%26aulast%3DBarthel%26aufirst%3DN.%26aulast%3DTeh%26aufirst%3DC.%2BE.%26aulast%3DRoots%26aufirst%3DC.%2BM.%26aulast%3DBull%26aufirst%3DK.%2BR.%26aulast%3DJeelall%26aufirst%3DY.%26aulast%3DHorikawa%26aufirst%3DK.%26aulast%3DWhittle%26aufirst%3DB.%26aulast%3DBalakishnan%26aufirst%3DB.%26aulast%3DSjollema%26aufirst%3DG.%26aulast%3DBertram%26aufirst%3DE.%2BM.%26aulast%3DMackay%26aufirst%3DF.%26aulast%3DRimmer%26aufirst%3DA.%2BJ.%26aulast%3DCornall%26aufirst%3DR.%2BJ.%26aulast%3DField%26aufirst%3DM.%2BA.%26aulast%3DAndrews%26aufirst%3DT.%2BD.%26aulast%3DGoodnow%26aufirst%3DC.%2BC.%26aulast%3DEnders%26aufirst%3DA.%26atitle%3DB%2520cell%2520survival%252C%2520surface%2520BCR%2520and%2520BAFFR%2520expression%252C%2520CD74%2520metabolism%252C%2520and%2520CD8%25E2%2580%2593%2520dendritic%2520cells%2520require%2520the%2520intramembrane%2520endopeptidase%2520SPPL2A%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D31%26epage%3D40%26doi%3D10.1084%2Fjem.20121076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Schneppenheim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dressel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hüttl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lüllmann-Rauch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wienands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskelinen, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermans-Borgmeyer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span> </span><span class="NLM_article-title">The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1084/jem.20121069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1084%2Fjem.20121069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23267015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Oiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=41-58&author=J.+Schneppenheimauthor=R.+Dresselauthor=S.+H%C3%BCttlauthor=R.+L%C3%BCllmann-Rauchauthor=M.+Engelkeauthor=K.+Dittmannauthor=J.+Wienandsauthor=E.+L.+Eskelinenauthor=I.+Hermans-Borgmeyerauthor=R.+Fluhrerauthor=P.+Saftigauthor=B.+Schr%C3%B6der&title=The+intramembrane+protease+SPPL2a+promotes+B+cell+development+and+controls+endosomal+traffic+by+cleavage+of+the+invariant+chain&doi=10.1084%2Fjem.20121069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain</span></div><div class="casAuthors">Schneppenheim, Janna; Dressel, Ralf; Huettl, Susann; Luellmann-Rauch, Renate; Engelke, Michael; Dittmann, Kai; Wienands, Juergen; Eskelinen, Eeva-Liisa; Hermans-Borgmeyer, Irm; Fluhrer, Regina; Saftig, Paul; Schroeder, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-58</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Regulated intramembrane proteolysis is a central cellular process involved in signal transduction and membrane protein turnover.  The presenilin homolog signal-peptide-peptidase-like 2a (SPPL2a) has been implicated in the cleavage of type 2 transmembrane proteins.  We show that the invariant chain (li, CD74) of the major histocompatibility class II complex (MHCII) undergoes intramembrane proteolysis mediated by SPPL2a.  B lymphocytes of SPPL2a-/- mice accumulate an N-terminal fragment (NTF) of CD74, which severely impairs membrane traffic within the endocytic system and leads to an altered response to B cell receptor stimulation, reduced BAFF-R surface expression, and accumulation of MHCII in transitional developmental stage T1 B cells.  This results in significant loss of B cell subsets beyond the T1 stage and disrupted humoral immune responses, which can be recovered by addnl. ablation of CD74.  Hence, we provide evidence that regulation of CD74-NTF levels by SPPL2a is indispensable for B cell development and function by maintaining trafficking and integrity of MHCII-contg. endosomes, highlighting SPPL2a as a promising pharmacol. target for depleting and/or modulating B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZnP7A8vHZkbVg90H21EOLACvtfcHk0li50U37UD3jIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Oiur4%253D&md5=569515655d4afbc18e6a0627bdf16708</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1084%2Fjem.20121069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20121069%26sid%3Dliteratum%253Aachs%26aulast%3DSchneppenheim%26aufirst%3DJ.%26aulast%3DDressel%26aufirst%3DR.%26aulast%3DH%25C3%25BCttl%26aufirst%3DS.%26aulast%3DL%25C3%25BCllmann-Rauch%26aufirst%3DR.%26aulast%3DEngelke%26aufirst%3DM.%26aulast%3DDittmann%26aufirst%3DK.%26aulast%3DWienands%26aufirst%3DJ.%26aulast%3DEskelinen%26aufirst%3DE.%2BL.%26aulast%3DHermans-Borgmeyer%26aufirst%3DI.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26atitle%3DThe%2520intramembrane%2520protease%2520SPPL2a%2520promotes%2520B%2520cell%2520development%2520and%2520controls%2520endosomal%2520traffic%2520by%2520cleavage%2520of%2520the%2520invariant%2520chain%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D41%26epage%3D58%26doi%3D10.1084%2Fjem.20121069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Brady, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, F.</span><span> </span><span class="NLM_article-title">Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by Signal Peptide Peptidase-like 2a (SPPL2a)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">19670</span><span class="NLM_x">–</span> <span class="NLM_lpage">19680</span><span class="refDoi"> DOI: 10.1074/jbc.M113.515700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M113.515700" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=19670-19680&author=O.+A.+Bradyauthor=X.+Zhouauthor=F.+Hu&title=Regulated+intramembrane+proteolysis+of+the+frontotemporal+lobar+degeneration+risk+factor%2C+TMEM106B%2C+by+Signal+Peptide+Peptidase-like+2a+%28SPPL2a%29&doi=10.1074%2Fjbc.M113.515700"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.515700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.515700%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DO.%2BA.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DF.%26atitle%3DRegulated%2520intramembrane%2520proteolysis%2520of%2520the%2520frontotemporal%2520lobar%2520degeneration%2520risk%2520factor%252C%2520TMEM106B%252C%2520by%2520Signal%2520Peptide%2520Peptidase-like%25202a%2520%2528SPPL2a%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D19670%26epage%3D19680%26doi%3D10.1074%2Fjbc.M113.515700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fleck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brankatschk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwenk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edbauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug-Kröper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Proteolytic processing of Neuregulin 1 type III by three intramembrane-cleaving proteases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1074/jbc.M115.697995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M115.697995" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=318-333&author=D.+Fleckauthor=M.+Vossauthor=B.+Brankatschkauthor=C.+Giudiciauthor=H.+Hampelauthor=B.+Schwenkauthor=D.+Edbauerauthor=A.+Fukumoriauthor=H.+Steinerauthor=E.+Kremmerauthor=M.+Haug-Kr%C3%B6perauthor=M.+J.+Rossnerauthor=R.+Fluhrerauthor=M.+Willemauthor=C.+Haass&title=Proteolytic+processing+of+Neuregulin+1+type+III+by+three+intramembrane-cleaving+proteases&doi=10.1074%2Fjbc.M115.697995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.697995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.697995%26sid%3Dliteratum%253Aachs%26aulast%3DFleck%26aufirst%3DD.%26aulast%3DVoss%26aufirst%3DM.%26aulast%3DBrankatschk%26aufirst%3DB.%26aulast%3DGiudici%26aufirst%3DC.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DSchwenk%26aufirst%3DB.%26aulast%3DEdbauer%26aufirst%3DD.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DHaug-Kr%25C3%25B6per%26aufirst%3DM.%26aulast%3DRossner%26aufirst%3DM.%2BJ.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DProteolytic%2520processing%2520of%2520Neuregulin%25201%2520type%2520III%2520by%2520three%2520intramembrane-cleaving%2520proteases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D318%26epage%3D333%26doi%3D10.1074%2Fjbc.M115.697995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Voss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grammer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug-Kröper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span> </span><span class="NLM_article-title">Foamy virus envelope protein is a substrate for signal peptide peptidase-like 3 (SPPL3)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x"> (</span><span class="NLM_issue">52</span><span class="NLM_x">) </span> <span class="NLM_fpage">43401</span><span class="NLM_x">–</span> <span class="NLM_lpage">43409</span><span class="refDoi"> DOI: 10.1074/jbc.M112.371369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M112.371369" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=43401-43409&issue=52&author=M.+Vossauthor=A.+Fukumoriauthor=P.-H.+Kuhnauthor=U.+K%C3%BCnzelauthor=B.+Klierauthor=G.+Grammerauthor=M.+Haug-Kr%C3%B6perauthor=E.+Kremmerauthor=S.+F.+Lichtenthalerauthor=H.+Steinerauthor=B.+Schr%C3%B6derauthor=C.+Haassauthor=R.+Fluhrer&title=Foamy+virus+envelope+protein+is+a+substrate+for+signal+peptide+peptidase-like+3+%28SPPL3%29&doi=10.1074%2Fjbc.M112.371369"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.371369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.371369%26sid%3Dliteratum%253Aachs%26aulast%3DVoss%26aufirst%3DM.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DKuhn%26aufirst%3DP.-H.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DU.%26aulast%3DKlier%26aufirst%3DB.%26aulast%3DGrammer%26aufirst%3DG.%26aulast%3DHaug-Kr%25C3%25B6per%26aufirst%3DM.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DFluhrer%26aufirst%3DR.%26atitle%3DFoamy%2520virus%2520envelope%2520protein%2520is%2520a%2520substrate%2520for%2520signal%2520peptide%2520peptidase-like%25203%2520%2528SPPL3%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D52%26spage%3D43401%26epage%3D43409%26doi%3D10.1074%2Fjbc.M112.371369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hüttl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kläsener, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneppenheim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberg, H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabelitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span> </span><span class="NLM_article-title">Processing of CD74 by the intramembrane protease SPPL2a is critical for B cell receptor signaling in transitional B cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">1548</span><span class="NLM_x">–</span> <span class="NLM_lpage">1563</span><span class="refDoi"> DOI: 10.4049/jimmunol.1403171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.4049%2Fjimmunol.1403171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=26157172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12gt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2015&pages=1548-1563&author=S.+H%C3%BCttlauthor=K.+Kl%C3%A4senerauthor=M.+Schweizerauthor=J.+Schneppenheimauthor=H.-H.+Obergauthor=D.+Kabelitzauthor=M.+Rethauthor=P.+Saftigauthor=B.+Schr%C3%B6der&title=Processing+of+CD74+by+the+intramembrane+protease+SPPL2a+is+critical+for+B+cell+receptor+signaling+in+transitional+B+cells&doi=10.4049%2Fjimmunol.1403171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells</span></div><div class="casAuthors">Huettl, Susann; Klaesener, Kathrin; Schweizer, Michaela; Schneppenheim, Janna; Oberg, Hans-Heinrich; Kabelitz, Dieter; Reth, Michael; Saftig, Paul; Schroeder, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1548-1563</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The invariant chain (CD74), a chaperone in MHC class II-mediated Ag presentation, is sequentially processed by different endosomal proteases.  We reported recently that clearance of the final membrane-bound N-terminal fragment (NTF) of CD74 is mediated by the intramembrane protease signal peptide peptidase-like (SPPL)2a, a process crit. for B cell development.  In mice, SPPL2a deficiency provokes the accumulation of this NTF in endocytic vesicles, which leads to a B cell maturation arrest at the transitional 1 stage.  To define the underlying mechanism, we analyzed the impact of SPPL2a deficiency on signaling pathways involved in B cell homeostasis.  We demonstrate that tonic as well as BCR-induced activation of the PI3K/Akt pathway is massively compromised in SPPL2a-/- B cells and identify this as major cause of the B cell maturation defect in these mice.  Altered BCR trafficking induces a redn. of surface IgM in SPPL2a-deficient B cells, leading to a diminished signal transmission via the BCR and the tyrosine kinase Syk.  We provide evidence that in SPPL2a-/- mice impaired BCR signaling is to a great extent provoked by the accumulating CD74 NTF, which can interact with the BCR and Syk, and that impaired PI3K/Akt signaling and reduced surface IgM are not directly linked processes.  In line with disturbances in PI3K/Akt signaling, SPPL2a-/- B cells show a dysregulation of the transcription factor FOXO1, causing elevated transcription of proapoptotic genes.  We conclude that SPPL2a-mediated processing of CD74 NTF is indispensable to maintain appropriate levels of tonic BCR signaling to promote B cell maturation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0ydWpcrySrVg90H21EOLACvtfcHk0ljYJkL8apbjqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12gt77K&md5=ef43a32e3c81ac53a7a893edf413fa6c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1403171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1403171%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCttl%26aufirst%3DS.%26aulast%3DKl%25C3%25A4sener%26aufirst%3DK.%26aulast%3DSchweizer%26aufirst%3DM.%26aulast%3DSchneppenheim%26aufirst%3DJ.%26aulast%3DOberg%26aufirst%3DH.-H.%26aulast%3DKabelitz%26aufirst%3DD.%26aulast%3DReth%26aufirst%3DM.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26atitle%3DProcessing%2520of%2520CD74%2520by%2520the%2520intramembrane%2520protease%2520SPPL2a%2520is%2520critical%2520for%2520B%2520cell%2520receptor%2520signaling%2520in%2520transitional%2520B%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2015%26volume%3D195%26spage%3D1548%26epage%3D1563%26doi%3D10.4049%2Fjimmunol.1403171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hampe, C. S.</span><span> </span><span class="NLM_article-title">B cells in autoimmune diseases</span> <span class="citation_source-journal">Scientifica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">215308</span><span class="refDoi"> DOI: 10.6064/2012/215308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.6064%2F2012%2F215308" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=215308&author=C.+S.+Hampe&title=B+cells+in+autoimmune+diseases&doi=10.6064%2F2012%2F215308"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.6064%2F2012%2F215308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6064%252F2012%252F215308%26sid%3Dliteratum%253Aachs%26aulast%3DHampe%26aufirst%3DC.%2BS.%26atitle%3DB%2520cells%2520in%2520autoimmune%2520diseases%26jtitle%3DScientifica%26date%3D2012%26volume%3D2012%26spage%3D215308%26doi%3D10.6064%2F2012%2F215308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mentrup, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loock, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span> </span><span class="NLM_article-title">Signal peptide peptidase and SPP-like proteases - possible therapeutic targets?</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">1864</span><span class="NLM_x">, </span> <span class="NLM_fpage">2169</span><span class="NLM_x">–</span> <span class="NLM_lpage">2182</span><span class="refDoi"> DOI: 10.1016/j.bbamcr.2017.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bbamcr.2017.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=28624439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2017&pages=2169-2182&author=T.+Mentrupauthor=A.-C.+Loockauthor=R.+Fluhrerauthor=B.+Schr%C3%B6der&title=Signal+peptide+peptidase+and+SPP-like+proteases+-+possible+therapeutic+targets%3F&doi=10.1016%2Fj.bbamcr.2017.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Signal peptide peptidase and SPP-like proteases - Possible therapeutic targets?</span></div><div class="casAuthors">Mentrup, Torben; Loock, Ann-Christine; Fluhrer, Regina; Schroeder, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">11_Part_B</span>),
    <span class="NLM_cas:pages">2169-2182</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Signal peptide peptidase (SPP) and the four homologous SPP-like proteases SPPL2a, SPPL2b, SPPL2c and SPPL3 are GxGD-type intramembrane-cleaving proteases (I-CLIPs).  In addn. to divergent subcellular localisations, distinct differences in the mechanistic properties and substrate requirements of individual family members have been unravelled.  SPP/SPPL proteases employ a catalytic mechanism related to that of the γ-secretase complex.  Nevertheless, differential targeting of SPP/SPPL proteases and γ-secretase by inhibitors has been demonstrated.  Furthermore, also within the SPP/SPPL family significant differences in the sensitivity to currently available inhibitory compds. have been reported.  Though far from complete, our knowledge on pathophysiol. functions of SPP/SPPL proteases, in particular based on studies in mice, has been significantly increased over the last years.  Based on this, inhibition of distinct SPP/SPPL proteases has been proposed as a novel therapeutic concept e.g. for the treatment of autoimmunity and viral or protozoal infections, as we will discuss in this review.  This article is part of a Special Issue entitled: Proteolysis as a Regulatory Event in Pathophysiol. edited by Stefan Rose-John.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqppqzdGfSk_LVg90H21EOLACvtfcHk0ljYJkL8apbjqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtL3J&md5=a4f313effb63568e571e87e7ba7a6422</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2017.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2017.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DMentrup%26aufirst%3DT.%26aulast%3DLoock%26aufirst%3DA.-C.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26atitle%3DSignal%2520peptide%2520peptidase%2520and%2520SPP-like%2520proteases%2520-%2520possible%2520therapeutic%2520targets%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2017%26volume%3D1864%26spage%3D2169%26epage%3D2182%26doi%3D10.1016%2Fj.bbamcr.2017.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miele, L.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors and modulators</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1828</span><span class="NLM_x">, </span> <span class="NLM_fpage">2898</span><span class="NLM_x">–</span> <span class="NLM_lpage">2907</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bbamem.2013.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23791707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOntLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1828&publication_year=2013&pages=2898-2907&author=T.+E.+Goldeauthor=E.+H.+Kooauthor=K.+M.+Felsensteinauthor=B.+A.+Osborneauthor=L.+Miele&title=%CE%B3-Secretase+inhibitors+and+modulators&doi=10.1016%2Fj.bbamem.2013.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase inhibitors and modulators</span></div><div class="casAuthors">Golde, Todd E.; Koo, Edward H.; Felsenstein, Kevin M.; Osborne, Barbara A.; Miele, Lucio</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1828</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2898-2907</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is a fascinating, multi-subunit, intramembrane cleaving protease that is now being considered as a therapeutic target for a no. of diseases.  Potent, orally bioavailable γ-secretase inhibitors (GSIs) have been developed and tested in humans with Alzheimer's disease (AD) and cancer.  Preclin. studies also suggest the therapeutic potential for GSIs in other disease conditions.  However, due to inherent mechanism based-toxicity of non-selective inhibition of γ-secretase, clin. development of GSIs will require empirical testing with careful evaluation of benefit vs. risk.  In addn. to GSIs, compds. referred to as γ-secretase modulators (GSMs) remain in development as AD therapeutics.  GSMs do not inhibit γ-secretase, but modulate γ-secretase processivity and thereby shift the profile of the secreted amyloid β peptides (Aβ) peptides produced.  Although GSMs are thought to have an inherently safe mechanism of action, their effects on substrates other than the amyloid β protein precursor (APP) have not been extensively investigated.  Herein, we will review the current state of development of GSIs and GSMs and explore pertinent biol. and pharmacol. questions pertaining to the use of these agents for select indications.  This article is part of a Special Issue entitled: Intramembrane Proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxnnsmOtdDJLVg90H21EOLACvtfcHk0lgZTfAPoF3n0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOntLfK&md5=b6069836c464b99d217b25b8f67e4e60</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DOsborne%26aufirst%3DB.%2BA.%26aulast%3DMiele%26aufirst%3DL.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520and%2520modulators%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2013%26volume%3D1828%26spage%3D2898%26epage%3D2907%26doi%3D10.1016%2Fj.bbamem.2013.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Bray, S. J.</span><span> </span><span class="NLM_article-title">Notch signalling in context</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span><span class="refDoi"> DOI: 10.1038/nrm.2016.94</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1038%2Fnrm.2016.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=27507209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaitb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=722-735&author=S.+J.+Bray&title=Notch+signalling+in+context&doi=10.1038%2Fnrm.2016.94"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Notch signalling in context</span></div><div class="casAuthors">Bray, Sarah J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">722-735</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The highly conserved Notch signalling pathway functions in many different developmental and homeostatic processes, which raises the question of how this pathway can achieve such diverse outcomes.  With a direct route from the membrane to the nucleus, the Notch pathway has fewer opportunities for regulation than do many other signalling pathways, yet it generates exquisitely patterned structures, including sensory hair cells and branched arterial networks.  More confusingly, its activity promotes tissue growth and cancers in some circumstances but cell death and tumor suppression in others.  Many different regulatory mechanisms help to shape the activity of the Notch pathway, generating functional outputs that are appropriate for each context.  These mechanisms include the receptor-ligand landscape, the tissue topol., the nuclear environment and the connectivity of the regulatory networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgXD9AhFBN_7Vg90H21EOLACvtfcHk0lgZTfAPoF3n0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaitb3N&md5=27bdab1ece68eb46abdeea7e85aac7e8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2016.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2016.94%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DS.%2BJ.%26atitle%3DNotch%2520signalling%2520in%2520context%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2016%26volume%3D17%26spage%3D722%26epage%3D735%26doi%3D10.1038%2Fnrm.2016.94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rizzo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osipo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miele, L.</span><span> </span><span class="NLM_article-title">Rational targeting of Notch signaling in cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5124</span><span class="NLM_x">–</span> <span class="NLM_lpage">5131</span><span class="refDoi"> DOI: 10.1038/onc.2008.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1038%2Fonc.2008.226" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5124-5131&author=P.+Rizzoauthor=C.+Osipoauthor=K.+Foremanauthor=T.+Goldeauthor=B.+Osborneauthor=L.+Miele&title=Rational+targeting+of+Notch+signaling+in+cancer&doi=10.1038%2Fonc.2008.226"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fonc.2008.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2008.226%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DP.%26aulast%3DOsipo%26aufirst%3DC.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DOsborne%26aufirst%3DB.%26aulast%3DMiele%26aufirst%3DL.%26atitle%3DRational%2520targeting%2520of%2520Notch%2520signaling%2520in%2520cancer%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5124%26epage%3D5131%26doi%3D10.1038%2Fonc.2008.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ryeom, S. W.</span><span> </span><span class="NLM_article-title">The cautionary tale of side effects of chronic Notch1 inhibition</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1172/JCI45976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1172%2FJCI45976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=21266769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsl2rur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=508-509&author=S.+W.+Ryeom&title=The+cautionary+tale+of+side+effects+of+chronic+Notch1+inhibition&doi=10.1172%2FJCI45976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The cautionary tale of side effects of chronic Notch1 inhibition</span></div><div class="casAuthors">Ryeom, Sandra W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">508-509</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Aberrant Notch1 signaling is implicated in several types of cancer.  Therefore, Notch signaling pathways are important anticancer targets.  Pan-Notch receptor inhibition is assocd. with numerous complications; thus, selective Notch receptor inhibition has been pursued.  Studies have shown minimal side effects with short-term blockade of either Notch1 or its ligand Delta-like 4, but long-term side effects were not investigated.  In this issue of the JCI, Liu et al. use mouse models to demonstrate the consequence of long-term Notch1 inhibition.  They present evidence that chronic Notch1 inhibition leads to vascular tumors in the liver and decreased survival, which suggests that Notch1 therapies should be reevaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAByudPYROzbVg90H21EOLACvtfcHk0lgZTfAPoF3n0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsl2rur8%253D&md5=9ec0e3b021234ef1b734c5395a032bc0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1172%2FJCI45976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI45976%26sid%3Dliteratum%253Aachs%26aulast%3DRyeom%26aufirst%3DS.%2BW.%26atitle%3DThe%2520cautionary%2520tale%2520of%2520side%2520effects%2520of%2520chronic%2520Notch1%2520inhibition%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D508%26epage%3D509%26doi%3D10.1172%2FJCI45976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span> </span><span class="NLM_article-title">A phase 3 trial of semagacestat for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1056/NEJMoa1210951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1056%2FNEJMoa1210951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23883379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=341-350&author=R.+S.+Doodyauthor=R.+Ramanauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=F.+Heauthor=X.+Sunauthor=R.+G.+Thomasauthor=P.+S.+Aisenauthor=E.+Siemersauthor=G.+Sethuramanauthor=R.+Mohs&title=A+phase+3+trial+of+semagacestat+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1210951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 3 trial of semagacestat for treatment of Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Raman, Rema; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; He, Feng; Sun, Xiaoying; Thomas, Ronald G.; Aisen, Paul S.; Siemers, Eric; Sethuraman, Gopalan; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-350</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the presence of cortical amyloid-beta (Aβ) protein plaques, which result from the sequential action of β-secretase and γ-secretase on amyloid precursor protein.  Semagacestat is a small-mol. γ-secretase inhibitor that was developed as a potential treatment for Alzheimer's disease.  Methods: We conducted a double-blind, placebo-controlled trial in which 1537 patients with probable Alzheimer's disease underwent randomization to receive 100 mg of semagacestat, 140 mg of semagacestat, or placebo daily.  Changes in cognition from baseline to week 76 were assessed with the use of the cognitive subscale of the Alzheimer's Disease Assessment Scale for cognition (ADAS-cog), on which scores range from 0 to 70 and higher scores indicate greater cognitive impairment, and changes in functioning were assessed with the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale, on which scores range from 0 to 78 and higher scores indicate better functioning.  A mixed-model repeated-measures anal. was used.  Results: The trial was terminated before completion on the basis of a recommendation by the data and safety monitoring board.  At termination, there were 189 patients in the group receiving placebo, 153 patients in the group receiving 100 mg of semagacestat, and 121 patients in the group receiving 140 mg of semagacestat.  The ADAS-cog scores worsened in all three groups (mean change, 6.4 points in the placebo group, 7.5 points in the group receiving 100 mg of the study drug, and 7.8 points in the group receiving 140 mg; P = 0.15 and P = 0.07, resp., for the comparison with placebo).  The ADCS-ADL scores also worsened in all groups (mean change at week 76, -9.0 points in the placebo group, -10.5 points in the 100-mg group, and -12.6 points in the 140-mg group; P = 0.14 and P<0.001, resp., for the comparison with placebo).  Patients treated with semagacestat lost more wt. and had more skin cancers and infections, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo).  Lab. abnormalities included reduced levels of lymphocytes, T cells, Igs, albumin, total protein, and uric acid and elevated levels of eosinophils, monocytes, and cholesterol; the urine pH was also elevated.  Conclusions: As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability.  Semagacestat was assocd. with more adverse events, including skin cancers and infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMQCX6dUTyl7Vg90H21EOLACvtfcHk0lgMDmOiyATOcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L&md5=366f2545b2156100af31993c809feac1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1210951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1210951%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DA%2520phase%25203%2520trial%2520of%2520semagacestat%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D341%26epage%3D350%26doi%3D10.1056%2FNEJMoa1210951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceballos-Diaz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Differential inhibition of signal peptide peptidase family members by established γ-secretase inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0128619</span><span class="refDoi"> DOI: 10.1371/journal.pone.0128619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1371%2Fjournal.pone.0128619" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0128619&author=Y.+Ranauthor=G.+Z.+Laddauthor=C.+Ceballos-Diazauthor=J.+I.+Jungauthor=D.+Greenbaumauthor=K.+M.+Felsensteinauthor=T.+E.+Golde&title=Differential+inhibition+of+signal+peptide+peptidase+family+members+by+established+%CE%B3-secretase+inhibitors&doi=10.1371%2Fjournal.pone.0128619"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0128619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0128619%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DY.%26aulast%3DLadd%26aufirst%3DG.%2BZ.%26aulast%3DCeballos-Diaz%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DJ.%2BI.%26aulast%3DGreenbaum%26aufirst%3DD.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDifferential%2520inhibition%2520of%2520signal%2520peptide%2520peptidase%2520family%2520members%2520by%2520established%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0128619%26doi%3D10.1371%2Fjournal.pone.0128619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibig-Rehm, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuffenhauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beisner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siebert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonamy, G. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodendorf, U.</span><span> </span><span class="NLM_article-title">Identification of SPPL2a inhibitors by multiparametric analysis of a high-content ultra-high-throughput screen</span> <span class="citation_source-journal">SLAS Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1177/2472555217719834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1177%2F2472555217719834" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1106-1119&author=X.+Zhangauthor=M.+G%C3%B6tteauthor=Y.+Ibig-Rehmauthor=A.+Schuffenhauerauthor=M.+Kamkeauthor=D.+Beisnerauthor=D.+Gueriniauthor=D.+Siebertauthor=G.+M.+C.+Bonamyauthor=D.+Gabrielauthor=U.+Bodendorf&title=Identification+of+SPPL2a+inhibitors+by+multiparametric+analysis+of+a+high-content+ultra-high-throughput+screen&doi=10.1177%2F2472555217719834"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1177%2F2472555217719834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555217719834%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DIbig-Rehm%26aufirst%3DY.%26aulast%3DSchuffenhauer%26aufirst%3DA.%26aulast%3DKamke%26aufirst%3DM.%26aulast%3DBeisner%26aufirst%3DD.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DSiebert%26aufirst%3DD.%26aulast%3DBonamy%26aufirst%3DG.%2BM.%2BC.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DBodendorf%26aufirst%3DU.%26atitle%3DIdentification%2520of%2520SPPL2a%2520inhibitors%2520by%2520multiparametric%2520analysis%2520of%2520a%2520high-content%2520ultra-high-throughput%2520screen%26jtitle%3DSLAS%2520Discovery%26date%3D2017%26volume%3D22%26spage%3D1106%26epage%3D1119%26doi%3D10.1177%2F2472555217719834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Lead- and drug-like compounds: the rule-of-five revolution</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.ddtec.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.ddtec.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=24981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=337-41&author=C.+A.+Lipinski&title=Lead-+and+drug-like+compounds%3A+the+rule-of-five+revolution&doi=10.1016%2Fj.ddtec.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lead- and drug-like compounds: the rule-of-five revolution</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004.  Trends in the RO5 literature explosion that can be discerned are the further definitions of drug-like.  This topic is explored in terms of drug-like physicochem. features, drug-like structural features, a comparison of drug-like and non-drug-like in drug discovery and a discussion of how drug-like features relate to clin. success.  Physicochem. features of CNS drugs and features related to CNS blood-brain transporter affinity are briefly reviewed.  Recent literature on features of non-oral drugs is reviewed and how features of lead-like compds. differ from those of drug-like compds. is discussed.  Most recently, partly driven by NIH roadmap initiatives, considerations have arisen as to what tool-like means in the search for chem. tools to probe biol. space.  All these topics frame the scope of this short review/perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjiyP3CY7lLVg90H21EOLACvtfcHk0ljphb-vbk3FsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D&md5=952c29b47003b884116d790ae9e4721f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DLead-%2520and%2520drug-like%2520compounds%253A%2520the%2520rule-of-five%2520revolution%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D337%26epage%3D41%26doi%3D10.1016%2Fj.ddtec.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Prasad, C. V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsa, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleczka, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dangler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrick, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span> </span><span class="NLM_article-title">Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4006</span><span class="NLM_x">–</span> <span class="NLM_lpage">4011</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bmcl.2007.04.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4006-4011&author=C.+V.+C.+Prasadauthor=M.+Zhengauthor=S.+Vigauthor=C.+Bergstromauthor=D.+W.+Smithauthor=Q.+Gaoauthor=S.+Yeolaauthor=C.+T.+Polsonauthor=J.+A.+Corsaauthor=V.+L.+Gussauthor=A.+Looauthor=J.+Wangauthor=B.+G.+Sleczkaauthor=C.+Danglerauthor=B.+J.+Robertsonauthor=J.+P.+Hendrickauthor=S.+B.+Robertsauthor=D.+M.+Barten&title=Discovery+of+%28S%29-2-%28%28S%29-2-%283%2C5-difluorophenyl%29-2-hydroxyacetamido%29-N-%28%28S%2CZ%29-3-methyl-4-oxo-4%2C5-dihydro-3H-benzo%5Bd%5D%5B1%2C2%5Ddiazepin-5-yl%29propanamide+%28BMS-433796%29%3A+A+%CE%B3-secretase+inhibitor+with+A%CE%B2+lowering+activity+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2007.04.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.082%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DC.%2BV.%2BC.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DVig%26aufirst%3DS.%26aulast%3DBergstrom%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DD.%2BW.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DYeola%26aufirst%3DS.%26aulast%3DPolson%26aufirst%3DC.%2BT.%26aulast%3DCorsa%26aufirst%3DJ.%2BA.%26aulast%3DGuss%26aufirst%3DV.%2BL.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSleczka%26aufirst%3DB.%2BG.%26aulast%3DDangler%26aufirst%3DC.%26aulast%3DRobertson%26aufirst%3DB.%2BJ.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26atitle%3DDiscovery%2520of%2520%2528S%2529-2-%2528%2528S%2529-2-%25283%252C5-difluorophenyl%2529-2-hydroxyacetamido%2529-N-%2528%2528S%252CZ%2529-3-methyl-4-oxo-4%252C5-dihydro-3H-benzo%255Bd%255D%255B1%252C2%255Ddiazepin-5-yl%2529propanamide%2520%2528BMS-433796%2529%253A%2520A%2520%25CE%25B3-secretase%2520inhibitor%2520with%2520A%25CE%25B2%2520lowering%2520activity%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4006%26epage%3D4011%26doi%3D10.1016%2Fj.bmcl.2007.04.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Boros, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randhawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, M. H.</span><span> </span><span class="NLM_article-title">A Convenient synthesis of pyrazolidine and 3-amino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span><span class="refDoi"> DOI: 10.1002/jhet.5570380310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1002%2Fjhet.5570380310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVSlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=613-616&author=E.+E.+Borosauthor=F.+Bouvierauthor=S.+Randhawaauthor=M.+H.+Rabinowitz&title=A+Convenient+synthesis+of+pyrazolidine+and+3-amino-6%2C7-dihydro-1H%2C5H-pyrazolo%5B1%2C2-a%5Dpyrazol-1-one&doi=10.1002%2Fjhet.5570380310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient synthesis of pyrazolidine and 3-amino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one</span></div><div class="casAuthors">Boros, Eric E.; Bouvier, Frederic; Randhawa, Sab; Rabinowitz, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">613-616</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    
            (<span class="NLM_cas:orgname">HeteroCorporation</span>)
        </div><div class="casAbstract">A convenient four-step synthesis of the aminobicyclopyrazolone hydrochloride (I) was achieved starting from di-tert-Bu hydrazodiformate (II).  The route entails cyclization of II with 1,3-dibromopropane under phase transfer conditions followed by deprotection of 1,2-di-tert-butoxycarbonylpyrazolidine to give pyrazolidine hydrochloride.  Cyanoacetylation of the latter and ring closure of the resulting cyanoacetyl pyrazolidine gave I.  This novel synthesis circumvents distn. of pyrazolidine and flash chromatog. to provide I in 35-46% overall yields compared to 6% yield for the patent procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoimEvwLo0a3bVg90H21EOLACvtfcHk0ljphb-vbk3FsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVSlt7Y%253D&md5=a7b3e32a50b82d4a3cc0f0949cf2d873</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570380310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570380310%26sid%3Dliteratum%253Aachs%26aulast%3DBoros%26aufirst%3DE.%2BE.%26aulast%3DBouvier%26aufirst%3DF.%26aulast%3DRandhawa%26aufirst%3DS.%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3DA%2520Convenient%2520synthesis%2520of%2520pyrazolidine%2520and%25203-amino-6%252C7-dihydro-1H%252C5H-pyrazolo%255B1%252C2-a%255Dpyrazol-1-one%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2001%26volume%3D38%26spage%3D613%26epage%3D616%26doi%3D10.1002%2Fjhet.5570380310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ritchie, D. J.; McCann, H. S. R.; Standen, M. C. H.; Jones, R. V. H.</span><span> </span><span class="NLM_article-title">One-step process for preparing methyl 2-(halomethyl)phenylacetate from 3-isochromanone</span>. US6048998,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>CAN128:75194.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=D.+J.+Ritchie&author=H.+S.+R.+McCann&author=M.+C.+H.+Standen&author=R.+V.+H.+Jones&title=One-step+process+for+preparing+methyl+2-%28halomethyl%29phenylacetate+from+3-isochromanone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DD.%2BJ.%26atitle%3DOne-step%2520process%2520for%2520preparing%2520methyl%25202-%2528halomethyl%2529phenylacetate%2520from%25203-isochromanone%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Schultz, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzi, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakkar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidlack, J. M.</span><span> </span><span class="NLM_article-title">Preparation and diastereoselective Birch reduction-alkylation of chiral 3,4-dihydro-1(2H)-isoquinolinones. Enantiospecific syntheses and opioid receptor affinities of several hydro-2,3-dimethyl-1H-7,12a-methanobenzo[6,7]cycloocta[1,2-c]pyridine-9-ols</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7795</span><span class="NLM_x">–</span> <span class="NLM_lpage">7804</span><span class="refDoi"> DOI: 10.1021/jo980921g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo980921g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=7795-7804&author=A.+G.+Schultzauthor=T.+J.+Guziauthor=E.+Larssonauthor=R.+Rahmauthor=K.+Thakkarauthor=J.+M.+Bidlack&title=Preparation+and+diastereoselective+Birch+reduction-alkylation+of+chiral+3%2C4-dihydro-1%282H%29-isoquinolinones.+Enantiospecific+syntheses+and+opioid+receptor+affinities+of+several+hydro-2%2C3-dimethyl-1H-7%2C12a-methanobenzo%5B6%2C7%5Dcycloocta%5B1%2C2-c%5Dpyridine-9-ols&doi=10.1021%2Fjo980921g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo980921g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980921g%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DA.%2BG.%26aulast%3DGuzi%26aufirst%3DT.%2BJ.%26aulast%3DLarsson%26aufirst%3DE.%26aulast%3DRahm%26aufirst%3DR.%26aulast%3DThakkar%26aufirst%3DK.%26aulast%3DBidlack%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520and%2520diastereoselective%2520Birch%2520reduction-alkylation%2520of%2520chiral%25203%252C4-dihydro-1%25282H%2529-isoquinolinones.%2520Enantiospecific%2520syntheses%2520and%2520opioid%2520receptor%2520affinities%2520of%2520several%2520hydro-2%252C3-dimethyl-1H-7%252C12a-methanobenzo%255B6%252C7%255Dcycloocta%255B1%252C2-c%255Dpyridine-9-ols%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D7795%26epage%3D7804%26doi%3D10.1021%2Fjo980921g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiggins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span> </span><span class="NLM_article-title">3,4-Dihydrobenz[<i>f</i>]isoquinoline and 3,4-dihydrobenz[<i>g</i>]isoquinoline</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span><span class="refDoi"> DOI: 10.1021/jo00240a042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00240a042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=1114-1116&author=S.+D.+Youngauthor=J.+M.+Wigginsauthor=J.+R.+Huff&title=3%2C4-Dihydrobenz%5Bf%5Disoquinoline+and+3%2C4-dihydrobenz%5Bg%5Disoquinoline&doi=10.1021%2Fjo00240a042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00240a042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00240a042%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DWiggins%26aufirst%3DJ.%2BM.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26atitle%3D3%252C4-Dihydrobenz%255Bf%255Disoquinoline%2520and%25203%252C4-dihydrobenz%255Bg%255Disoquinoline%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D1114%26epage%3D1116%26doi%3D10.1021%2Fjo00240a042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Prasad, C. V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsa, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span> </span><span class="NLM_article-title">2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3535</span><span class="NLM_x">–</span> <span class="NLM_lpage">3538</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bmcl.2004.04.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=15177468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3535-3538&author=C.+V.+C.+Prasadauthor=S.+Vigauthor=D.+W.+Smithauthor=Q.+Gaoauthor=C.+T.+Polsonauthor=J.+A.+Corsaauthor=V.+L.+Gussauthor=A.+Looauthor=D.+M.+Bartenauthor=M.+Zhengauthor=K.+M.+Felsensteinauthor=S.+B.+Roberts&title=2%2C3-Benzodiazepin-1%2C4-diones+as+peptidomimetic+inhibitors+of+%CE%B3-secretase&doi=10.1016%2Fj.bmcl.2004.04.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase</span></div><div class="casAuthors">Prasad, C. V. C.; Vig, Shikha; Smith, David W.; Gao, Qi; Polson, Craig T.; Corsa, Jason A.; Guss, Valerie L.; Loo, Alice; Barten, Donna M.; Zheng, Ming; Felsenstein, Kevin M.; Roberts, Susan B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3535-3538</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">2,3-Benzodiazepin-1,4-diones were designed as peptidomimetics at the carboxy terminus of hydroxyamides.  Inhibition of brain Aβ prodn. was improved by one of the compds. contg. constrained modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowfqVuTjFHXLVg90H21EOLACvtfcHk0lgJGHkMD-B8mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gmsrk%253D&md5=a2453adcdd637fa5f45d739c44d51a78</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.056%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DC.%2BV.%2BC.%26aulast%3DVig%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BW.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DPolson%26aufirst%3DC.%2BT.%26aulast%3DCorsa%26aufirst%3DJ.%2BA.%26aulast%3DGuss%26aufirst%3DV.%2BL.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26atitle%3D2%252C3-Benzodiazepin-1%252C4-diones%2520as%2520peptidomimetic%2520inhibitors%2520of%2520%25CE%25B3-secretase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3535%26epage%3D3538%26doi%3D10.1016%2Fj.bmcl.2004.04.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Evans, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiener, J. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripin, D. H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedrow, J. S.</span><span> </span><span class="NLM_article-title">A general method for the synthesis of enantiomerically pure β-substituted, β-amino acids through α-substituted succinic acid derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6411</span><span class="NLM_x">–</span> <span class="NLM_lpage">6417</span><span class="refDoi"> DOI: 10.1021/jo990756k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo990756k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=6411-6417&author=D.+A.+Evansauthor=L.+D.+Wuauthor=J.+J.+M.+Wienerauthor=J.+S.+Johnsonauthor=D.+H.+B.+Ripinauthor=J.+S.+Tedrow&title=A+general+method+for+the+synthesis+of+enantiomerically+pure+%CE%B2-substituted%2C+%CE%B2-amino+acids+through+%CE%B1-substituted+succinic+acid+derivatives&doi=10.1021%2Fjo990756k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo990756k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo990756k%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DL.%2BD.%26aulast%3DWiener%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DJohnson%26aufirst%3DJ.%2BS.%26aulast%3DRipin%26aufirst%3DD.%2BH.%2BB.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26atitle%3DA%2520general%2520method%2520for%2520the%2520synthesis%2520of%2520enantiomerically%2520pure%2520%25CE%25B2-substituted%252C%2520%25CE%25B2-amino%2520acids%2520through%2520%25CE%25B1-substituted%2520succinic%2520acid%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D6411%26epage%3D6417%26doi%3D10.1021%2Fjo990756k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Milano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagenais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster-Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadient, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, P. J.</span><span> </span><span class="NLM_article-title">Modulation of Notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1093/toxsci/kfh254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1093%2Ftoxsci%2Fkfh254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=15319485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2004&pages=341-358&author=J.+Milanoauthor=J.+McKayauthor=C.+Dagenaisauthor=L.+Foster-Brownauthor=F.+Pognanauthor=R.+Gadientauthor=R.+T.+Jacobsauthor=A.+Zaccoauthor=B.+Greenbergauthor=P.+J.+Ciaccio&title=Modulation+of+Notch+processing+by+%CE%B3-secretase+inhibitors+causes+intestinal+goblet+cell+metaplasia+and+induction+of+genes+known+to+specify+gut+secretory+lineage+differentiation&doi=10.1093%2Ftoxsci%2Fkfh254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Notch Processing by γ-Secretase Inhibitors Causes Intestinal Goblet Cell Metaplasia and Induction of Genes Known to Specify Gut Secretory Lineage Differentiation</span></div><div class="casAuthors">Milano, Joseph; McKay, Jenny; Dagenais, Claude; Foster-Brown, Linda; Pognan, Francois; Gadient, Reto; Jacobs, Robert T.; Zacco, Anna; Greenberg, Barry; Ciaccio, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">341-358</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">It is anticipated that γ-secretase inhibitors (γ-Sec-I) that modulate Notch processing will alter differentiation in tissues whose architecture is governed by Notch signaling.  To explore this hypothesis, Han Wistar rats were dosed for up to 5 days with 10-100 μmol/kg b.i.d. γ-Sec-I from three chem. series that inhibit Notch processing in vitro at various potencies (Notch IC50).  These included an arylsulfonamide (AS) (142 nM), a dibenzazepine (DBZ) (1.7 nM), and a benzodiazepine (BZ) (2.2 nM).  The DBZ and BZ caused dose-dependent intestinal goblet cell metaplasia.  In contrast, the AS produced no detectable in vivo toxicity, despite higher exposure to free drug.  In a time course using BZ, small intestinal crypt cell and large intestinal glandular cell epithelial apoptosis was obsd. on days 1-5, followed by goblet cell metaplasia on days 2-5 and crypt epithelial and glandular epithelial regenerative hyperplasia on days 4-5.  Gene expression profiling of duodenal samples from BZ-dosed animals revealed significant time-dependent deregulation of mRNAs for various panendocrine, hormonal, and transcription factor genes.  Somatostatin, secretin, mucin, CCK, and gastrin mRNAs were elevated twofold or more by day 2, and a no. of candidate early-predictive' genes were altered on days 1-2, remaining changed for 4-5 days; these included Delta1, NeuroD, Hes1-regulated adipsin, and the Hes-regulated transcriptional activator of gut secretory lineage differentiation, the rat homolog of Drosophila atonal, Rath1.  Western blotting of fecal protein from BZ-and DBZ-dosed animals exhibited increased levels of both anti-Rath1 reactive protein and anti-adipsin reactive proteins, confirming their potential value as noninvasive biomarkers of intestinal goblet metaplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2qB_JewBHJrVg90H21EOLACvtfcHk0lgJGHkMD-B8mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLc%253D&md5=ba57bf26d54ef933a6dc738468bb07e4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfh254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfh254%26sid%3Dliteratum%253Aachs%26aulast%3DMilano%26aufirst%3DJ.%26aulast%3DMcKay%26aufirst%3DJ.%26aulast%3DDagenais%26aufirst%3DC.%26aulast%3DFoster-Brown%26aufirst%3DL.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DGadient%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZacco%26aufirst%3DA.%26aulast%3DGreenberg%26aufirst%3DB.%26aulast%3DCiaccio%26aufirst%3DP.%2BJ.%26atitle%3DModulation%2520of%2520Notch%2520processing%2520by%2520%25CE%25B3-secretase%2520inhibitors%2520causes%2520intestinal%2520goblet%2520cell%2520metaplasia%2520and%2520induction%2520of%2520genes%2520known%2520to%2520specify%2520gut%2520secretory%2520lineage%2520differentiation%26jtitle%3DToxicol.%2520Sci.%26date%3D2004%26volume%3D82%26spage%3D341%26epage%3D358%26doi%3D10.1093%2Ftoxsci%2Fkfh254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Searfoss, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbreath, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirtzinger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berridge, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, T. P.</span><span> </span><span class="NLM_article-title">Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">46107</span><span class="NLM_x">–</span> <span class="NLM_lpage">46116</span><span class="refDoi"> DOI: 10.1074/jbc.M307757200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M307757200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=46107-46116&author=G.+H.+Searfossauthor=W.+H.+Jordanauthor=D.+O.+Calligaroauthor=E.+J.+Galbreathauthor=L.+M.+Schirtzingerauthor=B.+R.+Berridgeauthor=H.+Gaoauthor=M.+A.+Higginsauthor=P.+C.+Mayauthor=T.+P.+Ryan&title=Adipsin%2C+a+biomarker+of+gastrointestinal+toxicity+mediated+by+a+functional+gamma-secretase+inhibitor&doi=10.1074%2Fjbc.M307757200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307757200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307757200%26sid%3Dliteratum%253Aachs%26aulast%3DSearfoss%26aufirst%3DG.%2BH.%26aulast%3DJordan%26aufirst%3DW.%2BH.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DGalbreath%26aufirst%3DE.%2BJ.%26aulast%3DSchirtzinger%26aufirst%3DL.%2BM.%26aulast%3DBerridge%26aufirst%3DB.%2BR.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DHiggins%26aufirst%3DM.%2BA.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DRyan%26aufirst%3DT.%2BP.%26atitle%3DAdipsin%252C%2520a%2520biomarker%2520of%2520gastrointestinal%2520toxicity%2520mediated%2520by%2520a%2520functional%2520gamma-secretase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D46107%26epage%3D46116%26doi%3D10.1074%2Fjbc.M307757200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span> <span class="citation_source-book">Some Aromatic Amines, Organic Dyes, and Related Exposures</span>; <span class="NLM_series">IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 99</span>; <span class="NLM_publisher-name">International Agency for Research on Cancer</span>: <span class="NLM_publisher-loc">Lyon, France</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span> pp.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Some+Aromatic+Amines%2C+Organic+Dyes%2C+and+Related+Exposures%3B+IARC+Monographs+on+the+Evaluation+of+Carcinogenic+Risks+to+Humans%2C+Vol.+99%3B+International+Agency+for+Research+on+Cancer%3A+Lyon%2C+France%2C+2010%3B+Vol.+99%2C+658+pp."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSome%2520Aromatic%2520Amines%252C%2520Organic%2520Dyes%252C%2520and%2520Related%2520Exposures%26pub%3DInternational%2520Agency%2520for%2520Research%2520on%2520Cancer%26date%3D2010%26volume%3D99%26spage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Ohkuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, M.</span><span> </span><span class="NLM_article-title">Distinct mechanisms of oxidative DNA damage by two metabolites of carcinogenic <i>o</i>-toluidine</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1006/abbi.1999.1461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1006%2Fabbi.1999.1461" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1999&pages=97-106&author=Y.+Ohkumaauthor=Y.+Hirakuauthor=S.+Oikawaauthor=N.+Yamashitaauthor=M.+Murataauthor=M.+Kawanishi&title=Distinct+mechanisms+of+oxidative+DNA+damage+by+two+metabolites+of+carcinogenic+o-toluidine&doi=10.1006%2Fabbi.1999.1461"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1999.1461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1999.1461%26sid%3Dliteratum%253Aachs%26aulast%3DOhkuma%26aufirst%3DY.%26aulast%3DHiraku%26aufirst%3DY.%26aulast%3DOikawa%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DN.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DKawanishi%26aufirst%3DM.%26atitle%3DDistinct%2520mechanisms%2520of%2520oxidative%2520DNA%2520damage%2520by%2520two%2520metabolites%2520of%2520carcinogenic%2520o-toluidine%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D372%26spage%3D97%26epage%3D106%26doi%3D10.1006%2Fabbi.1999.1461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chung, K.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkovsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, W. P.</span><span> </span><span class="NLM_article-title">Review of mutagenicity of monocyclic aromatic amines: quantitative structure–activity relationships</span> <span class="citation_source-journal">Mutat. Res., Rev. Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1016/S1383-5742(97)00019-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2FS1383-5742%2897%2900019-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=9254889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADyaK2sXlsFKqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=1997&pages=1-16&author=K.-T.+Chungauthor=L.+Kirkovskyauthor=A.+Kirkovskyauthor=W.+P.+Purcell&title=Review+of+mutagenicity+of+monocyclic+aromatic+amines%3A+quantitative+structure%E2%80%93activity+relationships&doi=10.1016%2FS1383-5742%2897%2900019-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Review of mutagenicity of monocyclic aromatic amines: quantitative structure-activity relationships</span></div><div class="casAuthors">Chung, King-thom; Kirkovsky, Leonid; Kirkovsky, Alexander; Purcell, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Reviews in Mutation Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">MRRRFK</span>;
        ISSN:<span class="NLM_cas:issn">1383-5742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 75 refs.  Monocyclic arom. amines (MAAs) are environmental pollutants.  Many of them are genotoxic and imposed hazards to human health.  The mutagenicity of more than 80 of these amines was reviewed with primary emphasis on evaluation by the Ames Salmonella/microsome testing system.  Many amines are mutagenic in Salmonella tester stains TA98 and TA100, but S9 mix is required for activity for most of the active ones.  2,4-Diaminotoluene, 2,4-diaminoethylbenzene, and a few amines contg. a nitro-group are direct mutagens.  There are several quant. structure-activity relation (QSAR) models which rationalize mutagenicity of many arom. amines and several parameters, such as the LUMO energy (ELUMO), HOMO energy (EHOMO), and hydrophobicity that are important.  What factors det. the min. requirement for the compd. to be mutagenic and what factors det. the extent of mutagenicity suggest questions for further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4zAXaqemHrVg90H21EOLACvtfcHk0lgA_N1E2QvHbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsFKqt7g%253D&md5=8fb846476d9075c1206a094fd439ceb8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS1383-5742%2897%2900019-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1383-5742%252897%252900019-7%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DK.-T.%26aulast%3DKirkovsky%26aufirst%3DL.%26aulast%3DKirkovsky%26aufirst%3DA.%26aulast%3DPurcell%26aufirst%3DW.%2BP.%26atitle%3DReview%2520of%2520mutagenicity%2520of%2520monocyclic%2520aromatic%2520amines%253A%2520quantitative%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DMutat.%2520Res.%252C%2520Rev.%2520Mutat.%2520Res.%26date%3D1997%26volume%3D387%26spage%3D1%26epage%3D16%26doi%3D10.1016%2FS1383-5742%2897%2900019-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Birch, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, C.</span><span> </span><span class="NLM_article-title">Rationally designing safer anilines: the challenging case of 4-aminobiphenyls</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3933</span><span class="refDoi"> DOI: 10.1021/jm3001295</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3001295" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3923-3933&author=A.+M.+Birchauthor=S.+Groombridgeauthor=R.+Lawauthor=A.+G.+Leachauthor=C.+D.+Meeauthor=C.+Schramm&title=Rationally+designing+safer+anilines%3A+the+challenging+case+of+4-aminobiphenyls&doi=10.1021%2Fjm3001295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally Designing Safer Anilines: The Challenging Case of 4-Aminobiphenyls</span></div><div class="casAuthors">Birch, Alan M.; Groombridge, Sam; Law, Robert; Leach, Andrew G.; Mee, Christine D.; Schramm, Carolin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3923-3933</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe how we have been able to design 4-aminobiphenyls that are nonmutagenic (inactive in the Ames test).  No such 4-aminobiphenyls were known to us, but insights provided by quantum mech. calcns. have permitted us to design and synthesize some examples.  Importantly, the quantum mech. calcns. could be combined with predictions of other properties of the compds. that contained the 4-aminobiphenyls so that these remained druglike.  Having found compds. that are not active, the calcns. can provide insight into which factors (electronic and conformational in this case) are important.  The calcns. provided SAR-like information that was able guide the design of further examples of 4-aminobiphenyls that are not active in the Ames test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgF2W_kOt0ErVg90H21EOLACvtfcHk0lgA_N1E2QvHbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWksL0%253D&md5=40c8c5e5d7ed166cda9c410f5fa1cfab</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm3001295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3001295%26sid%3Dliteratum%253Aachs%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DGroombridge%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DR.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DMee%26aufirst%3DC.%2BD.%26aulast%3DSchramm%26aufirst%3DC.%26atitle%3DRationally%2520designing%2520safer%2520anilines%253A%2520the%2520challenging%2520case%2520of%25204-aminobiphenyls%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3923%26epage%3D3933%26doi%3D10.1021%2Fjm3001295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Ames, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, E.</span><span> </span><span class="NLM_article-title">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1016/0165-1161(75)90046-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2F0165-1161%2875%2990046-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=768755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=347-364&author=B.+N.+Amesauthor=J.+McCannauthor=E.+Yamasaki&title=Methods+for+detecting+carcinogens+and+mutagens+with+the+salmonella%2Fmammalian-microsome+mutagenicity+test&doi=10.1016%2F0165-1161%2875%2990046-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span></div><div class="casAuthors">Ames, Bruce N.; McCann, Joyce; Yamasaki, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-63</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    </div><div class="casAbstract">The general methods for using the Salmonella/microsome test as a mutagenesis screening system are described.  The methods include the std. plate test, the use and storage of bacterial tester strains, prepn. and use of the liver homogenates (S-9), and the methods of inducing rats for elevated microsomal enzyme activity.  The application of this system to screening large nos. of compds. and interpreting the test results are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXRCaWgf4xbbVg90H21EOLACvtfcHk0lgVuROun5wShg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D&md5=93881a3b91fc231635ca1086b945fb5d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2875%2990046-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252875%252990046-1%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DMcCann%26aufirst%3DJ.%26aulast%3DYamasaki%26aufirst%3DE.%26atitle%3DMethods%2520for%2520detecting%2520carcinogens%2520and%2520mutagens%2520with%2520the%2520salmonella%252Fmammalian-microsome%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1975%26volume%3D31%26spage%3D347%26epage%3D364%26doi%3D10.1016%2F0165-1161%2875%2990046-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, C.</span><span> </span><span class="NLM_article-title">pH-Metric Solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span><span class="refDoi"> DOI: 10.1023/A:1007526826979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1023%2FA%3A1007526826979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10714613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFCqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2000&pages=85-89&author=A.+Avdeefauthor=C.+M.+Bergerauthor=C.+Brownell&title=pH-Metric+Solubility.+2%3A+Correlation+between+the+acid-base+titration+and+the+saturation+shake-flask+solubility-pH+methods&doi=10.1023%2FA%3A1007526826979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">pH-metric solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods</span></div><div class="casAuthors">Avdeef, Alex; Berger, Cynthia M.; Brownell, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-89</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">The objective of this study was to compare the results of a normal satn. shake-flask method to a new potentiometric acid-base titrn. method for detg. the intrinsic soly. and the soly.-pH profiles of ionizable mols., and to report the soly. consts. detd. by the latter technique.  The soly.-pH profiles of 12 generic drugs with solubilities spanning over six orders of magnitude, were detd. both by the new pH-metric method and by a traditional approach (24 h shaking of satd. solns., followed by filtration, then HPLC assaying with UV detection).  The 212 sep. satn. shake-flask soly. measurements and those derived from 65 potentiometric titrns. agreed well.  The anal. produced the correlation equation: log(1/S)titration=-0.063(±0.032)+ 1.025(±0.011)log(1/S)shake-flask; s=0.20, r2 = 0.978.  The potentiometrically-derived intrinsic solubilities of the drugs were: atenolol 13.5 mg/mL, diclofenac.Na 0.82 μg/mL, famotidine 1.1 mg/mL, flurbiprofen 10.6 μg/mL, furosemide 5.9 μg/mL, hydrochlorothiazide 0.70 mg/mL, ibuprofen 49 μg/mL, ketoprofen 118 μg/mL, labetolol.HCl 128 μg/mL, naproxen 14 μg/mL, phenytoin 19 μg/mL, and propranolol.HCl 70 μg/mL.  The new potentiometric method was shown to be reliable for detg. the soly.-pH profiles of uncharged ionizable drug substances.  Its speed compared to conventional equil. measurements, its sound theor. basis, its ability to generate the full soly.-pH profile from a single titrn., and its dynamic range (currently estd. to be seven orders of magnitude) make the new pH-metric method an attractive addn. to traditional approaches used by preformulation and development scientists.  It may be useful even to discovery scientists in crit. decision situations (such as calibrating computational prediction methods).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrErPM4EuG2xbVg90H21EOLACvtfcHk0lgVuROun5wShg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFCqt7w%253D&md5=9c34cbabef890292c5586c7310f07532</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1023%2FA%3A1007526826979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1007526826979%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DC.%2BM.%26aulast%3DBrownell%26aufirst%3DC.%26atitle%3DpH-Metric%2520Solubility.%25202%253A%2520Correlation%2520between%2520the%2520acid-base%2520titration%2520and%2520the%2520saturation%2520shake-flask%2520solubility-pH%2520methods%26jtitle%3DPharm.%2520Res.%26date%3D2000%26volume%3D17%26spage%3D85%26epage%3D89%26doi%3D10.1023%2FA%3A1007526826979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couttet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junker, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laengle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledieu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivière, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trendelenburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, D.</span><span> </span><span class="NLM_article-title">Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span><span class="refDoi"> DOI: 10.1016/j.leukres.2010.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.leukres.2010.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=20122731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=1180-1188&author=A.+Wolfauthor=P.+Couttetauthor=M.+Dongauthor=O.+Grenetauthor=M.+Heronauthor=U.+Junkerauthor=U.+Laengleauthor=D.+Ledieuauthor=E.+Marrerauthor=A.+Nussherauthor=E.+Persohnauthor=F.+Pognanauthor=G.+J.+Rivi%C3%A8reauthor=D.+R.+Rothauthor=C.+Trendelenburgauthor=J.+Tsaoauthor=D.+Roman&title=Imatinib+does+not+induce+cardiotoxicity+at+clinically+relevant+concentrations+in+preclinical+studies&doi=10.1016%2Fj.leukres.2010.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies</span></div><div class="casAuthors">Wolf, Armin; Couttet, Philippe; Dong, Min; Grenet, Olivier; Heron, Marcia; Junker, Ursula; Laengle, Ulrich; Ledieu, David; Marrer, Estelle; Nussher, Anja; Persohn, Elke; Pognan, Francois; Riviere, Gilles-Jacques; Roth, Daniel Robert; Trendelenburg, Christian; Tsao, Jeffrey; Roman, Danielle</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1180-1188</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cytotoxic concns. of imatinib mesylate (10-50 μM) were required to trigger markers of apoptosis and endoplasmic reticulum stress response in neonatal rat ventricular myocytes and fibroblasts, with no significant differences obsd. between c-Abl silenced and nonsilenced cells.  In mice, oral or i.p. imatinib treatment did not induce cardiovascular pathol. or heart failure.  In rats, high doses of oral imatinib did result in some cardiac hypertrophy.  Multi-organ toxicities may have increased the cardiac workload and contributed to the cardiac hypertrophy obsd. in rats only.  These data suggest that imatinib is not cardiotoxic at clin. relevant concns. (5 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox1CNv7YuPPbVg90H21EOLACvtfcHk0lgVuROun5wShg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wlu7w%253D&md5=f14bba5d30aba43cf4852fdac20f2ae1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2010.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2010.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DCouttet%26aufirst%3DP.%26aulast%3DDong%26aufirst%3DM.%26aulast%3DGrenet%26aufirst%3DO.%26aulast%3DHeron%26aufirst%3DM.%26aulast%3DJunker%26aufirst%3DU.%26aulast%3DLaengle%26aufirst%3DU.%26aulast%3DLedieu%26aufirst%3DD.%26aulast%3DMarrer%26aufirst%3DE.%26aulast%3DNussher%26aufirst%3DA.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DRivi%25C3%25A8re%26aufirst%3DG.%2BJ.%26aulast%3DRoth%26aufirst%3DD.%2BR.%26aulast%3DTrendelenburg%26aufirst%3DC.%26aulast%3DTsao%26aufirst%3DJ.%26aulast%3DRoman%26aufirst%3DD.%26atitle%3DImatinib%2520does%2520not%2520induce%2520cardiotoxicity%2520at%2520clinically%2520relevant%2520concentrations%2520in%2520preclinical%2520studies%26jtitle%3DLeuk.%2520Res.%26date%3D2010%26volume%3D34%26spage%3D1180%26epage%3D1188%26doi%3D10.1016%2Fj.leukres.2010.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xiao-Yu Zhang, Xiao-Yun Wu, Bo Zhang, Yin Wei, <span class="NLM_string-name hlFld-ContribAuthor">Min Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Silyl Radical-Mediated Carbocyclization of Acrylamide-/Vinyl Sulfonamide-Attached Alkylidenecyclopropanes via Photoredox Catalysis with a Catalytic Amount of Silane Reagent. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (8)
                                     , 4372-4380. <a href="https://doi.org/10.1021/acscatal.1c00240" title="DOI URL">https://doi.org/10.1021/acscatal.1c00240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.1c00240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.1c00240%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DSilyl%252BRadical-Mediated%252BCarbocyclization%252Bof%252BAcrylamide-%25252FVinyl%252BSulfonamide-Attached%252BAlkylidenecyclopropanes%252Bvia%252BPhotoredox%252BCatalysis%252Bwith%252Ba%252BCatalytic%252BAmount%252Bof%252BSilane%252BReagent%26aulast%3DZhang%26aufirst%3DXiao-Yu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D18012021%26date%3D16032021%26date%3D25032021%26volume%3D11%26issue%3D8%26spage%3D4372%26epage%3D4380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13291-13315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00829" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Bfor%252BTapping%252Binto%252BThree-Dimensional%252BChemical%252BSpace%252Bthrough%252Ba%252BQuaternary%252BCarbon%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D31082020%26date%3D17082020%26volume%3D63%26issue%3D22%26spage%3D13291%26epage%3D13315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiao-Yu Zhang, Chao Ning, Yong-Jie Long, Yin Wei, <span class="NLM_string-name hlFld-ContribAuthor">Min Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-Light-Mediated Decarboxylative Tandem Carbocyclization of Acrylamide-Attached Alkylidenecyclopropanes: Access to Polycyclic Benzazepine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (13)
                                     , 5212-5216. <a href="https://doi.org/10.1021/acs.orglett.0c01856" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01856%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DVisible-Light-Mediated%252BDecarboxylative%252BTandem%252BCarbocyclization%252Bof%252BAcrylamide-Attached%252BAlkylidenecyclopropanes%25253A%252BAccess%252Bto%252BPolycyclic%252BBenzazepine%252BDerivatives%26aulast%3DZhang%26aufirst%3DXiao-Yu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02062020%26date%3D17062020%26volume%3D22%26issue%3D13%26spage%3D5212%26epage%3D5216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Juraj Velcicky, Casey J. N. Mathison, Victor Nikulin, Daniel Pflieger, Robert Epple, Mihai Azimioara, Christopher Cow, Pierre-Yves Michellys, Pascal Rigollier, Daniel R. Beisner, Ursula Bodendorf, Danilo Guerini, Bo Liu, Ben Wen, Samantha Zaharevitz, <span class="NLM_string-name hlFld-ContribAuthor">Trixi Brandl</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (6)
                                     , 887-892. <a href="https://doi.org/10.1021/acsmedchemlett.9b00044" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00044%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BOrally%252BActive%252BHydroxyethylamine%252BBased%252BSPPL2a%252BInhibitors%26aulast%3DVelcicky%26aufirst%3DJuraj%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04022019%26date%3D16052019%26date%3D23052019%26volume%3D10%26issue%3D6%26spage%3D887%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shuang-Qi Tang, Jacques Bricard, Martine Schmitt, <span class="NLM_string-name hlFld-ContribAuthor">Frédéric Bihel</span>. </span><span class="cited-content_cbyCitation_article-title">Fukuyama Cross-Coupling Approach to Isoprekinamycin: Discovery of the Highly Active and Bench-Stable Palladium Precatalyst POxAP. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (3)
                                     , 844-848. <a href="https://doi.org/10.1021/acs.orglett.9b00031" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00031%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DFukuyama%252BCross-Coupling%252BApproach%252Bto%252BIsoprekinamycin%25253A%252BDiscovery%252Bof%252Bthe%252BHighly%252BActive%252Band%252BBench-Stable%252BPalladium%252BPrecatalyst%252BPOxAP%26aulast%3DTang%26aufirst%3DShuang-Qi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D18012019%26volume%3D21%26issue%3D3%26spage%3D844%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alkmini A.  Papadopoulou</span>, <span class="hlFld-ContribAuthor ">Regina  Fluhrer</span>. </span><span class="cited-content_cbyCitation_article-title">Signaling Functions of Intramembrane Aspartyl-Proteases. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cardiovascular Medicine</span><span> <strong>2020,</strong> <em>7 </em><a href="https://doi.org/10.3389/fcvm.2020.591787" title="DOI URL">https://doi.org/10.3389/fcvm.2020.591787</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcvm.2020.591787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcvm.2020.591787%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cardiovascular%2520Medicine%26atitle%3DSignaling%252BFunctions%252Bof%252BIntramembrane%252BAspartyl-Proteases%26aulast%3DPapadopoulou%26aufirst%3DAlkmini%2BA.%26date%3D2020%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tessa S.  Kempen</span>, <span class="hlFld-ContribAuthor ">Emmerik F.A.  Leijten</span>, <span class="hlFld-ContribAuthor ">Marthe F.S.  Lindenbergh</span>, <span class="hlFld-ContribAuthor ">Michel Olde  Nordkamp</span>, <span class="hlFld-ContribAuthor ">Christoph  Driessen</span>, <span class="hlFld-ContribAuthor ">Robert‐Jan  Lebbink</span>, <span class="hlFld-ContribAuthor ">Niklas  Baerlecken</span>, <span class="hlFld-ContribAuthor ">Torsten  Witte</span>, <span class="hlFld-ContribAuthor ">Timothy R.D.J.  Radstake</span>, <span class="hlFld-ContribAuthor ">Marianne  Boes</span>. </span><span class="cited-content_cbyCitation_article-title">Impaired proteolysis by SPPL2a causes CD74 fragment accumulation that can be recognized by anti‐CD74 autoantibodies in human ankylosing spondylitis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Immunology</span><span> <strong>2020,</strong> <em>50 </em>
                                    (8)
                                     , 1209-1219. <a href="https://doi.org/10.1002/eji.201948502" title="DOI URL">https://doi.org/10.1002/eji.201948502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/eji.201948502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Feji.201948502%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Immunology%26atitle%3DImpaired%252Bproteolysis%252Bby%252BSPPL2a%252Bcauses%252BCD74%252Bfragment%252Baccumulation%252Bthat%252Bcan%252Bbe%252Brecognized%252Bby%252Banti%2525E2%252580%252590CD74%252Bautoantibodies%252Bin%252Bhuman%252Bankylosing%252Bspondylitis%26aulast%3DKempen%26aufirst%3DTessa%2BS.%26date%3D2020%26date%3D2020%26volume%3D50%26issue%3D8%26spage%3D1209%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Torben  Mentrup</span>, <span class="hlFld-ContribAuthor ">Florencia  Cabrera-Cabrera</span>, <span class="hlFld-ContribAuthor ">Regina  Fluhrer</span>, <span class="hlFld-ContribAuthor ">Bernd  Schröder</span>. </span><span class="cited-content_cbyCitation_article-title">Physiological functions of SPP/SPPL intramembrane proteases. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2020,</strong> <em>77 </em>
                                    (15)
                                     , 2959-2979. <a href="https://doi.org/10.1007/s00018-020-03470-6" title="DOI URL">https://doi.org/10.1007/s00018-020-03470-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-020-03470-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-020-03470-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DPhysiological%252Bfunctions%252Bof%252BSPP%25252FSPPL%252Bintramembrane%252Bproteases%26aulast%3DMentrup%26aufirst%3DTorben%26date%3D2020%26date%3D2020%26volume%3D77%26issue%3D15%26spage%3D2959%26epage%3D2979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathália G.  Souza-Silva</span>, <span class="hlFld-ContribAuthor ">Eduardo S.  Nicolau</span>, <span class="hlFld-ContribAuthor ">Kate  Hoy</span>, <span class="hlFld-ContribAuthor ">Ziarih  Hawi</span>, <span class="hlFld-ContribAuthor ">Mark A.  Bellgrove</span>, <span class="hlFld-ContribAuthor ">Débora M.  Miranda</span>, <span class="hlFld-ContribAuthor ">Marco A.  Romano-Silva</span>, <span class="hlFld-ContribAuthor ">Paul B.  Fitzgerald</span>. </span><span class="cited-content_cbyCitation_article-title">A genetic profile of refractory individuals with major depressive disorder and their responsiveness to transcranial magnetic stimulation. </span><span class="cited-content_cbyCitation_journal-name">Brain Stimulation</span><span> <strong>2020,</strong> <em>13 </em>
                                    (4)
                                     , 1091-1093. <a href="https://doi.org/10.1016/j.brs.2020.04.019" title="DOI URL">https://doi.org/10.1016/j.brs.2020.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brs.2020.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brs.2020.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Stimulation%26atitle%3DA%252Bgenetic%252Bprofile%252Bof%252Brefractory%252Bindividuals%252Bwith%252Bmajor%252Bdepressive%252Bdisorder%252Band%252Btheir%252Bresponsiveness%252Bto%252Btranscranial%252Bmagnetic%252Bstimulation%26aulast%3DSouza-Silva%26aufirst%3DNath%25C3%25A1lia%2BG.%26date%3D2020%26volume%3D13%26issue%3D4%26spage%3D1091%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Gazzotti</span>, <span class="hlFld-ContribAuthor ">Marco  Manenti</span>, <span class="hlFld-ContribAuthor ">Leonardo  Lo Presti</span>, <span class="hlFld-ContribAuthor ">Alessandra  Silvani</span>. </span><span class="cited-content_cbyCitation_article-title">Allylation of isatin-derived N-Boc-hydrazones followed by Pd-catalyzed carboamination reaction: an entry to 3-spiro-pyrazolidyl-oxindoles. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (65)
                                     , 37788-37800. <a href="https://doi.org/10.1039/C9RA07712J" title="DOI URL">https://doi.org/10.1039/C9RA07712J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA07712J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA07712J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAllylation%252Bof%252Bisatin-derived%252BN-Boc-hydrazones%252Bfollowed%252Bby%252BPd-catalyzed%252Bcarboamination%252Breaction%25253A%252Ban%252Bentry%252Bto%252B3-spiro-pyrazolidyl-oxindoles%26aulast%3DGazzotti%26aufirst%3DStefano%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D65%26spage%3D37788%26epage%3D37800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dehai  Liu</span>, <span class="hlFld-ContribAuthor ">Zhouli  Hu</span>, <span class="hlFld-ContribAuthor ">Yuxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Minghua  Gong</span>, <span class="hlFld-ContribAuthor ">Zhenqian  Fu</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Access to Enantioenriched Spiro‐
              ϵ
              ‐Lactam Oxindoles by an N‐Heterocyclic Carbene‐Catalyzed [4+3] Annulation of Flexible Oxotryptamines with Enals. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>131 </em><a href="https://doi.org/10.1002/chem.201903144" title="DOI URL">https://doi.org/10.1002/chem.201903144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201903144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201903144%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DAccess%252Bto%252BEnantioenriched%252BSpiro%2525E2%252580%252590%252B%2525CF%2525B5%252B%2525E2%252580%252590Lactam%252BOxindoles%252Bby%252Ban%252BN%2525E2%252580%252590Heterocyclic%252BCarbene%2525E2%252580%252590Catalyzed%252B%25255B4%25252B3%25255D%252BAnnulation%252Bof%252BFlexible%252BOxotryptamines%252Bwith%252BEnals%26aulast%3DLiu%26aufirst%3DDehai%26date%3D2019%26date%3D2019%26volume%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Tricyclic Amines <b>7</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, 0 °C to rt, 16 h (96%); (b) pyrazolidine·2HCl, DIPEA, NaI, NaOAc, DMF, rt, 16 h (57%); (c) LiHMDS, <i>i</i>-pentyl-ONO, THF, 0 °C, 2 h (67%); (d) Zn, HCl, AcOH, rt, 2 h; (e) Boc<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, rt, 16 h; (f) chiral separation using preparative chiral SFC (37% over 3 steps); (g) HCl, dioxane/CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (94–99%); (h) RuO<sub>2</sub>·H<sub>2</sub>O (cat.), NaIO<sub>4</sub>, EtOAc/H<sub>2</sub>O, rt, 15 min (91%).</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Fluoro and Cyclopropyl Tricyclic Amines <b>15</b> and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOEt/EtOH, CuBr, reflux, 2 h (92%); (b) (1) EtOOCCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h, (2) NaBH<sub>4</sub>, THF/H<sub>2</sub>O, −15 °C, 1 h, (3) TsOH·H<sub>2</sub>O (cat.), PhMe, 80 °C, 1 h (77%); (c) SOCl<sub>2</sub>, MeOH, 0 °C to rt, 16 h (77%); (d) pyrazolidine·2HCl, DIPEA, NaI, NaOAc, DMF, 200 °C, 10 min (40%); (e) LiHMDS, <i>i</i>-pentyl-ONO, THF, 0 °C, 2 h (used in the next step); (f) H<sub>2</sub> (4 bar), Pd/C, HCl, EtOH, rt, 16 h (quantitative over two steps); (g) (1) Boc<sub>2</sub>O, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, (2) chiral separation using preparative chiral HPLC (44%); (h) HCl, dioxane/CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 2 h (100%); (i) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 16 h (59%); (j) NaH, (BocNH)<sub>2</sub>, DMF, rt, 16 h (93%); (k) HBr/AcOH, Et<sub>2</sub>O, rt, 16 h (91%); (l) homophthalic anhydride, AcOH/py, 130 °C, 20 h (69%); (m) Zn, HCl, AcOH, rt, 2 h (55%); (n) (1) Boc<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, rt, 2 h, (2) chiral separation using preparative chiral SFC (48%).</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Succinates and Completion of the Molecules<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) cyclo-Pr-CH<sub>2</sub>COOH, EDC, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (86%); (b) NaHMDS, THF, −78 °C, 1 h, then <i>t</i>-BuOOCCH<sub>2</sub>Br, −78 °C, 1 h (54–75%); (c) LiOH, H<sub>2</sub>O<sub>2</sub>, THF/H<sub>2</sub>O, 0 °C, 2 h (70–91%); (d) TOTU, DIPEA, CH<sub>3</sub>CN, rt, 16 h (<b>25</b> and <b>27</b>, 64–95%); (e) EDC, py, rt, 4–18 h (<b>26</b> and <b>28</b>, 80–89%); (f) HATU, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (<b>29</b>, 82%); (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (80–98%); (h) Ar-NH<sub>2</sub>, EDC, py, rt, 16 h (<b>30</b>, <b>32</b>–<b>34</b>, <b>36</b>–<b>40</b>, 50–78%); (i) Ar-NH<sub>2</sub>, HATU, DIPEA, DMF, rt, 2 h (<b>31</b>, 60%); (j) Ar-NH<sub>2</sub>, 1-Me-1<i>H</i>-imidazole, MsCl, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (<b>35</b>, 58%).</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selective SPPL2a inhibitor <b>31</b> inhibits CD74/p8 processing in vivo and spares γ-secretase activity. (A) Mice (<i>n</i> = 3 per group) received either a single oral dose of 100 mg/kg <b>42</b> or 10, 30, and 100 mg/kg of SPPL2a selective inhibitor <b>31</b>. In vivo inhibition of SPPL2a was assessed by measuring CD74/p8 accumulation in splenocytes 4 h later. CD74 full-length (FL) and CD74/p8 were detected by Western blot analysis of splenocyte lysates (with an antimouse CD74 antibody, shown on the left; quantification of the p8 bands relative to the reference <b>42</b> and normalized to FL CD74 are shown on the right; each lane on the Western blot corresponds to an individual animal). (B) Total plasma and spleen concentrations (means ± SEM) of <b>31</b> at termination of the study (4 h after single oral dosing). (C) In vivo inhibition of γ-secretase was assessed by mRNA levels of Hes1 in thymus and jejunum. Statistics are one-way ANOVA followed by Dunnett’s test compared to matched vehicle group: * <i>p</i> ≤ 0.05; ** <i>p</i> ≤ 0.01; *** <i>p</i> ≤ 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CD74/p8 accumulation is reversible upon inhibitor withdrawal. The mouse B cell line A20 was incubated in vitro with 2 μM <b>31</b> for 16 h to achieve maximal CD74/p8 accumulation. Subsequently, cells were washed in medium without inhibitor and either lysed directly (time point 0) or further incubated for up to 120 min without inhibitor and analyzed for remaining p8 levels by Western blotting using an antimouse CD74 antibody. p8 Bands were quantified using a ChemiDoc TM MP imaging system and evaluated with Image Lab 4.1 (BioRad). Data are blotted relative to the p8 levels detected at 0 h (all data points were determined in duplicate, the p8 band with the highest intensity was set arbitrarily to 100%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Metabolite profiling study on <b>31</b> in liver microsomes. <b>31</b> was incubated at 37 °C for 60 min with liver microsomes from human, rat, and mouse. The structure of the identified metabolites was proposed based on elemental composition, fragmentation relative to the parent compound, and number of exchangeable hydrogen atoms. <i>P</i> = parent, m = metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of CD74/p8-fragment processing in mice after oral treatment with <b>40</b>. (A) Mice received single oral doses of 150 mg/kg <b>31</b> or 1, 3, 10, and 30 mg/kg <b>40</b>. Then 16 h after dosing, inhibition of SPPL2a in vivo was assessed by measuring CD74/p8 accumulation in splenocyte lysates by Western blot analysis with an antimouse CD74 antibody. Relative quantification of the p8 bands is shown, where the samples with the strongest signal was set arbitrarily as 100%. (B) Total plasma concentrations (means ± SEM) of <b>40</b> at termination of the study 16 h after dosing showed an overdose proportional increase. Statistics are one-way ANOVA followed by Dunnett’s test compared to matched vehicle group: * <i>p</i> ≤ 0.05; ** <i>p</i> ≤ 0.01; *** <i>p</i> ≤ 0.001; **** <i>p</i> ≤ 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of CD74/p8-fragment processing in rat after oral treatment with <b>40</b>. (A) Female Lewis rats received <b>40</b> (1, 3, 10, and 30 mg/kg b.i.d.; first dose at 0 h, second dose at 8 h). Then 16 h after the second dose (24 h in total), inhibition of SPPL2a in vivo was assessed by measuring CD74/p8 accumulation in blood and splenocyte extracts by Western blot analysis with an antirat CD74 antibody (top) and relative quantification of the p8 bands shown (bottom). *p8 bands which were arbitrarily set as 100%. Note: the low CD74/p8 accumulation detected in two samples of the 10 mg/kg dose group in blood is probably due to an artifact arising from technical challenges in cell preparation from blood and lack of a possibility to normalize beyond initial blood volume used for the cell preparation. (B) Total spleen and blood concentration (means ± SEM) of <b>40</b> at termination (24 h after first dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/medium/jm-2017-01371k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Treatment of mice with the SPPL2a inhibitor <b>40</b> leads to a reduction in B cells and myeloid dendritic cells without affecting γ-secretase activity. Mice were treated orally with 3, 10, and 30 mg/kg <b>40</b> b.i.d. (with 8 and 16 h dosing intervals) for 11 days. The study was terminated 16 h after the last dose of <b>40</b> on day 12. Mice dosed with 30 mg/kg <b>40</b> b.i.d. showed a significant body weight loss by day 5, therefore Nutra Cal high calorie gel food supplement was added to all cages on day 5, which resulted in the animals regaining weight. (A) Total B cells numbers in spleen, analyzed by flow cytometry by B220<sup>+</sup> staining, a significant reduction of total B cell numbers were observed in the 10 and 30 mg/kg <b>40</b> treatment groups. (B) FACS analysis of different B cell subsets in spleen, FO = follicular B cells, T1 = transitional T1 B cells, T2 = transitional T2 cells, MZ = marginal zone B cells; a significant reduction of FO, T1, and MZ B cell numbers were observed in the 10 and 30 mg/kg <b>40</b> treatment groups and a significant reduction in all <b>40</b> dose groups for the T2 B cell numbers. (C) Flow cytometry analysis of mDCs and pDCs numbers in spleen, a significant reduction of mDC numbers were observed in the 3, 10, and 30 mg/kg <b>40</b> treatment groups, whereas the trend toward a reduction in pDC numbers did not reach significance for any of the dose groups. (D) total plasma concentration of <b>40</b> at predose on day 12 (<i>C</i><sub>trough</sub> level), showing an over dose proportional increase in through levels. (E) Hes1 mRNA levels in the thymus measured by qPCR and expressed as fold-change compared to the vehicle treated group, no significant changes for any of the dose groups were observed. Statistics are one-way ANOVA followed by Dunnett’s test compared to matched vehicle group: * <i>p</i> ≤ 0.05; ** <i>p</i> ≤ 0.01; *** <i>p</i> ≤ 0.001; **** <i>p</i> ≤ 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01371/20180201/images/large/jm-2017-01371k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01371&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Regulated intramembrane proteolysis-lessons from amyloid precursor protein processing</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07248.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1111%2Fj.1471-4159.2011.07248.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=21413990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFCmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=779-796&author=S.+F.+Lichtenthalerauthor=C.+Haassauthor=H.+Steiner&title=Regulated+intramembrane+proteolysis-lessons+from+amyloid+precursor+protein+processing&doi=10.1111%2Fj.1471-4159.2011.07248.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing</span></div><div class="casAuthors">Lichtenthaler, Stefan F.; Haass, Christian; Steiner, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">779-796</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Regulated intramembrane proteolysis (RIP) controls the communication between cells and the extracellular environment.  RIP is essential in the nervous system, but also in other tissues.  In the RIP process, a membrane protein typically undergoes two consecutive cleavages.  The first one results in the shedding of its ectodomain.  The second one occurs within its transmembrane domain, resulting in secretion of a small peptide and the release of the intracellular domain into the cytosol.  The proteolytic cleavage fragments act as versatile signaling mols. or are further degraded.  An increasing no. of membrane proteins undergo RIP.  These include growth factors, cytokines, cell adhesion proteins, receptors, viral proteins and signal peptides.  A dysregulation of RIP is found in diseases, such as leukemia and Alzheimer's disease.  One of the first RIP substrates discovered was the amyloid precursor protein (APP).  RIP processing of APP controls the generation of the amyloid β-peptide, which is believed to cause Alzheimer's disease.  Focusing on APP as the best-studied RIP substrate, this review describes the function and mechanism of the APP RIP proteases with the goal to elucidate cellular mechanisms and common principles of the RIP process in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-9xiT7_ssWrVg90H21EOLACvtfcHk0lg6arAN_Ja1HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFCmt7w%253D&md5=37055c2d190701cc5c8eaf80c439a42f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07248.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07248.x%26sid%3Dliteratum%253Aachs%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DRegulated%2520intramembrane%2520proteolysis-lessons%2520from%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D117%26spage%3D779%26epage%3D796%26doi%3D10.1111%2Fj.1471-4159.2011.07248.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Urban, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, M.</span><span> </span><span class="NLM_article-title">Intramembrane proteolysis controls diverse signaling pathways throughout evolution</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1016/S0959-437X(02)00334-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2FS0959-437X%2802%2900334-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=512-518&author=S.+Urbanauthor=M.+Freeman&title=Intramembrane+proteolysis+controls+diverse+signaling+pathways+throughout+evolution&doi=10.1016%2FS0959-437X%2802%2900334-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0959-437X%2802%2900334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-437X%252802%252900334-9%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DS.%26aulast%3DFreeman%26aufirst%3DM.%26atitle%3DIntramembrane%2520proteolysis%2520controls%2520diverse%2520signaling%2520pathways%2520throughout%2520evolution%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2002%26volume%3D12%26spage%3D512%26epage%3D518%26doi%3D10.1016%2FS0959-437X%2802%2900334-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Intramembrane-cleaving proteases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">13969</span><span class="NLM_x">–</span> <span class="NLM_lpage">13973</span><span class="refDoi"> DOI: 10.1074/jbc.R800039200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.R800039200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=13969-13973&author=M.+S.+Wolfe&title=Intramembrane-cleaving+proteases&doi=10.1074%2Fjbc.R800039200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R800039200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R800039200%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DIntramembrane-cleaving%2520proteases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D13969%26epage%3D13973%26doi%3D10.1074%2Fjbc.R800039200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">MacLeod, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillert, E.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, G. S.</span><span> </span><span class="NLM_article-title">The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer’s disease</span> <span class="citation_source-journal">Future Sci. OA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">FSO.15.9</span><span class="refDoi"> DOI: 10.4155/fso.15.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.4155%2Ffso.15.9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=FSO.15.9&author=R.+MacLeodauthor=E.-K.+Hillertauthor=R.+T.+Cameronauthor=G.+S.+Baillie&title=The+role+and+therapeutic+targeting+of+%CE%B1-%2C+%CE%B2-+and+%CE%B3-secretase+in+Alzheimer%E2%80%99s+disease&doi=10.4155%2Ffso.15.9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4155%2Ffso.15.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffso.15.9%26sid%3Dliteratum%253Aachs%26aulast%3DMacLeod%26aufirst%3DR.%26aulast%3DHillert%26aufirst%3DE.-K.%26aulast%3DCameron%26aufirst%3DR.%2BT.%26aulast%3DBaillie%26aufirst%3DG.%2BS.%26atitle%3DThe%2520role%2520and%2520therapeutic%2520targeting%2520of%2520%25CE%25B1-%252C%2520%25CE%25B2-%2520and%2520%25CE%25B3-secretase%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFuture%2520Sci.%2520OA%26date%3D2015%26volume%3D1%26spage%3DFSO.15.9%26doi%3D10.4155%2Ffso.15.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Weihofen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemberg, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span> </span><span class="NLM_article-title">Identification of signal peptide peptidase, a presenilin-type aspartic protease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">2215</span><span class="NLM_x">–</span> <span class="NLM_lpage">2218</span><span class="refDoi"> DOI: 10.1126/science.1070925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1126%2Fscience.1070925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=12077416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFGhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=2215-2218&author=A.+Weihofenauthor=K.+Binnsauthor=M.+K.+Lembergauthor=K.+Ashmanauthor=B.+Martoglio&title=Identification+of+signal+peptide+peptidase%2C+a+presenilin-type+aspartic+protease&doi=10.1126%2Fscience.1070925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of signal peptide peptidase, a presenilin-type aspartic protease</span></div><div class="casAuthors">Weihofen, Andreas; Binns, Kathleen; Lemberg, Marius K.; Ashman, Keith; Martoglio, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5576</span>),
    <span class="NLM_cas:pages">2215-2218</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Signal peptide peptidase (SPP) catalyzes intramembrane proteolysis of some signal peptides after they have been cleaved from a preprotein.  In humans, SPP activity is required to generate signal sequence-derived human lymphocyte antigen-E epitopes that are recognized by the immune system, and to process hepatitis C virus core protein.  We have identified human SPP as a polytopic membrane protein with sequence motifs characteristic of the presenilin-type aspartic proteases.  SPP and potential eukaryotic homologs may represent another family of aspartic proteases that promote intramembrane proteolysis to release biol. important peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ6nsu9YfU2bVg90H21EOLACvtfcHk0lg6arAN_Ja1HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFGhtrg%253D&md5=65ab559d2949577e92d7e9da70031698</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1070925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1070925%26sid%3Dliteratum%253Aachs%26aulast%3DWeihofen%26aufirst%3DA.%26aulast%3DBinns%26aufirst%3DK.%26aulast%3DLemberg%26aufirst%3DM.%2BK.%26aulast%3DAshman%26aufirst%3DK.%26aulast%3DMartoglio%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520signal%2520peptide%2520peptidase%252C%2520a%2520presenilin-type%2520aspartic%2520protease%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D2215%26epage%3D2218%26doi%3D10.1126%2Fscience.1070925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mentrup, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span> </span><span class="NLM_article-title">Latest emerging functions of SPP/SPPL intramembrane proteases</span> <span class="citation_source-journal">Eur. J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span><span class="refDoi"> DOI: 10.1016/j.ejcb.2017.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.ejcb.2017.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=28366434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVCjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2017&pages=372-382&author=T.+Mentrupauthor=R.+Fluhrerauthor=B.+Schr%C3%B6der&title=Latest+emerging+functions+of+SPP%2FSPPL+intramembrane+proteases&doi=10.1016%2Fj.ejcb.2017.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Latest emerging functions of SPP/SPPL intramembrane proteases</span></div><div class="casAuthors">Mentrup, Torben; Fluhrer, Regina; Schroeder, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-382</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  Signal peptide peptidase (SPP) and the four related SPP-like (SPPL) proteases are homologues of the presenilins, which comprise the catalytic center of the γ-secretase complex.  SPP/SPPL proteases are GxGD-type aspartyl intramembrane proteases selective for substrates with a type II membrane topol.  Subcellular localisations of SPP/SPPL proteases range from the early secretory pathway to the plasma membrane and the endocytic system.  Similarly diverse are their functional roles at the cellular level covering the turnover of signal peptides and membrane proteins, a contribution to the ERAD pathway as well as the regulation of cellular protein glycosylation and certain signaling pathways.  Much less well understood are the physiol. functions of SPP/SPPL proteases in complex organisms.  Whereas a major role of SPPL2a for homeostasis of B cells and dendritic cells has been documented in mice, in vivo functions of SPP and the other SPPLs remain largely elusive to date.  SPP/SPPL proteases contribute to regulated intramembrane proteolysis (RIP), a sequential processing of single-spanning transmembrane proteins by an ectodomain sheddase and an intramembrane-cleaving protease (I-CLIP).  However, recent studies reported the cleavage of tail-anchored and multi-pass membrane proteins by SPP as well as the capability of SPPL3 to accept substrates without a preceding ectodomain shedding.  This revealed that the mechanistic properties within this family are more diverse than initially thought.  With this review, we aim to provide an update on recent achievements in defining the function and (patho-) physiol. relevance of SPP/SPPL proteases and to highlight open questions in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEEXnd2id2-bVg90H21EOLACvtfcHk0lhLYIu09U2tXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVCjtLc%253D&md5=425b512d8753cea339a384582855e95a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ejcb.2017.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejcb.2017.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMentrup%26aufirst%3DT.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26atitle%3DLatest%2520emerging%2520functions%2520of%2520SPP%252FSPPL%2520intramembrane%2520proteases%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D2017%26volume%3D96%26spage%3D372%26epage%3D382%26doi%3D10.1016%2Fj.ejcb.2017.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Friedmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauben, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maylandt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleeger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vreugde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span> </span><span class="NLM_article-title">SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1038/ncb1440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1038%2Fncb1440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=16829952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFWqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=843-848&author=E.+Friedmannauthor=E.+Haubenauthor=K.+Maylandtauthor=S.+Schleegerauthor=S.+Vreugdeauthor=S.+F.+Lichtenthalerauthor=P.-H.+Kuhnauthor=D.+Staufferauthor=G.+Rovelliauthor=B.+Martoglio&title=SPPL2a+and+SPPL2b+promote+intramembrane+proteolysis+of+TNF%CE%B1+in+activated+dendritic+cells+to+trigger+IL-12+production&doi=10.1038%2Fncb1440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production</span></div><div class="casAuthors">Friedmann, Elena; Hauben, Ehud; Maylandt, Kerstin; Schleeger, Simone; Vreugde, Sarah; Lichtenthaler, Stefan F.; Kuhn, Peer-Hendrik; Stauffer, Daniela; Rovelli, Giorgio; Martoglio, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">843-848</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Homologs of signal peptide peptidase (SPPLs) are putative aspartic proteases that may catalyze regulated intramembrane proteolysis of type II membrane-anchored signaling factors.  Here, the authors show that four human SPPLs are each sorted to a different compartment of the secretory pathway.  The authors demonstrate that SPPL2a and SPPL2b, which are sorted to endosomes and the plasma membrane, resp., are functional proteases that catalyze intramembrane cleavage of tumor necrosis factor alpha (TNFα).  The two proteases promoted the release of the TNFα intracellular domain, which in turn triggers expression of the pro-inflammatory cytokine interleukin-12 by activated human dendritic cells.  The authors' study reveals a crit. function for SPPL2a and SPPL2b in the regulation of innate and adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqqsJFjHHbobVg90H21EOLACvtfcHk0lhLYIu09U2tXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFWqur4%253D&md5=dda66127e85387cde033b66726c6fc18</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncb1440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1440%26sid%3Dliteratum%253Aachs%26aulast%3DFriedmann%26aufirst%3DE.%26aulast%3DHauben%26aufirst%3DE.%26aulast%3DMaylandt%26aufirst%3DK.%26aulast%3DSchleeger%26aufirst%3DS.%26aulast%3DVreugde%26aufirst%3DS.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DKuhn%26aufirst%3DP.-H.%26aulast%3DStauffer%26aufirst%3DD.%26aulast%3DRovelli%26aufirst%3DG.%26aulast%3DMartoglio%26aufirst%3DB.%26atitle%3DSPPL2a%2520and%2520SPPL2b%2520promote%2520intramembrane%2520proteolysis%2520of%2520TNF%25CE%25B1%2520in%2520activated%2520dendritic%2520cells%2520to%2520trigger%2520IL-12%2520production%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2006%26volume%3D8%26spage%3D843%26epage%3D848%26doi%3D10.1038%2Fncb1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Voss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span> </span><span class="NLM_article-title">Mechanism, specificity, and physiology of Signal Peptide Peptidase (SPP) and SPP-like proteases</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1828</span><span class="NLM_x">, </span> <span class="NLM_fpage">2828</span><span class="NLM_x">–</span> <span class="NLM_lpage">2839</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.03.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bbamem.2013.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=24099004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOgur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1828&publication_year=2013&pages=2828-2839&author=M.+Vossauthor=B.+Schr%C3%B6derauthor=R.+Fluhrer&title=Mechanism%2C+specificity%2C+and+physiology+of+Signal+Peptide+Peptidase+%28SPP%29+and+SPP-like+proteases&doi=10.1016%2Fj.bbamem.2013.03.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases</span></div><div class="casAuthors">Voss, Matthias; Schroeder, Bernd; Fluhrer, Regina</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1828</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2828-2839</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Signal peptide peptidase (SPP) and the homologous SPP-like (SPPL) proteases SPPL2a, SPPL2b, SPPL2c and SPPL3 belong to the family of GxGD intramembrane proteases.  SPP/SPPLs selectively cleave transmembrane domains in type II orientation and do not require addnl. co-factors for proteolytic activity.  Orthologues of SPP and SPPLs have been identified in other vertebrates, plants, and eukaryotes.  In line with their diverse subcellular localizations ranging from the ER (SPP, SPPL2c), the Golgi (SPPL3), the plasma membrane (SPPL2b) to lysosomes/late endosomes (SPPL2a), the different members of the SPP/SPPL family seem to exhibit distinct functions.  Here, we review the substrates of these proteases identified to date as well as the current state of knowledge about the physiol. implications of these proteolytic events as deduced from in vivo studies.  Furthermore, the present knowledge on the structure of intramembrane proteases of the SPP/SPPL family, their cleavage mechanism and their substrate requirements are summarized.  This article is part of a Special Issue entitled: Intramembrane Proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZysnLRit4f7Vg90H21EOLACvtfcHk0lhLYIu09U2tXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOgur3I&md5=60410dfbc6511de4bb2e029a3dbda3e7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DVoss%26aufirst%3DM.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26aulast%3DFluhrer%26aufirst%3DR.%26atitle%3DMechanism%252C%2520specificity%252C%2520and%2520physiology%2520of%2520Signal%2520Peptide%2520Peptidase%2520%2528SPP%2529%2520and%2520SPP-like%2520proteases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2013%26volume%3D1828%26spage%3D2828%26epage%3D2839%26doi%3D10.1016%2Fj.bbamem.2013.03.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kirkin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahuzac, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardiola-Serrano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckerath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novac, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wels, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hueber, A.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zornig, M.</span><span> </span><span class="NLM_article-title">The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1678</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4402175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1038%2Fsj.cdd.4402175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=17557115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFymtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1678-1687&author=V.+Kirkinauthor=N.+Cahuzacauthor=F.+Guardiola-Serranoauthor=S.+Huaultauthor=K.+Luckerathauthor=E.+Friedmannauthor=N.+Novacauthor=W.+S.+Welsauthor=B.+Martoglioauthor=A.-O.+Hueberauthor=M.+Zornig&title=The+Fas+ligand+intracellular+domain+is+released+by+ADAM10+and+SPPL2a+cleavage+in+T-cells&doi=10.1038%2Fsj.cdd.4402175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells</span></div><div class="casAuthors">Kirkin, V.; Cahuzac, N.; Guardiola-Serrano, F.; Huault, S.; Lueckerath, K.; Friedmann, E.; Novac, N.; Wels, W. S.; Martoglio, B.; Hueber, A.-O.; Zoernig, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1678-1687</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fas ligand (FasL) is a type II transmembrane protein belonging to the tumor necrosis factor family.  Its binding to the cognate Fas receptor triggers the apoptosis that plays a pivotal role in the maintenance of immune system homeostasis.  The cell death-inducing property of FasL has been assocd. with its extracellular domain, which can be cleaved off by metalloprotease activity to produce sol. FasL.  The fate of the remaining membrane-anchored N-terminal part of the FasL mol. has not been detd.  Here we show that post-translational processing of overexpressed and endogenous FasL in T-cells by the disintegrin and metalloprotease ADAM10 generates a 17-kDa N-terminal fragment, which lacks the receptor-binding extracellular domain.  This FasL remnant is membrane anchored and further processed by SPPL2a, a member of the signal peptide peptidase-like family of intramembrane-cleaving proteases.  SPPL2a cleavage liberates a smaller and highly unstable fragment mainly contg. the intracellular FasL domain (FasL ICD).  We show that this fragment translocates to the nucleus and is capable of inhibiting gene transcription.  With ADAM10 and SPPL2a we have identified two proteases implicated in FasL processing and release of the FasL ICD, which has been shown to be important for retrograde FasL signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrziEQPMDtDZrVg90H21EOLACvtfcHk0liWCfwyPXcXIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFymtbc%253D&md5=8201ec4f8ca123cd41076e64cdf40049</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402175%26sid%3Dliteratum%253Aachs%26aulast%3DKirkin%26aufirst%3DV.%26aulast%3DCahuzac%26aufirst%3DN.%26aulast%3DGuardiola-Serrano%26aufirst%3DF.%26aulast%3DHuault%26aufirst%3DS.%26aulast%3DLuckerath%26aufirst%3DK.%26aulast%3DFriedmann%26aufirst%3DE.%26aulast%3DNovac%26aufirst%3DN.%26aulast%3DWels%26aufirst%3DW.%2BS.%26aulast%3DMartoglio%26aufirst%3DB.%26aulast%3DHueber%26aufirst%3DA.-O.%26aulast%3DZornig%26aufirst%3DM.%26atitle%3DThe%2520Fas%2520ligand%2520intracellular%2520domain%2520is%2520released%2520by%2520ADAM10%2520and%2520SPPL2a%2520cleavage%2520in%2520T-cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D1678%26epage%3D1687%26doi%3D10.1038%2Fsj.cdd.4402175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1644</span><span class="NLM_x">–</span> <span class="NLM_lpage">1652</span><span class="refDoi"> DOI: 10.1074/jbc.M706661200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M706661200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=1644-1652&author=L.+Martinauthor=R.+Fluhrerauthor=K.+Reissauthor=E.+Kremmerauthor=P.+Saftigauthor=C.+Haass&title=Regulated+intramembrane+proteolysis+of+Bri2+%28Itm2b%29+by+ADAM10+and+SPPL2a%2FSPPL2b&doi=10.1074%2Fjbc.M706661200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M706661200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M706661200%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DReiss%26aufirst%3DK.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DRegulated%2520intramembrane%2520proteolysis%2520of%2520Bri2%2520%2528Itm2b%2529%2520by%2520ADAM10%2520and%2520SPPL2a%252FSPPL2b%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D1644%26epage%3D1652%26doi%3D10.1074%2Fjbc.M706661200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Beisner, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langerak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otero, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltshire, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodendorf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span> </span><span class="NLM_article-title">The intramembrane protease SPPL2a is required for B cell and DC development and survival via cleavage of the invariant chain</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1084/jem.20121072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1084%2Fjem.20121072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23267013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Oitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=23-30&author=D.+R.+Beisnerauthor=P.+Langerakauthor=A.+E.+Parkerauthor=C.+Dahlbergauthor=F.+J.+Oteroauthor=S.+E.+Suttonauthor=L.+Poirotauthor=W.+Barnesauthor=M.+A.+Youngauthor=S.+Niessenauthor=T.+Wiltshireauthor=U.+Bodendorfauthor=B.+Martoglioauthor=B.+Cravattauthor=M.+P.+Cooke&title=The+intramembrane+protease+SPPL2a+is+required+for+B+cell+and+DC+development+and+survival+via+cleavage+of+the+invariant+chain&doi=10.1084%2Fjem.20121072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain</span></div><div class="casAuthors">Beisner, Daniel R.; Langerak, Petra; Parker, Albert E.; Dahlberg, Carol; Otero, Francella J.; Sutton, Sue E.; Poirot, Laurent; Barnes, Whitney; Young, Michael A.; Niessen, Sherry; Wiltshire, Tim; Bodendorf, Ursula; Martoglio, Bruno; Cravatt, Benjamin; Cooke, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-30</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">B cell development requires tight regulation to allow for the generation of a diverse repertoire while preventing the development of autoreactive cells.  We report, using N-ethyl-N-nitrosourea (ENU)-induced mutagenesis, the identification of a mutant mouse (chompB) with a block in early B cell development.  The blockade occurs after the transitional 1 (T1) stage and leads to a decrease in mature B cell subsets and deficits in T cell-dependent antibody responses.  Addnl., chompB mice have decreases in myeloid dendritic cells (DCs).  The mutation was mapped to the intramembrane protease signal peptide peptidase-like 2a (Sppl2a), a gene not previously implicated in immune cell development.  Proteomic anal. identified the invariant chain (CD74) as a key substrate of Sppl2a and suggests that regulated intramembrane proteolysis of CD74 by Sppl2a contributes to B cell and DC survival.  Moreover, these data suggest that modulation of Sppl2a may be a useful therapeutic strategy for treatment of B cell dependent autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz5IaIoDFCJrVg90H21EOLACvtfcHk0liWCfwyPXcXIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Oitbs%253D&md5=001a2fe7aca2a8d5bb669833e155dff9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1084%2Fjem.20121072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20121072%26sid%3Dliteratum%253Aachs%26aulast%3DBeisner%26aufirst%3DD.%2BR.%26aulast%3DLangerak%26aufirst%3DP.%26aulast%3DParker%26aufirst%3DA.%2BE.%26aulast%3DDahlberg%26aufirst%3DC.%26aulast%3DOtero%26aufirst%3DF.%2BJ.%26aulast%3DSutton%26aufirst%3DS.%2BE.%26aulast%3DPoirot%26aufirst%3DL.%26aulast%3DBarnes%26aufirst%3DW.%26aulast%3DYoung%26aufirst%3DM.%2BA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DWiltshire%26aufirst%3DT.%26aulast%3DBodendorf%26aufirst%3DU.%26aulast%3DMartoglio%26aufirst%3DB.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26atitle%3DThe%2520intramembrane%2520protease%2520SPPL2a%2520is%2520required%2520for%2520B%2520cell%2520and%2520DC%2520development%2520and%2520survival%2520via%2520cleavage%2520of%2520the%2520invariant%2520chain%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D23%26epage%3D30%26doi%3D10.1084%2Fjem.20121072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bergmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Short, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miosge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teh, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roots, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeelall, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakishnan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjollema, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimmer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornall, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodnow, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enders, A.</span><span> </span><span class="NLM_article-title">B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8– dendritic cells require the intramembrane endopeptidase SPPL2A</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1084/jem.20121076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1084%2Fjem.20121076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23267016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=31-40&author=H.+Bergmannauthor=M.+Yabasauthor=A.+Shortauthor=L.+Miosgeauthor=N.+Barthelauthor=C.+E.+Tehauthor=C.+M.+Rootsauthor=K.+R.+Bullauthor=Y.+Jeelallauthor=K.+Horikawaauthor=B.+Whittleauthor=B.+Balakishnanauthor=G.+Sjollemaauthor=E.+M.+Bertramauthor=F.+Mackayauthor=A.+J.+Rimmerauthor=R.+J.+Cornallauthor=M.+A.+Fieldauthor=T.+D.+Andrewsauthor=C.+C.+Goodnowauthor=A.+Enders&title=B+cell+survival%2C+surface+BCR+and+BAFFR+expression%2C+CD74+metabolism%2C+and+CD8%E2%80%93+dendritic+cells+require+the+intramembrane+endopeptidase+SPPL2A&doi=10.1084%2Fjem.20121076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A</span></div><div class="casAuthors">Bergmann, Hannes; Yabas, Mehmet; Short, Alanna; Miosge, Lisa; Barthel, Nadine; Teh, Charis E.; Roots, Carla M.; Bull, Katherine R.; Jeelall, Yogesh; Horikawa, Keisuke; Whittle, Belinda; Balakishnan, Bhavani; Sjollema, Geoff; Bertram, Edward M.; Mackay, Fabienne; Rimmer, Andrew J.; Cornall, Richard J.; Field, Matthew A.; Andrews, T. Daniel; Goodnow, Christopher C.; Enders, Anselm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Druggable proteins required for B lymphocyte survival and immune responses are an emerging source of new treatments for autoimmunity and lymphoid malignancy.  In this study, we show that mice with an inactivating mutation in the intramembrane protease signal peptide peptidase-like 2A (SPPL2A) unexpectedly exhibit profound humoral immunodeficiency and lack mature B cell subsets, mirroring deficiency of the cytokine B cell-activating factor (BAFF).  Accumulation of Sppl2a-deficient B cells was rescued by overexpression of the BAFF-induced survival protein B cell lymphoma 2 (BCL2) but not BAFF and was distinguished by low surface BAFF receptor and IgM and IgD B cell receptors.  CD8-neg. dendritic cells were also greatly decreased.  SPPL2A deficiency blocked the proteolytic processing of CD74 MHC II invariant chain in both cell types, causing dramatic build-up of the p8 product of Cathepsin S and interfering with earlier steps in CD74 endosomal retention and processing.  The findings illuminate an important role for the final step in the CD74-MHC II pathway and a new target for protease inhibitor treatment of B cell diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz2NdHY5Fb0bVg90H21EOLACvtfcHk0lhNTUchyj8IVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OitbY%253D&md5=d9fe646a22d2639d4fdf22e271736b98</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1084%2Fjem.20121076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20121076%26sid%3Dliteratum%253Aachs%26aulast%3DBergmann%26aufirst%3DH.%26aulast%3DYabas%26aufirst%3DM.%26aulast%3DShort%26aufirst%3DA.%26aulast%3DMiosge%26aufirst%3DL.%26aulast%3DBarthel%26aufirst%3DN.%26aulast%3DTeh%26aufirst%3DC.%2BE.%26aulast%3DRoots%26aufirst%3DC.%2BM.%26aulast%3DBull%26aufirst%3DK.%2BR.%26aulast%3DJeelall%26aufirst%3DY.%26aulast%3DHorikawa%26aufirst%3DK.%26aulast%3DWhittle%26aufirst%3DB.%26aulast%3DBalakishnan%26aufirst%3DB.%26aulast%3DSjollema%26aufirst%3DG.%26aulast%3DBertram%26aufirst%3DE.%2BM.%26aulast%3DMackay%26aufirst%3DF.%26aulast%3DRimmer%26aufirst%3DA.%2BJ.%26aulast%3DCornall%26aufirst%3DR.%2BJ.%26aulast%3DField%26aufirst%3DM.%2BA.%26aulast%3DAndrews%26aufirst%3DT.%2BD.%26aulast%3DGoodnow%26aufirst%3DC.%2BC.%26aulast%3DEnders%26aufirst%3DA.%26atitle%3DB%2520cell%2520survival%252C%2520surface%2520BCR%2520and%2520BAFFR%2520expression%252C%2520CD74%2520metabolism%252C%2520and%2520CD8%25E2%2580%2593%2520dendritic%2520cells%2520require%2520the%2520intramembrane%2520endopeptidase%2520SPPL2A%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D31%26epage%3D40%26doi%3D10.1084%2Fjem.20121076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Schneppenheim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dressel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hüttl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lüllmann-Rauch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wienands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskelinen, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermans-Borgmeyer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span> </span><span class="NLM_article-title">The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1084/jem.20121069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1084%2Fjem.20121069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23267015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Oiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=41-58&author=J.+Schneppenheimauthor=R.+Dresselauthor=S.+H%C3%BCttlauthor=R.+L%C3%BCllmann-Rauchauthor=M.+Engelkeauthor=K.+Dittmannauthor=J.+Wienandsauthor=E.+L.+Eskelinenauthor=I.+Hermans-Borgmeyerauthor=R.+Fluhrerauthor=P.+Saftigauthor=B.+Schr%C3%B6der&title=The+intramembrane+protease+SPPL2a+promotes+B+cell+development+and+controls+endosomal+traffic+by+cleavage+of+the+invariant+chain&doi=10.1084%2Fjem.20121069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain</span></div><div class="casAuthors">Schneppenheim, Janna; Dressel, Ralf; Huettl, Susann; Luellmann-Rauch, Renate; Engelke, Michael; Dittmann, Kai; Wienands, Juergen; Eskelinen, Eeva-Liisa; Hermans-Borgmeyer, Irm; Fluhrer, Regina; Saftig, Paul; Schroeder, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-58</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Regulated intramembrane proteolysis is a central cellular process involved in signal transduction and membrane protein turnover.  The presenilin homolog signal-peptide-peptidase-like 2a (SPPL2a) has been implicated in the cleavage of type 2 transmembrane proteins.  We show that the invariant chain (li, CD74) of the major histocompatibility class II complex (MHCII) undergoes intramembrane proteolysis mediated by SPPL2a.  B lymphocytes of SPPL2a-/- mice accumulate an N-terminal fragment (NTF) of CD74, which severely impairs membrane traffic within the endocytic system and leads to an altered response to B cell receptor stimulation, reduced BAFF-R surface expression, and accumulation of MHCII in transitional developmental stage T1 B cells.  This results in significant loss of B cell subsets beyond the T1 stage and disrupted humoral immune responses, which can be recovered by addnl. ablation of CD74.  Hence, we provide evidence that regulation of CD74-NTF levels by SPPL2a is indispensable for B cell development and function by maintaining trafficking and integrity of MHCII-contg. endosomes, highlighting SPPL2a as a promising pharmacol. target for depleting and/or modulating B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZnP7A8vHZkbVg90H21EOLACvtfcHk0lhNTUchyj8IVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Oiur4%253D&md5=569515655d4afbc18e6a0627bdf16708</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1084%2Fjem.20121069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20121069%26sid%3Dliteratum%253Aachs%26aulast%3DSchneppenheim%26aufirst%3DJ.%26aulast%3DDressel%26aufirst%3DR.%26aulast%3DH%25C3%25BCttl%26aufirst%3DS.%26aulast%3DL%25C3%25BCllmann-Rauch%26aufirst%3DR.%26aulast%3DEngelke%26aufirst%3DM.%26aulast%3DDittmann%26aufirst%3DK.%26aulast%3DWienands%26aufirst%3DJ.%26aulast%3DEskelinen%26aufirst%3DE.%2BL.%26aulast%3DHermans-Borgmeyer%26aufirst%3DI.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26atitle%3DThe%2520intramembrane%2520protease%2520SPPL2a%2520promotes%2520B%2520cell%2520development%2520and%2520controls%2520endosomal%2520traffic%2520by%2520cleavage%2520of%2520the%2520invariant%2520chain%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D41%26epage%3D58%26doi%3D10.1084%2Fjem.20121069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Brady, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, F.</span><span> </span><span class="NLM_article-title">Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by Signal Peptide Peptidase-like 2a (SPPL2a)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">19670</span><span class="NLM_x">–</span> <span class="NLM_lpage">19680</span><span class="refDoi"> DOI: 10.1074/jbc.M113.515700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M113.515700" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=19670-19680&author=O.+A.+Bradyauthor=X.+Zhouauthor=F.+Hu&title=Regulated+intramembrane+proteolysis+of+the+frontotemporal+lobar+degeneration+risk+factor%2C+TMEM106B%2C+by+Signal+Peptide+Peptidase-like+2a+%28SPPL2a%29&doi=10.1074%2Fjbc.M113.515700"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.515700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.515700%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DO.%2BA.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DF.%26atitle%3DRegulated%2520intramembrane%2520proteolysis%2520of%2520the%2520frontotemporal%2520lobar%2520degeneration%2520risk%2520factor%252C%2520TMEM106B%252C%2520by%2520Signal%2520Peptide%2520Peptidase-like%25202a%2520%2528SPPL2a%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D19670%26epage%3D19680%26doi%3D10.1074%2Fjbc.M113.515700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fleck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brankatschk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwenk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edbauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug-Kröper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Proteolytic processing of Neuregulin 1 type III by three intramembrane-cleaving proteases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1074/jbc.M115.697995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M115.697995" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=318-333&author=D.+Fleckauthor=M.+Vossauthor=B.+Brankatschkauthor=C.+Giudiciauthor=H.+Hampelauthor=B.+Schwenkauthor=D.+Edbauerauthor=A.+Fukumoriauthor=H.+Steinerauthor=E.+Kremmerauthor=M.+Haug-Kr%C3%B6perauthor=M.+J.+Rossnerauthor=R.+Fluhrerauthor=M.+Willemauthor=C.+Haass&title=Proteolytic+processing+of+Neuregulin+1+type+III+by+three+intramembrane-cleaving+proteases&doi=10.1074%2Fjbc.M115.697995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.697995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.697995%26sid%3Dliteratum%253Aachs%26aulast%3DFleck%26aufirst%3DD.%26aulast%3DVoss%26aufirst%3DM.%26aulast%3DBrankatschk%26aufirst%3DB.%26aulast%3DGiudici%26aufirst%3DC.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DSchwenk%26aufirst%3DB.%26aulast%3DEdbauer%26aufirst%3DD.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DHaug-Kr%25C3%25B6per%26aufirst%3DM.%26aulast%3DRossner%26aufirst%3DM.%2BJ.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DProteolytic%2520processing%2520of%2520Neuregulin%25201%2520type%2520III%2520by%2520three%2520intramembrane-cleaving%2520proteases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D318%26epage%3D333%26doi%3D10.1074%2Fjbc.M115.697995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Voss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grammer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug-Kröper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span> </span><span class="NLM_article-title">Foamy virus envelope protein is a substrate for signal peptide peptidase-like 3 (SPPL3)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x"> (</span><span class="NLM_issue">52</span><span class="NLM_x">) </span> <span class="NLM_fpage">43401</span><span class="NLM_x">–</span> <span class="NLM_lpage">43409</span><span class="refDoi"> DOI: 10.1074/jbc.M112.371369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M112.371369" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=43401-43409&issue=52&author=M.+Vossauthor=A.+Fukumoriauthor=P.-H.+Kuhnauthor=U.+K%C3%BCnzelauthor=B.+Klierauthor=G.+Grammerauthor=M.+Haug-Kr%C3%B6perauthor=E.+Kremmerauthor=S.+F.+Lichtenthalerauthor=H.+Steinerauthor=B.+Schr%C3%B6derauthor=C.+Haassauthor=R.+Fluhrer&title=Foamy+virus+envelope+protein+is+a+substrate+for+signal+peptide+peptidase-like+3+%28SPPL3%29&doi=10.1074%2Fjbc.M112.371369"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.371369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.371369%26sid%3Dliteratum%253Aachs%26aulast%3DVoss%26aufirst%3DM.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DKuhn%26aufirst%3DP.-H.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DU.%26aulast%3DKlier%26aufirst%3DB.%26aulast%3DGrammer%26aufirst%3DG.%26aulast%3DHaug-Kr%25C3%25B6per%26aufirst%3DM.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DFluhrer%26aufirst%3DR.%26atitle%3DFoamy%2520virus%2520envelope%2520protein%2520is%2520a%2520substrate%2520for%2520signal%2520peptide%2520peptidase-like%25203%2520%2528SPPL3%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D52%26spage%3D43401%26epage%3D43409%26doi%3D10.1074%2Fjbc.M112.371369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hüttl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kläsener, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneppenheim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberg, H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabelitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span> </span><span class="NLM_article-title">Processing of CD74 by the intramembrane protease SPPL2a is critical for B cell receptor signaling in transitional B cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">1548</span><span class="NLM_x">–</span> <span class="NLM_lpage">1563</span><span class="refDoi"> DOI: 10.4049/jimmunol.1403171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.4049%2Fjimmunol.1403171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=26157172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12gt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2015&pages=1548-1563&author=S.+H%C3%BCttlauthor=K.+Kl%C3%A4senerauthor=M.+Schweizerauthor=J.+Schneppenheimauthor=H.-H.+Obergauthor=D.+Kabelitzauthor=M.+Rethauthor=P.+Saftigauthor=B.+Schr%C3%B6der&title=Processing+of+CD74+by+the+intramembrane+protease+SPPL2a+is+critical+for+B+cell+receptor+signaling+in+transitional+B+cells&doi=10.4049%2Fjimmunol.1403171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells</span></div><div class="casAuthors">Huettl, Susann; Klaesener, Kathrin; Schweizer, Michaela; Schneppenheim, Janna; Oberg, Hans-Heinrich; Kabelitz, Dieter; Reth, Michael; Saftig, Paul; Schroeder, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1548-1563</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The invariant chain (CD74), a chaperone in MHC class II-mediated Ag presentation, is sequentially processed by different endosomal proteases.  We reported recently that clearance of the final membrane-bound N-terminal fragment (NTF) of CD74 is mediated by the intramembrane protease signal peptide peptidase-like (SPPL)2a, a process crit. for B cell development.  In mice, SPPL2a deficiency provokes the accumulation of this NTF in endocytic vesicles, which leads to a B cell maturation arrest at the transitional 1 stage.  To define the underlying mechanism, we analyzed the impact of SPPL2a deficiency on signaling pathways involved in B cell homeostasis.  We demonstrate that tonic as well as BCR-induced activation of the PI3K/Akt pathway is massively compromised in SPPL2a-/- B cells and identify this as major cause of the B cell maturation defect in these mice.  Altered BCR trafficking induces a redn. of surface IgM in SPPL2a-deficient B cells, leading to a diminished signal transmission via the BCR and the tyrosine kinase Syk.  We provide evidence that in SPPL2a-/- mice impaired BCR signaling is to a great extent provoked by the accumulating CD74 NTF, which can interact with the BCR and Syk, and that impaired PI3K/Akt signaling and reduced surface IgM are not directly linked processes.  In line with disturbances in PI3K/Akt signaling, SPPL2a-/- B cells show a dysregulation of the transcription factor FOXO1, causing elevated transcription of proapoptotic genes.  We conclude that SPPL2a-mediated processing of CD74 NTF is indispensable to maintain appropriate levels of tonic BCR signaling to promote B cell maturation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0ydWpcrySrVg90H21EOLACvtfcHk0lgZnxZ50PGKCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12gt77K&md5=ef43a32e3c81ac53a7a893edf413fa6c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1403171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1403171%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCttl%26aufirst%3DS.%26aulast%3DKl%25C3%25A4sener%26aufirst%3DK.%26aulast%3DSchweizer%26aufirst%3DM.%26aulast%3DSchneppenheim%26aufirst%3DJ.%26aulast%3DOberg%26aufirst%3DH.-H.%26aulast%3DKabelitz%26aufirst%3DD.%26aulast%3DReth%26aufirst%3DM.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26atitle%3DProcessing%2520of%2520CD74%2520by%2520the%2520intramembrane%2520protease%2520SPPL2a%2520is%2520critical%2520for%2520B%2520cell%2520receptor%2520signaling%2520in%2520transitional%2520B%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2015%26volume%3D195%26spage%3D1548%26epage%3D1563%26doi%3D10.4049%2Fjimmunol.1403171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hampe, C. S.</span><span> </span><span class="NLM_article-title">B cells in autoimmune diseases</span> <span class="citation_source-journal">Scientifica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">215308</span><span class="refDoi"> DOI: 10.6064/2012/215308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.6064%2F2012%2F215308" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=215308&author=C.+S.+Hampe&title=B+cells+in+autoimmune+diseases&doi=10.6064%2F2012%2F215308"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.6064%2F2012%2F215308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6064%252F2012%252F215308%26sid%3Dliteratum%253Aachs%26aulast%3DHampe%26aufirst%3DC.%2BS.%26atitle%3DB%2520cells%2520in%2520autoimmune%2520diseases%26jtitle%3DScientifica%26date%3D2012%26volume%3D2012%26spage%3D215308%26doi%3D10.6064%2F2012%2F215308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mentrup, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loock, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluhrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, B.</span><span> </span><span class="NLM_article-title">Signal peptide peptidase and SPP-like proteases - possible therapeutic targets?</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">1864</span><span class="NLM_x">, </span> <span class="NLM_fpage">2169</span><span class="NLM_x">–</span> <span class="NLM_lpage">2182</span><span class="refDoi"> DOI: 10.1016/j.bbamcr.2017.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bbamcr.2017.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=28624439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2017&pages=2169-2182&author=T.+Mentrupauthor=A.-C.+Loockauthor=R.+Fluhrerauthor=B.+Schr%C3%B6der&title=Signal+peptide+peptidase+and+SPP-like+proteases+-+possible+therapeutic+targets%3F&doi=10.1016%2Fj.bbamcr.2017.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Signal peptide peptidase and SPP-like proteases - Possible therapeutic targets?</span></div><div class="casAuthors">Mentrup, Torben; Loock, Ann-Christine; Fluhrer, Regina; Schroeder, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">11_Part_B</span>),
    <span class="NLM_cas:pages">2169-2182</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Signal peptide peptidase (SPP) and the four homologous SPP-like proteases SPPL2a, SPPL2b, SPPL2c and SPPL3 are GxGD-type intramembrane-cleaving proteases (I-CLIPs).  In addn. to divergent subcellular localisations, distinct differences in the mechanistic properties and substrate requirements of individual family members have been unravelled.  SPP/SPPL proteases employ a catalytic mechanism related to that of the γ-secretase complex.  Nevertheless, differential targeting of SPP/SPPL proteases and γ-secretase by inhibitors has been demonstrated.  Furthermore, also within the SPP/SPPL family significant differences in the sensitivity to currently available inhibitory compds. have been reported.  Though far from complete, our knowledge on pathophysiol. functions of SPP/SPPL proteases, in particular based on studies in mice, has been significantly increased over the last years.  Based on this, inhibition of distinct SPP/SPPL proteases has been proposed as a novel therapeutic concept e.g. for the treatment of autoimmunity and viral or protozoal infections, as we will discuss in this review.  This article is part of a Special Issue entitled: Proteolysis as a Regulatory Event in Pathophysiol. edited by Stefan Rose-John.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqppqzdGfSk_LVg90H21EOLACvtfcHk0lgZnxZ50PGKCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtL3J&md5=a4f313effb63568e571e87e7ba7a6422</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2017.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2017.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DMentrup%26aufirst%3DT.%26aulast%3DLoock%26aufirst%3DA.-C.%26aulast%3DFluhrer%26aufirst%3DR.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DB.%26atitle%3DSignal%2520peptide%2520peptidase%2520and%2520SPP-like%2520proteases%2520-%2520possible%2520therapeutic%2520targets%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2017%26volume%3D1864%26spage%3D2169%26epage%3D2182%26doi%3D10.1016%2Fj.bbamcr.2017.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miele, L.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors and modulators</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1828</span><span class="NLM_x">, </span> <span class="NLM_fpage">2898</span><span class="NLM_x">–</span> <span class="NLM_lpage">2907</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bbamem.2013.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23791707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOntLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1828&publication_year=2013&pages=2898-2907&author=T.+E.+Goldeauthor=E.+H.+Kooauthor=K.+M.+Felsensteinauthor=B.+A.+Osborneauthor=L.+Miele&title=%CE%B3-Secretase+inhibitors+and+modulators&doi=10.1016%2Fj.bbamem.2013.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase inhibitors and modulators</span></div><div class="casAuthors">Golde, Todd E.; Koo, Edward H.; Felsenstein, Kevin M.; Osborne, Barbara A.; Miele, Lucio</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1828</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2898-2907</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is a fascinating, multi-subunit, intramembrane cleaving protease that is now being considered as a therapeutic target for a no. of diseases.  Potent, orally bioavailable γ-secretase inhibitors (GSIs) have been developed and tested in humans with Alzheimer's disease (AD) and cancer.  Preclin. studies also suggest the therapeutic potential for GSIs in other disease conditions.  However, due to inherent mechanism based-toxicity of non-selective inhibition of γ-secretase, clin. development of GSIs will require empirical testing with careful evaluation of benefit vs. risk.  In addn. to GSIs, compds. referred to as γ-secretase modulators (GSMs) remain in development as AD therapeutics.  GSMs do not inhibit γ-secretase, but modulate γ-secretase processivity and thereby shift the profile of the secreted amyloid β peptides (Aβ) peptides produced.  Although GSMs are thought to have an inherently safe mechanism of action, their effects on substrates other than the amyloid β protein precursor (APP) have not been extensively investigated.  Herein, we will review the current state of development of GSIs and GSMs and explore pertinent biol. and pharmacol. questions pertaining to the use of these agents for select indications.  This article is part of a Special Issue entitled: Intramembrane Proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxnnsmOtdDJLVg90H21EOLACvtfcHk0lh-pNeN5aB97Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOntLfK&md5=b6069836c464b99d217b25b8f67e4e60</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DOsborne%26aufirst%3DB.%2BA.%26aulast%3DMiele%26aufirst%3DL.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520and%2520modulators%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2013%26volume%3D1828%26spage%3D2898%26epage%3D2907%26doi%3D10.1016%2Fj.bbamem.2013.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Bray, S. J.</span><span> </span><span class="NLM_article-title">Notch signalling in context</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span><span class="refDoi"> DOI: 10.1038/nrm.2016.94</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1038%2Fnrm.2016.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=27507209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaitb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=722-735&author=S.+J.+Bray&title=Notch+signalling+in+context&doi=10.1038%2Fnrm.2016.94"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Notch signalling in context</span></div><div class="casAuthors">Bray, Sarah J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">722-735</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The highly conserved Notch signalling pathway functions in many different developmental and homeostatic processes, which raises the question of how this pathway can achieve such diverse outcomes.  With a direct route from the membrane to the nucleus, the Notch pathway has fewer opportunities for regulation than do many other signalling pathways, yet it generates exquisitely patterned structures, including sensory hair cells and branched arterial networks.  More confusingly, its activity promotes tissue growth and cancers in some circumstances but cell death and tumor suppression in others.  Many different regulatory mechanisms help to shape the activity of the Notch pathway, generating functional outputs that are appropriate for each context.  These mechanisms include the receptor-ligand landscape, the tissue topol., the nuclear environment and the connectivity of the regulatory networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgXD9AhFBN_7Vg90H21EOLACvtfcHk0lh-pNeN5aB97Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaitb3N&md5=27bdab1ece68eb46abdeea7e85aac7e8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2016.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2016.94%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DS.%2BJ.%26atitle%3DNotch%2520signalling%2520in%2520context%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2016%26volume%3D17%26spage%3D722%26epage%3D735%26doi%3D10.1038%2Fnrm.2016.94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rizzo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osipo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miele, L.</span><span> </span><span class="NLM_article-title">Rational targeting of Notch signaling in cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5124</span><span class="NLM_x">–</span> <span class="NLM_lpage">5131</span><span class="refDoi"> DOI: 10.1038/onc.2008.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1038%2Fonc.2008.226" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5124-5131&author=P.+Rizzoauthor=C.+Osipoauthor=K.+Foremanauthor=T.+Goldeauthor=B.+Osborneauthor=L.+Miele&title=Rational+targeting+of+Notch+signaling+in+cancer&doi=10.1038%2Fonc.2008.226"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fonc.2008.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2008.226%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DP.%26aulast%3DOsipo%26aufirst%3DC.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DOsborne%26aufirst%3DB.%26aulast%3DMiele%26aufirst%3DL.%26atitle%3DRational%2520targeting%2520of%2520Notch%2520signaling%2520in%2520cancer%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5124%26epage%3D5131%26doi%3D10.1038%2Fonc.2008.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ryeom, S. W.</span><span> </span><span class="NLM_article-title">The cautionary tale of side effects of chronic Notch1 inhibition</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1172/JCI45976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1172%2FJCI45976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=21266769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsl2rur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=508-509&author=S.+W.+Ryeom&title=The+cautionary+tale+of+side+effects+of+chronic+Notch1+inhibition&doi=10.1172%2FJCI45976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The cautionary tale of side effects of chronic Notch1 inhibition</span></div><div class="casAuthors">Ryeom, Sandra W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">508-509</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Aberrant Notch1 signaling is implicated in several types of cancer.  Therefore, Notch signaling pathways are important anticancer targets.  Pan-Notch receptor inhibition is assocd. with numerous complications; thus, selective Notch receptor inhibition has been pursued.  Studies have shown minimal side effects with short-term blockade of either Notch1 or its ligand Delta-like 4, but long-term side effects were not investigated.  In this issue of the JCI, Liu et al. use mouse models to demonstrate the consequence of long-term Notch1 inhibition.  They present evidence that chronic Notch1 inhibition leads to vascular tumors in the liver and decreased survival, which suggests that Notch1 therapies should be reevaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAByudPYROzbVg90H21EOLACvtfcHk0lh-pNeN5aB97Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsl2rur8%253D&md5=9ec0e3b021234ef1b734c5395a032bc0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1172%2FJCI45976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI45976%26sid%3Dliteratum%253Aachs%26aulast%3DRyeom%26aufirst%3DS.%2BW.%26atitle%3DThe%2520cautionary%2520tale%2520of%2520side%2520effects%2520of%2520chronic%2520Notch1%2520inhibition%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D508%26epage%3D509%26doi%3D10.1172%2FJCI45976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span> </span><span class="NLM_article-title">A phase 3 trial of semagacestat for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1056/NEJMoa1210951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1056%2FNEJMoa1210951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=23883379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=341-350&author=R.+S.+Doodyauthor=R.+Ramanauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=F.+Heauthor=X.+Sunauthor=R.+G.+Thomasauthor=P.+S.+Aisenauthor=E.+Siemersauthor=G.+Sethuramanauthor=R.+Mohs&title=A+phase+3+trial+of+semagacestat+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1210951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 3 trial of semagacestat for treatment of Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Raman, Rema; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; He, Feng; Sun, Xiaoying; Thomas, Ronald G.; Aisen, Paul S.; Siemers, Eric; Sethuraman, Gopalan; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-350</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the presence of cortical amyloid-beta (Aβ) protein plaques, which result from the sequential action of β-secretase and γ-secretase on amyloid precursor protein.  Semagacestat is a small-mol. γ-secretase inhibitor that was developed as a potential treatment for Alzheimer's disease.  Methods: We conducted a double-blind, placebo-controlled trial in which 1537 patients with probable Alzheimer's disease underwent randomization to receive 100 mg of semagacestat, 140 mg of semagacestat, or placebo daily.  Changes in cognition from baseline to week 76 were assessed with the use of the cognitive subscale of the Alzheimer's Disease Assessment Scale for cognition (ADAS-cog), on which scores range from 0 to 70 and higher scores indicate greater cognitive impairment, and changes in functioning were assessed with the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale, on which scores range from 0 to 78 and higher scores indicate better functioning.  A mixed-model repeated-measures anal. was used.  Results: The trial was terminated before completion on the basis of a recommendation by the data and safety monitoring board.  At termination, there were 189 patients in the group receiving placebo, 153 patients in the group receiving 100 mg of semagacestat, and 121 patients in the group receiving 140 mg of semagacestat.  The ADAS-cog scores worsened in all three groups (mean change, 6.4 points in the placebo group, 7.5 points in the group receiving 100 mg of the study drug, and 7.8 points in the group receiving 140 mg; P = 0.15 and P = 0.07, resp., for the comparison with placebo).  The ADCS-ADL scores also worsened in all groups (mean change at week 76, -9.0 points in the placebo group, -10.5 points in the 100-mg group, and -12.6 points in the 140-mg group; P = 0.14 and P<0.001, resp., for the comparison with placebo).  Patients treated with semagacestat lost more wt. and had more skin cancers and infections, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo).  Lab. abnormalities included reduced levels of lymphocytes, T cells, Igs, albumin, total protein, and uric acid and elevated levels of eosinophils, monocytes, and cholesterol; the urine pH was also elevated.  Conclusions: As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability.  Semagacestat was assocd. with more adverse events, including skin cancers and infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMQCX6dUTyl7Vg90H21EOLACvtfcHk0liOOtf5qhxpYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L&md5=366f2545b2156100af31993c809feac1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1210951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1210951%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DA%2520phase%25203%2520trial%2520of%2520semagacestat%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D341%26epage%3D350%26doi%3D10.1056%2FNEJMoa1210951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceballos-Diaz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Differential inhibition of signal peptide peptidase family members by established γ-secretase inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0128619</span><span class="refDoi"> DOI: 10.1371/journal.pone.0128619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1371%2Fjournal.pone.0128619" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0128619&author=Y.+Ranauthor=G.+Z.+Laddauthor=C.+Ceballos-Diazauthor=J.+I.+Jungauthor=D.+Greenbaumauthor=K.+M.+Felsensteinauthor=T.+E.+Golde&title=Differential+inhibition+of+signal+peptide+peptidase+family+members+by+established+%CE%B3-secretase+inhibitors&doi=10.1371%2Fjournal.pone.0128619"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0128619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0128619%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DY.%26aulast%3DLadd%26aufirst%3DG.%2BZ.%26aulast%3DCeballos-Diaz%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DJ.%2BI.%26aulast%3DGreenbaum%26aufirst%3DD.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDifferential%2520inhibition%2520of%2520signal%2520peptide%2520peptidase%2520family%2520members%2520by%2520established%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0128619%26doi%3D10.1371%2Fjournal.pone.0128619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibig-Rehm, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuffenhauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beisner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siebert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonamy, G. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodendorf, U.</span><span> </span><span class="NLM_article-title">Identification of SPPL2a inhibitors by multiparametric analysis of a high-content ultra-high-throughput screen</span> <span class="citation_source-journal">SLAS Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1177/2472555217719834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1177%2F2472555217719834" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1106-1119&author=X.+Zhangauthor=M.+G%C3%B6tteauthor=Y.+Ibig-Rehmauthor=A.+Schuffenhauerauthor=M.+Kamkeauthor=D.+Beisnerauthor=D.+Gueriniauthor=D.+Siebertauthor=G.+M.+C.+Bonamyauthor=D.+Gabrielauthor=U.+Bodendorf&title=Identification+of+SPPL2a+inhibitors+by+multiparametric+analysis+of+a+high-content+ultra-high-throughput+screen&doi=10.1177%2F2472555217719834"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1177%2F2472555217719834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555217719834%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DIbig-Rehm%26aufirst%3DY.%26aulast%3DSchuffenhauer%26aufirst%3DA.%26aulast%3DKamke%26aufirst%3DM.%26aulast%3DBeisner%26aufirst%3DD.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DSiebert%26aufirst%3DD.%26aulast%3DBonamy%26aufirst%3DG.%2BM.%2BC.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DBodendorf%26aufirst%3DU.%26atitle%3DIdentification%2520of%2520SPPL2a%2520inhibitors%2520by%2520multiparametric%2520analysis%2520of%2520a%2520high-content%2520ultra-high-throughput%2520screen%26jtitle%3DSLAS%2520Discovery%26date%3D2017%26volume%3D22%26spage%3D1106%26epage%3D1119%26doi%3D10.1177%2F2472555217719834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Lead- and drug-like compounds: the rule-of-five revolution</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.ddtec.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.ddtec.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=24981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=337-41&author=C.+A.+Lipinski&title=Lead-+and+drug-like+compounds%3A+the+rule-of-five+revolution&doi=10.1016%2Fj.ddtec.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lead- and drug-like compounds: the rule-of-five revolution</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004.  Trends in the RO5 literature explosion that can be discerned are the further definitions of drug-like.  This topic is explored in terms of drug-like physicochem. features, drug-like structural features, a comparison of drug-like and non-drug-like in drug discovery and a discussion of how drug-like features relate to clin. success.  Physicochem. features of CNS drugs and features related to CNS blood-brain transporter affinity are briefly reviewed.  Recent literature on features of non-oral drugs is reviewed and how features of lead-like compds. differ from those of drug-like compds. is discussed.  Most recently, partly driven by NIH roadmap initiatives, considerations have arisen as to what tool-like means in the search for chem. tools to probe biol. space.  All these topics frame the scope of this short review/perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjiyP3CY7lLVg90H21EOLACvtfcHk0liOOtf5qhxpYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D&md5=952c29b47003b884116d790ae9e4721f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DLead-%2520and%2520drug-like%2520compounds%253A%2520the%2520rule-of-five%2520revolution%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D337%26epage%3D41%26doi%3D10.1016%2Fj.ddtec.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Prasad, C. V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsa, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleczka, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dangler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrick, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span> </span><span class="NLM_article-title">Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4006</span><span class="NLM_x">–</span> <span class="NLM_lpage">4011</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bmcl.2007.04.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4006-4011&author=C.+V.+C.+Prasadauthor=M.+Zhengauthor=S.+Vigauthor=C.+Bergstromauthor=D.+W.+Smithauthor=Q.+Gaoauthor=S.+Yeolaauthor=C.+T.+Polsonauthor=J.+A.+Corsaauthor=V.+L.+Gussauthor=A.+Looauthor=J.+Wangauthor=B.+G.+Sleczkaauthor=C.+Danglerauthor=B.+J.+Robertsonauthor=J.+P.+Hendrickauthor=S.+B.+Robertsauthor=D.+M.+Barten&title=Discovery+of+%28S%29-2-%28%28S%29-2-%283%2C5-difluorophenyl%29-2-hydroxyacetamido%29-N-%28%28S%2CZ%29-3-methyl-4-oxo-4%2C5-dihydro-3H-benzo%5Bd%5D%5B1%2C2%5Ddiazepin-5-yl%29propanamide+%28BMS-433796%29%3A+A+%CE%B3-secretase+inhibitor+with+A%CE%B2+lowering+activity+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2007.04.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.082%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DC.%2BV.%2BC.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DVig%26aufirst%3DS.%26aulast%3DBergstrom%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DD.%2BW.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DYeola%26aufirst%3DS.%26aulast%3DPolson%26aufirst%3DC.%2BT.%26aulast%3DCorsa%26aufirst%3DJ.%2BA.%26aulast%3DGuss%26aufirst%3DV.%2BL.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSleczka%26aufirst%3DB.%2BG.%26aulast%3DDangler%26aufirst%3DC.%26aulast%3DRobertson%26aufirst%3DB.%2BJ.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26atitle%3DDiscovery%2520of%2520%2528S%2529-2-%2528%2528S%2529-2-%25283%252C5-difluorophenyl%2529-2-hydroxyacetamido%2529-N-%2528%2528S%252CZ%2529-3-methyl-4-oxo-4%252C5-dihydro-3H-benzo%255Bd%255D%255B1%252C2%255Ddiazepin-5-yl%2529propanamide%2520%2528BMS-433796%2529%253A%2520A%2520%25CE%25B3-secretase%2520inhibitor%2520with%2520A%25CE%25B2%2520lowering%2520activity%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4006%26epage%3D4011%26doi%3D10.1016%2Fj.bmcl.2007.04.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Boros, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randhawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, M. H.</span><span> </span><span class="NLM_article-title">A Convenient synthesis of pyrazolidine and 3-amino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span><span class="refDoi"> DOI: 10.1002/jhet.5570380310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1002%2Fjhet.5570380310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVSlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=613-616&author=E.+E.+Borosauthor=F.+Bouvierauthor=S.+Randhawaauthor=M.+H.+Rabinowitz&title=A+Convenient+synthesis+of+pyrazolidine+and+3-amino-6%2C7-dihydro-1H%2C5H-pyrazolo%5B1%2C2-a%5Dpyrazol-1-one&doi=10.1002%2Fjhet.5570380310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient synthesis of pyrazolidine and 3-amino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one</span></div><div class="casAuthors">Boros, Eric E.; Bouvier, Frederic; Randhawa, Sab; Rabinowitz, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">613-616</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    
            (<span class="NLM_cas:orgname">HeteroCorporation</span>)
        </div><div class="casAbstract">A convenient four-step synthesis of the aminobicyclopyrazolone hydrochloride (I) was achieved starting from di-tert-Bu hydrazodiformate (II).  The route entails cyclization of II with 1,3-dibromopropane under phase transfer conditions followed by deprotection of 1,2-di-tert-butoxycarbonylpyrazolidine to give pyrazolidine hydrochloride.  Cyanoacetylation of the latter and ring closure of the resulting cyanoacetyl pyrazolidine gave I.  This novel synthesis circumvents distn. of pyrazolidine and flash chromatog. to provide I in 35-46% overall yields compared to 6% yield for the patent procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoimEvwLo0a3bVg90H21EOLACvtfcHk0lgJFajY_c2Efw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVSlt7Y%253D&md5=a7b3e32a50b82d4a3cc0f0949cf2d873</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570380310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570380310%26sid%3Dliteratum%253Aachs%26aulast%3DBoros%26aufirst%3DE.%2BE.%26aulast%3DBouvier%26aufirst%3DF.%26aulast%3DRandhawa%26aufirst%3DS.%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3DA%2520Convenient%2520synthesis%2520of%2520pyrazolidine%2520and%25203-amino-6%252C7-dihydro-1H%252C5H-pyrazolo%255B1%252C2-a%255Dpyrazol-1-one%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2001%26volume%3D38%26spage%3D613%26epage%3D616%26doi%3D10.1002%2Fjhet.5570380310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ritchie, D. J.; McCann, H. S. R.; Standen, M. C. H.; Jones, R. V. H.</span><span> </span><span class="NLM_article-title">One-step process for preparing methyl 2-(halomethyl)phenylacetate from 3-isochromanone</span>. US6048998,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>CAN128:75194.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=D.+J.+Ritchie&author=H.+S.+R.+McCann&author=M.+C.+H.+Standen&author=R.+V.+H.+Jones&title=One-step+process+for+preparing+methyl+2-%28halomethyl%29phenylacetate+from+3-isochromanone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DD.%2BJ.%26atitle%3DOne-step%2520process%2520for%2520preparing%2520methyl%25202-%2528halomethyl%2529phenylacetate%2520from%25203-isochromanone%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Schultz, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzi, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakkar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidlack, J. M.</span><span> </span><span class="NLM_article-title">Preparation and diastereoselective Birch reduction-alkylation of chiral 3,4-dihydro-1(2H)-isoquinolinones. Enantiospecific syntheses and opioid receptor affinities of several hydro-2,3-dimethyl-1H-7,12a-methanobenzo[6,7]cycloocta[1,2-c]pyridine-9-ols</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7795</span><span class="NLM_x">–</span> <span class="NLM_lpage">7804</span><span class="refDoi"> DOI: 10.1021/jo980921g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo980921g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=7795-7804&author=A.+G.+Schultzauthor=T.+J.+Guziauthor=E.+Larssonauthor=R.+Rahmauthor=K.+Thakkarauthor=J.+M.+Bidlack&title=Preparation+and+diastereoselective+Birch+reduction-alkylation+of+chiral+3%2C4-dihydro-1%282H%29-isoquinolinones.+Enantiospecific+syntheses+and+opioid+receptor+affinities+of+several+hydro-2%2C3-dimethyl-1H-7%2C12a-methanobenzo%5B6%2C7%5Dcycloocta%5B1%2C2-c%5Dpyridine-9-ols&doi=10.1021%2Fjo980921g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo980921g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980921g%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DA.%2BG.%26aulast%3DGuzi%26aufirst%3DT.%2BJ.%26aulast%3DLarsson%26aufirst%3DE.%26aulast%3DRahm%26aufirst%3DR.%26aulast%3DThakkar%26aufirst%3DK.%26aulast%3DBidlack%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520and%2520diastereoselective%2520Birch%2520reduction-alkylation%2520of%2520chiral%25203%252C4-dihydro-1%25282H%2529-isoquinolinones.%2520Enantiospecific%2520syntheses%2520and%2520opioid%2520receptor%2520affinities%2520of%2520several%2520hydro-2%252C3-dimethyl-1H-7%252C12a-methanobenzo%255B6%252C7%255Dcycloocta%255B1%252C2-c%255Dpyridine-9-ols%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D7795%26epage%3D7804%26doi%3D10.1021%2Fjo980921g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiggins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span> </span><span class="NLM_article-title">3,4-Dihydrobenz[<i>f</i>]isoquinoline and 3,4-dihydrobenz[<i>g</i>]isoquinoline</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span><span class="refDoi"> DOI: 10.1021/jo00240a042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00240a042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=1114-1116&author=S.+D.+Youngauthor=J.+M.+Wigginsauthor=J.+R.+Huff&title=3%2C4-Dihydrobenz%5Bf%5Disoquinoline+and+3%2C4-dihydrobenz%5Bg%5Disoquinoline&doi=10.1021%2Fjo00240a042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00240a042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00240a042%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DWiggins%26aufirst%3DJ.%2BM.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26atitle%3D3%252C4-Dihydrobenz%255Bf%255Disoquinoline%2520and%25203%252C4-dihydrobenz%255Bg%255Disoquinoline%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D1114%26epage%3D1116%26doi%3D10.1021%2Fjo00240a042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Prasad, C. V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsa, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span> </span><span class="NLM_article-title">2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3535</span><span class="NLM_x">–</span> <span class="NLM_lpage">3538</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.bmcl.2004.04.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=15177468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3535-3538&author=C.+V.+C.+Prasadauthor=S.+Vigauthor=D.+W.+Smithauthor=Q.+Gaoauthor=C.+T.+Polsonauthor=J.+A.+Corsaauthor=V.+L.+Gussauthor=A.+Looauthor=D.+M.+Bartenauthor=M.+Zhengauthor=K.+M.+Felsensteinauthor=S.+B.+Roberts&title=2%2C3-Benzodiazepin-1%2C4-diones+as+peptidomimetic+inhibitors+of+%CE%B3-secretase&doi=10.1016%2Fj.bmcl.2004.04.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase</span></div><div class="casAuthors">Prasad, C. V. C.; Vig, Shikha; Smith, David W.; Gao, Qi; Polson, Craig T.; Corsa, Jason A.; Guss, Valerie L.; Loo, Alice; Barten, Donna M.; Zheng, Ming; Felsenstein, Kevin M.; Roberts, Susan B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3535-3538</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">2,3-Benzodiazepin-1,4-diones were designed as peptidomimetics at the carboxy terminus of hydroxyamides.  Inhibition of brain Aβ prodn. was improved by one of the compds. contg. constrained modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowfqVuTjFHXLVg90H21EOLACvtfcHk0lj-7uYs-ndUiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gmsrk%253D&md5=a2453adcdd637fa5f45d739c44d51a78</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.056%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DC.%2BV.%2BC.%26aulast%3DVig%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BW.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DPolson%26aufirst%3DC.%2BT.%26aulast%3DCorsa%26aufirst%3DJ.%2BA.%26aulast%3DGuss%26aufirst%3DV.%2BL.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26atitle%3D2%252C3-Benzodiazepin-1%252C4-diones%2520as%2520peptidomimetic%2520inhibitors%2520of%2520%25CE%25B3-secretase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3535%26epage%3D3538%26doi%3D10.1016%2Fj.bmcl.2004.04.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Evans, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiener, J. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripin, D. H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedrow, J. S.</span><span> </span><span class="NLM_article-title">A general method for the synthesis of enantiomerically pure β-substituted, β-amino acids through α-substituted succinic acid derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6411</span><span class="NLM_x">–</span> <span class="NLM_lpage">6417</span><span class="refDoi"> DOI: 10.1021/jo990756k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo990756k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=6411-6417&author=D.+A.+Evansauthor=L.+D.+Wuauthor=J.+J.+M.+Wienerauthor=J.+S.+Johnsonauthor=D.+H.+B.+Ripinauthor=J.+S.+Tedrow&title=A+general+method+for+the+synthesis+of+enantiomerically+pure+%CE%B2-substituted%2C+%CE%B2-amino+acids+through+%CE%B1-substituted+succinic+acid+derivatives&doi=10.1021%2Fjo990756k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo990756k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo990756k%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DL.%2BD.%26aulast%3DWiener%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DJohnson%26aufirst%3DJ.%2BS.%26aulast%3DRipin%26aufirst%3DD.%2BH.%2BB.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26atitle%3DA%2520general%2520method%2520for%2520the%2520synthesis%2520of%2520enantiomerically%2520pure%2520%25CE%25B2-substituted%252C%2520%25CE%25B2-amino%2520acids%2520through%2520%25CE%25B1-substituted%2520succinic%2520acid%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D6411%26epage%3D6417%26doi%3D10.1021%2Fjo990756k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Milano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagenais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster-Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadient, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, P. J.</span><span> </span><span class="NLM_article-title">Modulation of Notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1093/toxsci/kfh254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1093%2Ftoxsci%2Fkfh254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=15319485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2004&pages=341-358&author=J.+Milanoauthor=J.+McKayauthor=C.+Dagenaisauthor=L.+Foster-Brownauthor=F.+Pognanauthor=R.+Gadientauthor=R.+T.+Jacobsauthor=A.+Zaccoauthor=B.+Greenbergauthor=P.+J.+Ciaccio&title=Modulation+of+Notch+processing+by+%CE%B3-secretase+inhibitors+causes+intestinal+goblet+cell+metaplasia+and+induction+of+genes+known+to+specify+gut+secretory+lineage+differentiation&doi=10.1093%2Ftoxsci%2Fkfh254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Notch Processing by γ-Secretase Inhibitors Causes Intestinal Goblet Cell Metaplasia and Induction of Genes Known to Specify Gut Secretory Lineage Differentiation</span></div><div class="casAuthors">Milano, Joseph; McKay, Jenny; Dagenais, Claude; Foster-Brown, Linda; Pognan, Francois; Gadient, Reto; Jacobs, Robert T.; Zacco, Anna; Greenberg, Barry; Ciaccio, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">341-358</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">It is anticipated that γ-secretase inhibitors (γ-Sec-I) that modulate Notch processing will alter differentiation in tissues whose architecture is governed by Notch signaling.  To explore this hypothesis, Han Wistar rats were dosed for up to 5 days with 10-100 μmol/kg b.i.d. γ-Sec-I from three chem. series that inhibit Notch processing in vitro at various potencies (Notch IC50).  These included an arylsulfonamide (AS) (142 nM), a dibenzazepine (DBZ) (1.7 nM), and a benzodiazepine (BZ) (2.2 nM).  The DBZ and BZ caused dose-dependent intestinal goblet cell metaplasia.  In contrast, the AS produced no detectable in vivo toxicity, despite higher exposure to free drug.  In a time course using BZ, small intestinal crypt cell and large intestinal glandular cell epithelial apoptosis was obsd. on days 1-5, followed by goblet cell metaplasia on days 2-5 and crypt epithelial and glandular epithelial regenerative hyperplasia on days 4-5.  Gene expression profiling of duodenal samples from BZ-dosed animals revealed significant time-dependent deregulation of mRNAs for various panendocrine, hormonal, and transcription factor genes.  Somatostatin, secretin, mucin, CCK, and gastrin mRNAs were elevated twofold or more by day 2, and a no. of candidate early-predictive' genes were altered on days 1-2, remaining changed for 4-5 days; these included Delta1, NeuroD, Hes1-regulated adipsin, and the Hes-regulated transcriptional activator of gut secretory lineage differentiation, the rat homolog of Drosophila atonal, Rath1.  Western blotting of fecal protein from BZ-and DBZ-dosed animals exhibited increased levels of both anti-Rath1 reactive protein and anti-adipsin reactive proteins, confirming their potential value as noninvasive biomarkers of intestinal goblet metaplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2qB_JewBHJrVg90H21EOLACvtfcHk0liHySiOfwCY4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLc%253D&md5=ba57bf26d54ef933a6dc738468bb07e4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfh254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfh254%26sid%3Dliteratum%253Aachs%26aulast%3DMilano%26aufirst%3DJ.%26aulast%3DMcKay%26aufirst%3DJ.%26aulast%3DDagenais%26aufirst%3DC.%26aulast%3DFoster-Brown%26aufirst%3DL.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DGadient%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZacco%26aufirst%3DA.%26aulast%3DGreenberg%26aufirst%3DB.%26aulast%3DCiaccio%26aufirst%3DP.%2BJ.%26atitle%3DModulation%2520of%2520Notch%2520processing%2520by%2520%25CE%25B3-secretase%2520inhibitors%2520causes%2520intestinal%2520goblet%2520cell%2520metaplasia%2520and%2520induction%2520of%2520genes%2520known%2520to%2520specify%2520gut%2520secretory%2520lineage%2520differentiation%26jtitle%3DToxicol.%2520Sci.%26date%3D2004%26volume%3D82%26spage%3D341%26epage%3D358%26doi%3D10.1093%2Ftoxsci%2Fkfh254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Searfoss, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbreath, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirtzinger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berridge, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, T. P.</span><span> </span><span class="NLM_article-title">Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">46107</span><span class="NLM_x">–</span> <span class="NLM_lpage">46116</span><span class="refDoi"> DOI: 10.1074/jbc.M307757200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1074%2Fjbc.M307757200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=46107-46116&author=G.+H.+Searfossauthor=W.+H.+Jordanauthor=D.+O.+Calligaroauthor=E.+J.+Galbreathauthor=L.+M.+Schirtzingerauthor=B.+R.+Berridgeauthor=H.+Gaoauthor=M.+A.+Higginsauthor=P.+C.+Mayauthor=T.+P.+Ryan&title=Adipsin%2C+a+biomarker+of+gastrointestinal+toxicity+mediated+by+a+functional+gamma-secretase+inhibitor&doi=10.1074%2Fjbc.M307757200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307757200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307757200%26sid%3Dliteratum%253Aachs%26aulast%3DSearfoss%26aufirst%3DG.%2BH.%26aulast%3DJordan%26aufirst%3DW.%2BH.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DGalbreath%26aufirst%3DE.%2BJ.%26aulast%3DSchirtzinger%26aufirst%3DL.%2BM.%26aulast%3DBerridge%26aufirst%3DB.%2BR.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DHiggins%26aufirst%3DM.%2BA.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DRyan%26aufirst%3DT.%2BP.%26atitle%3DAdipsin%252C%2520a%2520biomarker%2520of%2520gastrointestinal%2520toxicity%2520mediated%2520by%2520a%2520functional%2520gamma-secretase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D46107%26epage%3D46116%26doi%3D10.1074%2Fjbc.M307757200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span> <span class="citation_source-book">Some Aromatic Amines, Organic Dyes, and Related Exposures</span>; <span class="NLM_series">IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 99</span>; <span class="NLM_publisher-name">International Agency for Research on Cancer</span>: <span class="NLM_publisher-loc">Lyon, France</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span> pp.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Some+Aromatic+Amines%2C+Organic+Dyes%2C+and+Related+Exposures%3B+IARC+Monographs+on+the+Evaluation+of+Carcinogenic+Risks+to+Humans%2C+Vol.+99%3B+International+Agency+for+Research+on+Cancer%3A+Lyon%2C+France%2C+2010%3B+Vol.+99%2C+658+pp."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSome%2520Aromatic%2520Amines%252C%2520Organic%2520Dyes%252C%2520and%2520Related%2520Exposures%26pub%3DInternational%2520Agency%2520for%2520Research%2520on%2520Cancer%26date%3D2010%26volume%3D99%26spage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Ohkuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, M.</span><span> </span><span class="NLM_article-title">Distinct mechanisms of oxidative DNA damage by two metabolites of carcinogenic <i>o</i>-toluidine</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1006/abbi.1999.1461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1006%2Fabbi.1999.1461" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1999&pages=97-106&author=Y.+Ohkumaauthor=Y.+Hirakuauthor=S.+Oikawaauthor=N.+Yamashitaauthor=M.+Murataauthor=M.+Kawanishi&title=Distinct+mechanisms+of+oxidative+DNA+damage+by+two+metabolites+of+carcinogenic+o-toluidine&doi=10.1006%2Fabbi.1999.1461"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1999.1461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1999.1461%26sid%3Dliteratum%253Aachs%26aulast%3DOhkuma%26aufirst%3DY.%26aulast%3DHiraku%26aufirst%3DY.%26aulast%3DOikawa%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DN.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DKawanishi%26aufirst%3DM.%26atitle%3DDistinct%2520mechanisms%2520of%2520oxidative%2520DNA%2520damage%2520by%2520two%2520metabolites%2520of%2520carcinogenic%2520o-toluidine%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D372%26spage%3D97%26epage%3D106%26doi%3D10.1006%2Fabbi.1999.1461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chung, K.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkovsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, W. P.</span><span> </span><span class="NLM_article-title">Review of mutagenicity of monocyclic aromatic amines: quantitative structure–activity relationships</span> <span class="citation_source-journal">Mutat. Res., Rev. Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1016/S1383-5742(97)00019-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2FS1383-5742%2897%2900019-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=9254889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADyaK2sXlsFKqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=1997&pages=1-16&author=K.-T.+Chungauthor=L.+Kirkovskyauthor=A.+Kirkovskyauthor=W.+P.+Purcell&title=Review+of+mutagenicity+of+monocyclic+aromatic+amines%3A+quantitative+structure%E2%80%93activity+relationships&doi=10.1016%2FS1383-5742%2897%2900019-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Review of mutagenicity of monocyclic aromatic amines: quantitative structure-activity relationships</span></div><div class="casAuthors">Chung, King-thom; Kirkovsky, Leonid; Kirkovsky, Alexander; Purcell, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Reviews in Mutation Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">MRRRFK</span>;
        ISSN:<span class="NLM_cas:issn">1383-5742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 75 refs.  Monocyclic arom. amines (MAAs) are environmental pollutants.  Many of them are genotoxic and imposed hazards to human health.  The mutagenicity of more than 80 of these amines was reviewed with primary emphasis on evaluation by the Ames Salmonella/microsome testing system.  Many amines are mutagenic in Salmonella tester stains TA98 and TA100, but S9 mix is required for activity for most of the active ones.  2,4-Diaminotoluene, 2,4-diaminoethylbenzene, and a few amines contg. a nitro-group are direct mutagens.  There are several quant. structure-activity relation (QSAR) models which rationalize mutagenicity of many arom. amines and several parameters, such as the LUMO energy (ELUMO), HOMO energy (EHOMO), and hydrophobicity that are important.  What factors det. the min. requirement for the compd. to be mutagenic and what factors det. the extent of mutagenicity suggest questions for further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4zAXaqemHrVg90H21EOLACvtfcHk0liHySiOfwCY4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsFKqt7g%253D&md5=8fb846476d9075c1206a094fd439ceb8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS1383-5742%2897%2900019-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1383-5742%252897%252900019-7%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DK.-T.%26aulast%3DKirkovsky%26aufirst%3DL.%26aulast%3DKirkovsky%26aufirst%3DA.%26aulast%3DPurcell%26aufirst%3DW.%2BP.%26atitle%3DReview%2520of%2520mutagenicity%2520of%2520monocyclic%2520aromatic%2520amines%253A%2520quantitative%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DMutat.%2520Res.%252C%2520Rev.%2520Mutat.%2520Res.%26date%3D1997%26volume%3D387%26spage%3D1%26epage%3D16%26doi%3D10.1016%2FS1383-5742%2897%2900019-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Birch, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, C.</span><span> </span><span class="NLM_article-title">Rationally designing safer anilines: the challenging case of 4-aminobiphenyls</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3933</span><span class="refDoi"> DOI: 10.1021/jm3001295</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3001295" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3923-3933&author=A.+M.+Birchauthor=S.+Groombridgeauthor=R.+Lawauthor=A.+G.+Leachauthor=C.+D.+Meeauthor=C.+Schramm&title=Rationally+designing+safer+anilines%3A+the+challenging+case+of+4-aminobiphenyls&doi=10.1021%2Fjm3001295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally Designing Safer Anilines: The Challenging Case of 4-Aminobiphenyls</span></div><div class="casAuthors">Birch, Alan M.; Groombridge, Sam; Law, Robert; Leach, Andrew G.; Mee, Christine D.; Schramm, Carolin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3923-3933</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe how we have been able to design 4-aminobiphenyls that are nonmutagenic (inactive in the Ames test).  No such 4-aminobiphenyls were known to us, but insights provided by quantum mech. calcns. have permitted us to design and synthesize some examples.  Importantly, the quantum mech. calcns. could be combined with predictions of other properties of the compds. that contained the 4-aminobiphenyls so that these remained druglike.  Having found compds. that are not active, the calcns. can provide insight into which factors (electronic and conformational in this case) are important.  The calcns. provided SAR-like information that was able guide the design of further examples of 4-aminobiphenyls that are not active in the Ames test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgF2W_kOt0ErVg90H21EOLACvtfcHk0lhOackxE1apnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWksL0%253D&md5=40c8c5e5d7ed166cda9c410f5fa1cfab</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm3001295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3001295%26sid%3Dliteratum%253Aachs%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DGroombridge%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DR.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DMee%26aufirst%3DC.%2BD.%26aulast%3DSchramm%26aufirst%3DC.%26atitle%3DRationally%2520designing%2520safer%2520anilines%253A%2520the%2520challenging%2520case%2520of%25204-aminobiphenyls%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3923%26epage%3D3933%26doi%3D10.1021%2Fjm3001295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Ames, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, E.</span><span> </span><span class="NLM_article-title">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1016/0165-1161(75)90046-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2F0165-1161%2875%2990046-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=768755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=347-364&author=B.+N.+Amesauthor=J.+McCannauthor=E.+Yamasaki&title=Methods+for+detecting+carcinogens+and+mutagens+with+the+salmonella%2Fmammalian-microsome+mutagenicity+test&doi=10.1016%2F0165-1161%2875%2990046-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span></div><div class="casAuthors">Ames, Bruce N.; McCann, Joyce; Yamasaki, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-63</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    </div><div class="casAbstract">The general methods for using the Salmonella/microsome test as a mutagenesis screening system are described.  The methods include the std. plate test, the use and storage of bacterial tester strains, prepn. and use of the liver homogenates (S-9), and the methods of inducing rats for elevated microsomal enzyme activity.  The application of this system to screening large nos. of compds. and interpreting the test results are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXRCaWgf4xbbVg90H21EOLACvtfcHk0lhOackxE1apnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D&md5=93881a3b91fc231635ca1086b945fb5d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2875%2990046-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252875%252990046-1%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DMcCann%26aufirst%3DJ.%26aulast%3DYamasaki%26aufirst%3DE.%26atitle%3DMethods%2520for%2520detecting%2520carcinogens%2520and%2520mutagens%2520with%2520the%2520salmonella%252Fmammalian-microsome%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1975%26volume%3D31%26spage%3D347%26epage%3D364%26doi%3D10.1016%2F0165-1161%2875%2990046-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, C.</span><span> </span><span class="NLM_article-title">pH-Metric Solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span><span class="refDoi"> DOI: 10.1023/A:1007526826979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1023%2FA%3A1007526826979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10714613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFCqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2000&pages=85-89&author=A.+Avdeefauthor=C.+M.+Bergerauthor=C.+Brownell&title=pH-Metric+Solubility.+2%3A+Correlation+between+the+acid-base+titration+and+the+saturation+shake-flask+solubility-pH+methods&doi=10.1023%2FA%3A1007526826979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">pH-metric solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods</span></div><div class="casAuthors">Avdeef, Alex; Berger, Cynthia M.; Brownell, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-89</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">The objective of this study was to compare the results of a normal satn. shake-flask method to a new potentiometric acid-base titrn. method for detg. the intrinsic soly. and the soly.-pH profiles of ionizable mols., and to report the soly. consts. detd. by the latter technique.  The soly.-pH profiles of 12 generic drugs with solubilities spanning over six orders of magnitude, were detd. both by the new pH-metric method and by a traditional approach (24 h shaking of satd. solns., followed by filtration, then HPLC assaying with UV detection).  The 212 sep. satn. shake-flask soly. measurements and those derived from 65 potentiometric titrns. agreed well.  The anal. produced the correlation equation: log(1/S)titration=-0.063(±0.032)+ 1.025(±0.011)log(1/S)shake-flask; s=0.20, r2 = 0.978.  The potentiometrically-derived intrinsic solubilities of the drugs were: atenolol 13.5 mg/mL, diclofenac.Na 0.82 μg/mL, famotidine 1.1 mg/mL, flurbiprofen 10.6 μg/mL, furosemide 5.9 μg/mL, hydrochlorothiazide 0.70 mg/mL, ibuprofen 49 μg/mL, ketoprofen 118 μg/mL, labetolol.HCl 128 μg/mL, naproxen 14 μg/mL, phenytoin 19 μg/mL, and propranolol.HCl 70 μg/mL.  The new potentiometric method was shown to be reliable for detg. the soly.-pH profiles of uncharged ionizable drug substances.  Its speed compared to conventional equil. measurements, its sound theor. basis, its ability to generate the full soly.-pH profile from a single titrn., and its dynamic range (currently estd. to be seven orders of magnitude) make the new pH-metric method an attractive addn. to traditional approaches used by preformulation and development scientists.  It may be useful even to discovery scientists in crit. decision situations (such as calibrating computational prediction methods).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrErPM4EuG2xbVg90H21EOLACvtfcHk0lhOackxE1apnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFCqt7w%253D&md5=9c34cbabef890292c5586c7310f07532</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1023%2FA%3A1007526826979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1007526826979%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DC.%2BM.%26aulast%3DBrownell%26aufirst%3DC.%26atitle%3DpH-Metric%2520Solubility.%25202%253A%2520Correlation%2520between%2520the%2520acid-base%2520titration%2520and%2520the%2520saturation%2520shake-flask%2520solubility-pH%2520methods%26jtitle%3DPharm.%2520Res.%26date%3D2000%26volume%3D17%26spage%3D85%26epage%3D89%26doi%3D10.1023%2FA%3A1007526826979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couttet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junker, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laengle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledieu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivière, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trendelenburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, D.</span><span> </span><span class="NLM_article-title">Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span><span class="refDoi"> DOI: 10.1016/j.leukres.2010.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=10.1016%2Fj.leukres.2010.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=20122731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=1180-1188&author=A.+Wolfauthor=P.+Couttetauthor=M.+Dongauthor=O.+Grenetauthor=M.+Heronauthor=U.+Junkerauthor=U.+Laengleauthor=D.+Ledieuauthor=E.+Marrerauthor=A.+Nussherauthor=E.+Persohnauthor=F.+Pognanauthor=G.+J.+Rivi%C3%A8reauthor=D.+R.+Rothauthor=C.+Trendelenburgauthor=J.+Tsaoauthor=D.+Roman&title=Imatinib+does+not+induce+cardiotoxicity+at+clinically+relevant+concentrations+in+preclinical+studies&doi=10.1016%2Fj.leukres.2010.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies</span></div><div class="casAuthors">Wolf, Armin; Couttet, Philippe; Dong, Min; Grenet, Olivier; Heron, Marcia; Junker, Ursula; Laengle, Ulrich; Ledieu, David; Marrer, Estelle; Nussher, Anja; Persohn, Elke; Pognan, Francois; Riviere, Gilles-Jacques; Roth, Daniel Robert; Trendelenburg, Christian; Tsao, Jeffrey; Roman, Danielle</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1180-1188</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cytotoxic concns. of imatinib mesylate (10-50 μM) were required to trigger markers of apoptosis and endoplasmic reticulum stress response in neonatal rat ventricular myocytes and fibroblasts, with no significant differences obsd. between c-Abl silenced and nonsilenced cells.  In mice, oral or i.p. imatinib treatment did not induce cardiovascular pathol. or heart failure.  In rats, high doses of oral imatinib did result in some cardiac hypertrophy.  Multi-organ toxicities may have increased the cardiac workload and contributed to the cardiac hypertrophy obsd. in rats only.  These data suggest that imatinib is not cardiotoxic at clin. relevant concns. (5 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox1CNv7YuPPbVg90H21EOLACvtfcHk0litCq-kNg4XHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wlu7w%253D&md5=f14bba5d30aba43cf4852fdac20f2ae1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2010.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2010.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DCouttet%26aufirst%3DP.%26aulast%3DDong%26aufirst%3DM.%26aulast%3DGrenet%26aufirst%3DO.%26aulast%3DHeron%26aufirst%3DM.%26aulast%3DJunker%26aufirst%3DU.%26aulast%3DLaengle%26aufirst%3DU.%26aulast%3DLedieu%26aufirst%3DD.%26aulast%3DMarrer%26aufirst%3DE.%26aulast%3DNussher%26aufirst%3DA.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DRivi%25C3%25A8re%26aufirst%3DG.%2BJ.%26aulast%3DRoth%26aufirst%3DD.%2BR.%26aulast%3DTrendelenburg%26aufirst%3DC.%26aulast%3DTsao%26aufirst%3DJ.%26aulast%3DRoman%26aufirst%3DD.%26atitle%3DImatinib%2520does%2520not%2520induce%2520cardiotoxicity%2520at%2520clinically%2520relevant%2520concentrations%2520in%2520preclinical%2520studies%26jtitle%3DLeuk.%2520Res.%26date%3D2010%26volume%3D34%26spage%3D1180%26epage%3D1188%26doi%3D10.1016%2Fj.leukres.2010.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01371">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01104"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01371">10.1021/acs.jmedchem.7b01371</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis procedures and characterization data for all compounds, HPLC and NMR charts and X-ray crystallographic data for compound <b>40</b> (CCDC 1574028) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_001.pdf">jm7b01371_si_001.pdf (1.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01371/suppl_file/jm7b01371_si_002.csv">jm7b01371_si_002.csv (1.48 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01371&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01371%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-3%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01371" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998f1c0c632440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
